Washington University in St. Louis

Washington University Open Scholarship
All Theses and Dissertations (ETDs)
5-24-2011

Analysis of Zinc Transporters in C. elegans
Hyun Cheol Roh
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/etd

Recommended Citation
Roh, Hyun Cheol, "Analysis of Zinc Transporters in C. elegans" (2011). All Theses and Dissertations
(ETDs). 875.
https://openscholarship.wustl.edu/etd/875

This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has
been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington
University Open Scholarship. For more information, please contact digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY
Division of Biology and Biomedical Sciences
Program in Molecular Cell Biology

Dissertation Examination Committee:
S. Kerry Kornfeld, Chair
Peter T. Chivers
Stuart A. Kornfeld
Jason C. Mills
Jeanne M. Nerbonne
Tim B. Scheldl

ANALYSIS OF ZINC TRANSPORTERS IN C. ELEGANS
by
Hyun Cheol Roh

A dissertation presented to the
Graduate School of Arts and Sciences
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

August 2011
Saint Louis, Missouri

ABSTRACT OF THE DISSERTATION
Analysis of Zinc Transporters in C. elegans
By
Hyun Cheol Roh
Doctor of Philosophy in Biology and Biomedical Sciences
(Molecular Cell Biology)
Washington University in Saint Louis, 2011
Professor S. Kerry Kornfeld, Chairperson

Zinc is a trace element essential for organisms, and organisms have homeostatic
mechanisms to control zinc metabolism. Zinc metabolism is mediated by numerous
proteins including zinc transporters, zinc-responsive transcription factors and zincbinding proteins. Of these proteins, zinc transporters, composed of CDF and ZIP families,
play a major role and are implicated in a variety of human diseases. However, the
mechanisms by which zinc transporters coordinate to regulate zinc homeostasis in whole
animals and by which they are related to human diseases are not well understood.
To address these questions, we used C. elegans as a model system. While three C.
elegans cdf genes have been characterized previously, the majority of zinc transporters
remain to be studied. Here, we characterized cdf-2 and ttm-1 and conducted initial
studies of other zinc transporters. We demonstrated that lysosome-related organelles in
intestinal cells, termed gut granules, function as a major site of zinc storage. Gut granules
were important for detoxification of excess zinc as well as mobilization of zinc in
response to low-zinc environments, and CDF-2 was necessary for these processes. In
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high zinc conditions, gut granules displayed morphological changes characterized by a
bilobed morphology with asymmetric distributions of molecules. These findings suggest
novel mechanisms of zinc storage, detoxification and mobilization in C. elegans.
ttm-1 encodes two isoforms, ttm-1a and ttm-1b, by using different transcription
start sites. TTM-1 plays a role in the excretion of zinc and is involved in zinc
detoxification via the action of TTM-1B which localizes to the apical membrane of
intestinal cells. These functions of TTM-1 are critical specifically in the absence of CDF2, suggesting that TTM-1coordinates with CDF-2 to regulate zinc homeostasis of whole
animals. Studies of other zinc transporters including expression pattern analysis
suggested novel functions of zinc transporters in biological processes. These results
suggest that further studies of C. elegans zinc transporters may contribute to
understanding of sophisticated networks of zinc transporters in zinc metabolism and
elucidate physiological functions of zinc transporters.
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CHAPTER 1

Introduction:
Overview of Zinc Metabolism

1

Metal ions are trace elements essential for all living organisms. Among the many
metal ions present in biological systems, zinc is the most widely used and is involved a
broad range of biological processes (Vallee and Falchuk, 1993). Zinc plays an important
role in the function of numerous proteins by acting as a catalytic and/or structural
cofactor. Zinc is required for more than 300 metalloproteins in all six major enzyme
classes, and it is a critical structural component of thousands of proteins including zincfinger transcription factors (Vallee and Falchuk, 1993). In humans, it has been estimated
that about 10% of the proteome are zinc-binding proteins (Andreini et al., 2006).
Furthermore, zinc functions in signal transduction during development,
neurotransmission and immune responses by acting as a signaling molecule (Murakami
and Hirano, 2008).
The wide use of zinc in biological system is likely to be attributed to its unique
chemical properties. First, zinc is a nontransition metal which lacks redox activity in
contrast to other biological metals such as iron and copper (Berg and Shi, 1996). This
property renders zinc stable and less damaging in physiological conditions where the
redox state fluctuates. Second, zinc has high coordination flexibility; it can accommodate
multiple coordination geometries ranging from two to eight coordinate complexes
(Vallee and Falchuk, 1993). This property enables zinc to make complexes with varying
ligand types in a broad range of proteins.
The biological significance of zinc is illustrated by the broad range of defects
resulting from zinc deficiency. Zinc deficiency results in defects in cell growth and
proliferation in all organisms (Beyersmann and Haase, 2001). In humans, zinc deficiency
leads to functional impairment of multiple tissues including of epidermal, gastrointestinal,
2

skeletal, reproductive, nervous, and immune systems (Hambidge, 2000). In addition to
zinc deficiency, excess zinc is toxic (Fosmire, 1990). Although the mechanism of zinc
toxicity is not understood, it is thought that excess zinc may interfere with the function of
other metal ions by competing for their protein binding sites. Therefore, organisms have
evolved precise homeostatic mechanisms for the regulation of zinc levels and
distribution at cellular and organismal levels. Over the past several decades, extensive
studies of zinc metabolism have identified many proteins that are involved in zinc
homeostasis including zinc transporters, zinc-responsive transcription factors and zincbinding proteins. Many of the genes have been implicated in human diseases. However,
the mechanism by which the zinc metabolism-related genes contribute to zinc
homeostasis of an individual, how multiple proteins interact to achieve zinc homeostasis,
and how zinc metabolism is related to human disease are not well understood.

ZINC METABOLISM IN THE YEAST, S. CEREVISIAE
Studies with the yeast, S. cerevisiae, have made significant contributions to the
molecular characterization of genes and proteins that mediate zinc metabolism (Eide,
2006). These studies have uncovered zinc transporters and zinc-responsive transcription
factors as important players in cellular zinc homeostasis. Zinc transporters are integral
membrane proteins that mediate the movement of zinc ions across membranes. There are
six families of zinc transporters from bacteria to mammals (Hantke, 2001). Three of
these families function only in prokaryotes, and they will not be discussed here. In
eukaryotes, two families of zinc transporters, CDF (cation diffusion facilitator) and ZIP
(Zrt-, Irt-like Protein) proteins, are well conserved in bacteria, fungi, plants and
3

mammals (Gaither and Eide, 2001a). CDF proteins decrease cytoplasmic zinc levels by
transporting zinc to the outside of the cell or into intracellular organelles(Eide, 2006).
Most CDF proteins have six transmembrane (TM) domains and a histidine-rich motif in
the loop between TM 4 and 5, which is predicted to be important for zinc binding or zinc
transport. Many CDF proteins have been reported to make homo- or heterocomplexes.
Regarding their mechanism of transport activity, CDF proteins appear to be secondary
active transporters which move zinc using another ion gradient such as H+ and K+. For
example, the yeast CDF protein Zrc1 is a Zn/H+ antiporter (MacDiarmid et al., 2002). In
contrast to CDF proteins, ZIP proteins increase cytoplasmic zinc levels through uptake of
zinc from the extracellular space and transporting zinc out of intracellular organelles .
ZIP proteins have eight TM domains and a histidine-rich motif in the loop between TM 3
and 4 similar to CDF proteins (Eide, 2006).
Zinc transporters regulate the flow of zinc across the plasma membrane, which is
the first step for the control of cellular zinc homeostasis. The yeast ZIP proteins, Zrt1 and
Zrt2, are localized on the plasma membrane and mediate the uptake of zinc into the cell
(Eide, 2006). While Zrt1 has a high affinity for zinc and is required for growth in low
zinc conditions (Zhao and Eide, 1996a), Zrt2 has a lower affinity for zinc and functions
during mild zinc deficiency (Zhao and Eide, 1996b). Since yeast CDF proteins on the
plasma membrane which mediate efflux of zinc have not been identified, the expression
levels of Zrt1 and Zrt2 proteins affect the uptake rate of zinc and thus regulate overall
cellular zinc levels. Once taken up into the cytoplasm, zinc is rapidly transported into
intracellular organelles by zinc transporters because free zinc is toxic. Zinc transporters
on the membranes of intracellular organelles regulate the level of zinc in the organelles
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and contribute to the control of intracellular zinc distribution. For instance, Msc2/Zrg17
CDF-heteromeric complex mediates the transport of zinc into the lumen of the ER and
Golgi complex (Ellis et al., 2005; Li and Kaplan, 2001), which is thought to be important
for the supply of zinc to zinc-dependent proteins synthesized in the organelles. The CDF
proteins Zrc1 and Cot1, and ZIP protein Zrt3 regulate the zinc level in the vacuolar
lumen (MacDiarmid et al., 2000), which functions as an important site for zinc storage
and detoxification. In high zinc conditions, Zrc1 and Cot1 move excess zinc into the
vacuole to protect the cell from zinc toxicity. In response to low zinc conditions, Zrt3
mobilizes zinc from the vacuole to meet the cellular zinc requirements.
Another major mechanism to maintain zinc homeostasis in response to
fluctuating levels of zinc in the environment is transcriptional regulation of the
expression of zinc-metabolism-related genes. The yeast Zap1 zinc-responsive
transcription factor senses cellular zinc levels through its zinc-finger domain and controls
target gene expression by binding to a specific DNA sequence called zinc-responsive
element (ZRE) (Zhao and Eide, 1997). When zinc is limiting, Zap1 is activated and
induces the expression of Zrt1 and Zrt2 to promote zinc uptake from the environment
and Zrt3 to mobilize zinc from the vacuole. Conversely, excess zinc causes the
downregulation of Zrt1 expression to decrease zinc influx and the induction of Zrc1 and
Cot1 to sequester excess zinc in the vacuole. Thus, cellular zinc metabolism is a
sophisticated process that involves the networks of zinc-responsive transcription factors
and zinc transporters from multiple intracellular localizations.

ZINC METABOLISM IN ANIMALS
5

The mechanisms underlying zinc metabolism in yeast are well conserved in
higher organisms. However, zinc metabolism in animals is more complicated because it
involves many processes in multiple tissues: the absorption and secretion of zinc by the
gastrointestinal tract, the excretion of zinc into urine by the kidneys, and the distribution
and exchange of zinc between tissues (Krebs, 2000). In addition, a large number of
proteins are involved in zinc metabolism in animals and they fall into three major
classes; zinc-binding proteins, zinc-responsive transcription factors and zinc transporters.
A number of studies have characterized these zinc metabolism-related proteins.
In animals, metallothioneins (MTs) are zinc-binding proteins that have been
widely studied and implicated in zinc metabolism. MTs are small intracellular cysteinerich proteins that bind metal ions including zinc and cadmium (Coyle et al., 2002). In
mice, there are four MT genes. MT-1 and MT-2 are ubiquitously expressed, while MT-3
is mainly expressed in the brain, and MT-4 is found in squamous epithelia and the
maternal decidua. Although many studies have suggested that MTs function in the
response to a variety of chemical and physical insults, the function of MTs has yet to be
clearly defined. One of the most feasible functions of MTs is their protective role against
metal toxicity. Mice lacking MT-1 and MT-2 displayed relatively normal development
and growth, but they were susceptible to metal toxicity. On the other hand, transgenic
mice overexpressing MTs displayed higher zinc accumulation and protection against
excess zinc and cadmium (Coyle et al., 2002; Klaassen and Liu, 1998). However, the
precise function of MTs in zinc homeostasis remains still elusive.
Metal-responsive element-binding transcription factor-1 (MTF-1) is a zincresponsive transcription factor (Radtke et al., 1993). Similar to yeast Zap1, MTF-1 is a
6

zinc-finger transcription factor, and its zinc finger domains are critical for sensing
cellular zinc levels. When zinc is abundant, MTF-1 is activated, translocates to the
nucleus, binds a metal-responsive element (MRE) in the promoter of its target genes and
induces expression (Smirnova et al., 2000). The targets of MTF-1 include many zinc
metabolism-related genes such as MTs and zinc transporters, suggesting it plays an
important role in zinc metabolism. Homozygous deletion of MTF-1 in mice results in
embryonic lethality due to degeneration of hepatocytes, suggesting that MTF-1 is
essential for liver development (Gunes et al., 1998).
In mammals, there are 10 members in the CDF (also called ZnT or SLC30)
family and 14 members in the ZIP (also called SLC39) family (Lichten and Cousins,
2009). Extensive studies using mammalian cell lines and mouse models have been
characterized each member of the zinc transporter families. ZnT-1, which is the first zinc
transporter identified in mammals, displays ubiquitous tissue expressions and is localized
to the plasma membrane (Liuzzi et al., 2001; Palmiter and Findley, 1995). ZnT-1
expression is regulated by dietary zinc levels via MTF-1 (Langmade et al., 2000). As
ZnT-1 is highly expressed in the intestine and localized to basolateral membrane of
enterocytes, it is thought to function in the transport of zinc from enterocytes into the
bloodstream (McMahon and Cousins, 1998). ZnT-1 deficient mice display early
embryonic lethality suggesting an essential role in embryonic development. ZnT-2 is
expressed in the small intestine, liver, kidney and mammary gland, and its expression is
upregulated by MTF-1 in response to high levels of zinc in the diet (Lichten and Cousins,
2009; Liuzzi et al., 2001). In contrast to ZnT-1, ZnT-2 is localized to the membrane of
intracellular vesicles (Palmiter et al., 1996a). ZnT-2 is involved in the transport of zinc
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into milk in the mammary gland, and a mutation in human ZnT-2 causes the production
of zinc deficient milk (Chowanadisai et al., 2006). ZnT-3 is expressed in the brain,
especially in the hippocampus and is required for the transport of zinc into synaptic
vesicles (Cole et al., 1999; Palmiter et al., 1996b). Synaptic zinc is not required for
normal brain function, as demonstrated by the ZnT-3 knockout mouse, but ZnT-3 is
likely to be involved in age-related learning and memory (Adlard et al., 2010; Sindreu et
al., 2011). ZnT-4 was identified by the search for a gene that causes lethal milk (lm)
syndrome (Huang and Gitschier, 1997). While ZnT-4 localizes to intracellular vesicles
and is involved in transporting zinc into milk in the mammary gland similar to ZnT-2, its
expression is independent of dietary zinc levels (Lichten and Cousins, 2009). ZnT-5 is
ubiquitously expressed but abundant in pancreatic β-cells (Kambe et al., 2002), and it
functions in the transport of zinc into secretory vesicles in heterooligomeric complexes
with ZnT-6 (Ellis et al., 2005). ZnT-5 knockout mice display growth defects, abnormal
bone development and male-specific cardiac arrhythmias, suggesting that ZnT-5 has
important roles in growth and development (Jackson et al., 2007). ZnT-7 is expressed
mainly in the lung and small intestine and localized to the Golgi apparatus (Kirschke and
Huang, 2003). ZnT-7 knockout mice displayed zinc deficiency, poor growth and reduced
fat content (Huang et al., 2007), suggesting ZnT-7 may function in fat metabolism in
addition to growth control. ZnT-8 is highly expressed in pancreatic β-cells and localized
to the membrane of insulin granules where zinc forms a complex with insulin (Chimienti
et al., 2004). Recent studies using mouse models and human genomic analyses suggest
that ZnT-8 is involved in pancreatic β-cell function and is implicated in the development
of diabetes (Rutter, 2010). ZnT-9 and ZnT-10 have been identified but not yet
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functionally characterized.
Mammalian ZIP proteins were identified based on the homology with ZIP
proteins from the yeast and plants. ZIP-1 is expressed a wide range of human tissues and
involved in zinc uptake (Gaither and Eide, 2001b). ZIP-1 is located on the plasma
membrane or in intracellular vesicles depending on the type of cell (Lichten and Cousins,
2009), and its localization is regulated by levels of zinc (Wang et al., 2004). Similar to
ZIP-1, ZIP-2 and ZIP-3 promote zinc uptake in cells, but their tissue distribution is
limited compared to ZIP-1 (Dufner-Beattie et al., 2003). Homozygous deletion of ZIP-1,
ZIP-2, or ZIP-3 in mice resulted in normal development and viability but increased
embryonic lethality when zinc is limited (Dufner-Beattie et al., 2006; Peters et al., 2007).
Even triple knockout of ZIP-1, 2 and 3 resulted in no phenotype while mice were fed a
normal zinc diet and they exhibited hypersensitivity to zinc deficiency (Kambe et al.,
2008). ZIP-4 is the best characterized protein in the ZIP family because mutations in
ZIP-4 gene cause the genetic disorder acrodermatitis enteropathica which is
characterized by zinc deficiency (Kury et al., 2002; Wang et al., 2002). ZIP-4 is highly
expressed in tissues mediating zinc absorption including the intestine. Acting on the
apical membrane of enterocytes, ZIP-4 mediates the uptake of zinc from the intestinal
lumen (Wang et al., 2002). ZIP-4 expression is regulated by zinc levels—ZIP-4
expression is induced by zinc deficiency, zinc excess downregulates ZIP-4 expression.
Regulation of ZIP-4 expression occurs at multiple levels including transcription, mRNA
stability, protein localization and stability (Lichten and Cousins, 2009). ZIP-5 displays
similar tissue distribution as ZIP-4, but it is localized to the basolateral membrane of the
cells (Dufner-Beattie et al., 2004), suggesting that ZIP-5 may function in the removal of
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zinc from the blood antagonistically to ZIP-4. ZIP-6 was identified as a novel gene
whose expression is regulated by estrogen in breast cancer cells (Manning et al., 1988).
ZIP-6 has a role in the epithelial-mesenchymal transition and the immune response in
dendritic cells (Kitamura et al., 2006; Yamashita et al., 2004). ZIP-7 is ubiquitously
expressed and localized to the Golgi apparatus in cells, and it is implicated in breast
cancer progression (Taylor et al., 2007; Taylor et al., 2008). ZIP-8 is detected in a wide
range of tissues including lung, kidney, liver, brain and intestine, and it is functionally
involved in immune activation in human monocytes (Begum et al., 2002). ZIP-10 was
the first ZIP protein found to be regulated by MTF-1. While other MTF-1-regulated
genes such as ZnT-1 are activated by MTF-1, ZIP-10 expression is suppressed by MTF-1
(Wimmer et al., 2005). ZIP-13 has been implicated in the development of connective
tissues, bone and teeth (Fukada et al., 2008), and ZIP-14 is involved in the response to
inflammation (Liuzzi et al., 2005). Although many zinc metabolism-related genes in
animals have been characterized as described above, understanding of the molecular
mechanisms of their actions and their networks for zinc homeostasis control is still
limited.

ZINC METABOLISM IN HUMAN HEALTH AND DISEASE
Zinc metabolism is closely associated with human health and a variety of human
diseases. First, as zinc is an essential micronutrient, failure to take adequate amounts of
zinc from the diet leads to zinc deficiency which is a significant problem in
underdeveloped countries (Hambidge and Krebs, 2007). Zinc deficiency can also be
caused by inherited genetic mutations. The autosomal recessive disease acrodermatitis
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enteropathica was identified by the symptoms of zinc deficiency in infants (Moynahan,
1974). Patients with the disease have a loss-of-function mutation in ZIP-4, which plays a
major role in the uptake of zinc from the diet in the intestine (Kury et al., 2002; Wang et
al., 2002). Since the mutations in ZIP-4 result in inefficient uptake of zinc, oral zinc
supplementation has been a successful treatment to the patient. Studies of infants with
the symptoms of zinc deficiency have identified loss-of-function mutations in another
zinc transporter, ZnT-2 (Chowanadisai et al., 2006). ZnT-2 is highly expressed in the
mammary gland and functions in the supply of zinc into secretory vesicles. Mutations in
ZnT-2 lead to generation of low zinc breast milk and subsequently cause zinc deficiency
in breastfed infants.
Abnormal zinc metabolism is implicated in several types of cancers. Studies of
prostate cancer demonstrated that there is an association between cellular zinc levels and
cell proliferation (Costello and Franklin, 2006). While normal prostate cells have higher
levels of zinc compared to other cell types, prostate cancer cells display significantly
reduced zinc levels. Treatment with supplemental zinc was shown to suppress cell
proliferation in prostate cancer cell lines (Liang et al., 1999), suggesting that high levels
of zinc may have inhibitory effects on cell growth and cancer progression. Zinc
metabolism is also implicated inbreast cancer progression. In contrast to prostate cancer
cells which accumulate less zinc, breast cancer cells display higher levels of zinc
compared to normal cells (Geraki et al., 2002). Studies with breast tissue biopsies
indicated that there is a correlation between the levels of zinc and the onset of breast
cancer (Cui et al., 2007b). Molecular studies have demonstrated that ZIP-6 and/or ZIP-7
are associated with breast cancer; Increased ZIP-6 expression is one of the markers of
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estrogen-receptor positive cancer (Schneider et al., 2006), and ZIP-7 is required for
increasing cellular zinc levels in breast cancer cell lines (Taylor et al., 2008).
Neurodegenerative diseases are associated with imbalance in zinc metabolism.
The brain contains a large amount of zinc, and zinc is concentrated in the presynaptic
vesicles in glutamatergic neurons (Frederickson et al., 2005). Upon excitation, zinc is
released from the neurons along with neurotransmitters, like glutamate, into the synapse
and then rapidly taken up by cells. During this process, zinc interacts with various ion
channels and transporters and thereby regulates synaptic activity and plasticity. However,
excessive release of zinc from synaptic vesicles is toxic and is involved in neuronal and
glial cell death. For instance, zinc released from dying cells during seizures or ischemia
contributes to cell death and thereby brain damage (Frederickson et al., 2004). Excess
zinc is also associated with the pathogenesis of Alzheimer’s disease. Zinc promotes the
aggregation of amyloid β-peptide, and zinc chelation inhibits the formation of amyloid βplaques in Alzheimer’s disease mouse models (Frederickson et al., 2005)
Diabetes is another disease related to zinc metabolism. The pancreas plays a
critical role in glucose homeostasis and contains high levels of zinc. Zinc is concentrated
in insulin-granules of pancreatic β-cells where zinc forms stable complexes with insulin.
Although the function of zinc stored in insulin granules is not well defined, zinc status
may be linked to the progression of diabetes. Type 1 diabetes patients display lower
serum zinc levels compared to the healthy individuals (Terres-Martos et al., 1998). Zinc
deficiency appears to contribute to pancreatic β-cell function failure (Chausmer, 1998),
while dietary supplemental zinc has a protective effect in diabetic mouse models (Ho et
al., 2001).. ZnT-8 has been implicated in the pathology of both of type 1 and 2 diabetes.
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ZnT-8 is as a major autoantigen in 60~80% of new onset of type 1 diabetes (Wenzlau et
al., 2007). Recent genome-wide association studies identified genetic variations in ZnT-8
that are significantly associated with type 2 diabetes (Sladek et al., 2007). Although the
mechanisms by which the genetic variations affect pancreatic β-cell function are
unknown, ZnT-8 knockout mice recently have been generated and exhibited glucose
intolerance in response to a high fat diet (Lemaire et al., 2009), suggesting that ZnT-8
may play a critical role in pancreatic β-cell function during stress conditions such as
obesity.
Recently, Ehlers-Danlos syndrome (EDS) type IV has been associated with
abnormal zinc metabolism. EDS is characterized by progressive kyphoscoliosis,
hypermobility of joints, hyperelasticity of skin and severe hypotonia of skeletal muscles,
caused by abnormal connective tissue development (Beighton et al., 1998). Analysis of
the genomes of EDS patients identified loss-of-function mutations in ZIP-13 (Giunta et
al., 2008). ZIP-13 knockout mice displayed phenotypes that are similar to the symptoms
observed in EDS patients such as defects in the maturation of osteoblasts, chondrocytes,
odontoblasts and fibroblasts (Fukada et al., 2008), suggesting that zinc metabolism is
involved in bone and connective tissue development. Despite the implication of zinc
metabolism in these various diseases, the molecular mechanisms by which zinc
metabolism affect the diseases are not well understood and remain to be addressed as one
of the most important topics in zinc pathophysiology.

ZINC METABOLISM IN C. ELEGANS
The nematode C. elegans is an important model system that has been used to
13

elucidate fundamental, evolutionarily conserved biological processes, such as apoptosis
and RNA interference (Fire et al., 1998; Sulston and Horvitz, 1977), and to develop
innovative experimental techniques, such as in vivo expression of green fluorescent
protein (GFP) (Chalfie et al., 1994). C. elegans has been a relevant model organism for
the study of metal biology, including iron and heme metabolism, and metal toxicity
(Gourley et al., 2003; Liao and Freedman, 1998; Rajagopal et al., 2008).
Mechanisms of zinc metabolism are well conserved between C. elegans and
other species. Analysis of the C. elegans genome revealed that C. elegans has 2
metallothionein genes (mtl-1 and mtl-2), 14 putative cdf genes and 14 zip genes (Kambe
et al., 2006). Intriguingly, there is no protein identified that has sequence similarity to the
known zinc-responsive transcription factors, the yeast Zap1 or mammalian MTF-1,
suggesting that C. elegans may have unique gene expression regulatory mechanisms for
zinc metabolism. C. elegans has several advantages to study zinc metabolism compared
to other model organisms such as the yeast and mouse. While it is a multicellular animal
that is complex enough to study the networks of zinc metabolism in the whole animal, it
has a simpler anatomy than mammals which facilitates the analysis of the system. C.
elegans is genetically tractable, allowing forward genetics, reverse genetics and the
analysis of genetic interactions among multiple genes. Furthermore, culture methods that
permit precise control over dietary zinc have been established (Bruinsma et al., 2008;
Davis et al., 2009; Szewczyk et al., 2003).
C. elegans has provided novel insights into zinc metabolism. The C. elegans cdf
genes cdf-1 and sur-7 were identified in a forward genetic screen for suppressors of Rasmediated signaling during vulva development (Bruinsma et al., 2002; Yoder et al., 2004).
14

These studies demonstrated not only the functional role of CDF-1 and SUR-7 in the
control of zinc metabolism of the animal but also the novel biological function of zinc
ions as signaling molecules that modulate developmental processes. Studies using
forward genetic screens also identified multiple mutations that confer resistance to zinc
toxicity and subsequently characterized a novel gene that mediates zinc resistance, haly-1
(Bruinsma et al., 2008; Murphy et al., 2011). These studies revealed a novel mechanism
of zinc metabolism in which histidine can act as a zinc buffering system to control zinc
toxicity. We recently developed various analytic methods to measure zinc metabolism,
such as maturation rate, population growth rate and total zinc content, and we applied
these methods to identify and characterize another cdf gene, cdf-2 (Davis et al., 2009).

ANALYSIS OF ZINC TRANSPOTERS IN C. ELEGANS
The analysis of C. elegans zinc transporters is important to understand the
function of these proteins in zinc metabolism and other biological processes.
Furthermore, the discoveries made by the analysis of C. elegans zinc transporters will
contribute to the understanding of the complicated processes of zinc metabolism and how
they are related to human disease.
In this study, I describe the function of zinc transporters in the regulation of zinc
metabolism in C. elegans and their roles in other biological processes. In Chapter 2, I
demonstrate that zinc is stored in lysosome-related organelles called gut granules in C.
elegans intestinal cells . Labile zinc was stored in gut granules by the action of the CDF2 zinc transporter, and zinc storage was important for zinc detoxification and
mobilization in response to fluctuating levels of zinc. Gut granules displayed novel
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morphological changes, the formation of asymmetric bilobed vesicles, in response to
high levels of zinc. These results suggest that zinc is stored in C. elegans gut granules by
active mechanisms that involve zinc transporters and vesicular transformation.
In Chapter 3, I describe the function of a novel cdf gene, ttm-1 (toxin-regulated
target of p38MAPK). ttm-1 encodes two isoforms, ttm-1a and ttm-1b, by using different
transcription start sites. Genetic analysis demonstrated that TTM-1 is important for zinc
excretion and involved in zinc detoxification, and TTM-1B plays a key role in these
processes by acting on the apical membrane of intestinal cells. TTM-1 interacts with
CDF-2 in regulating zinc metabolism. These studies suggest that TTM-1 is another
important player in the zinc metabolism of C. elegans.
In Chapter 4, I discuss the implication of these studies and the future studies to
further extend our knowledge of zinc metabolism.
In Appendix A, we report new methods to monitor zinc metabolism in C.
elegans and the initial studies of cdf-2. CDF-2 was expressed in the intestine and
localized to the membrane of intracellular vesicles, and a loss-of-function mutation in
cdf-2 caused reduced total zinc content. These findings led to the hypothesis that CDF-2
plays a role in zinc storage in C. elegans. In Appendix B, I describe the initial analyses of
uncharacterized C. elegans zinc transporters with the focus on ZIP family proteins.
Expression pattern studies identified the tissue distributions and intracellular localization
of many ZIP proteins. Genetic analysis using loss-of-function mutations suggested
several zinc transporters are involved in specific biological processes.
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CHAPTER 2

Lysosome-Related Organelles in Intestinal Cells
Function as a Zinc Storage Site in C. elegans

[The work in Chapter 2 will be published with the following citation: Hyun Cheol Roh,
Sara Collier, James Guthrie, J. David Robertson, and Kerry Kornfeld. Lysosome-Related
Organelles in Intestinal Cells Function as a Zinc Storage Site in C. elegans.
H.C.R designed and performed all experiments and analyses except: S.C. provided
assistance in generating transgenic strains, and J.G. and J.D.R. performed the ICP-MS
(Figure 2.2B and Supplemental Figure 2.3). H.C.R and K.K wrote the manuscript.]
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ABSTRACT

Zinc is an essential trace element involved in many biological processes and
human diseases. Animals require homeostatic mechanisms to store and mobilize zinc in
response to dietary fluctuations, but these mechanisms are not well defined. Here we
demonstrate that lysosome-related organelles called gut granules present in intestinal
cells of C. elegans function as the major site of zinc storage. Zinc storage in gut granules
promotes detoxification and subsequent mobilization, since mutant animals lacking gut
granules were defective in both processes. The cation diffusion facilitator protein CDF-2
plays a critical role in this process by transporting zinc into gut granules. In response to
high dietary zinc, gut granules displayed structural changes characterized by a bilobed
morphology with asymmetric distributions of molecular markers. Glo genes were
required for this structural change of gut granules. These findings elucidate novel
mechanisms of zinc storage, detoxification and mobilization in C. elegans and may be
relevant to other animals.
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INTRODUCTION

Zinc is a trace nutrient that is essential for all life. Zinc has roles in many
biological processes; protein-bound zinc contributes to enzymatic activity and protein
structure, and labile zinc functions in signal transduction (Murakami and Hirano, 2008;
Vallee and Falchuk, 1993). Zinc is important for human health, since zinc deficiency
causes a broad range of defects in multiple organ systems including skin, immune,
skeletal and reproductive (Hambidge, 2000). Zinc deficiency caused by inadequate
dietary intake is a major world-wide problem. Zinc deficiency is also associated with
genetic diseases caused by mutations of zinc transporters, such as acrodermatitis
enteropathica. Excess zinc is also deleterious, since it may displace other trace metals or
bind low affinity sites, leading to protein dysfunction (Fosmire, 1990). Therefore,
organisms require mechanisms for zinc metabolism and homeostasis to control the levels
and distribution of this essential metal.
Zinc metabolism in animals involves many processes: the absorption and
secretion of zinc by gastrointestinal tracts, the excretion of zinc into urine by kidney, and
the distribution and exchange of zinc between tissues (Cummings and Kovacic, 2009;
Krebs, 2000). Within cells, zinc is partitioned between the cytosol and the lumen of
intracellular organelles, and it can be labile or protein bound. Two families of zinc
transporters play critical roles in eukaryotic organisms: cation diffusion facilitator
(CDF/SLC30) and Zrt-, Irt-like protein (ZIP/SLC39) (Cragg et al., 2005; Eide, 2006;
Feeney et al., 2005). CDF proteins decrease cytoplasmic levels by transporting zinc
across the plasma membrane or into intracellular organelles, whereas ZIP proteins
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increase cytoplasmic levels by transporting zinc in the opposite direction. Mammals
contain 10 CDF and 14 ZIP proteins that have specific tissue distributions and
intracellular localizations (Lichten and Cousins, 2009). Thus, a network of zinc
transporters is likely to regulate zinc metabolism in animals.
Organisms have evolved to deal with variable nutrient availabilities by having
mechanisms to regulate uptake and excretion. Furthermore, when nutrients are replete,
excess nutrients are stored so that they can be mobilized under nutrient deficient
conditions. In natural environments, the availability of metal is variable, so it is likely
that organisms have mechanisms for metal storage and mobilization. For example, iron is
essential in mammals for erythropoietic function and oxidative metabolism, and iron is
stored in the liver in the forms of ferritin or hemosiderin (Munoz et al., 2009).
Mechanisms of zinc storage have been characterized in the yeast Saccharomyces
cerevisiae. When zinc is abundant, the CDF proteins Cot1 and Zrc1 transport zinc into
the vacuole, which functions to store excess zinc and protect from zinc toxicity. When
yeast are challenged with zinc deficient conditions, the ZIP protein Zrt3 mobilizes stored
zinc by transporting it out of the vacuole (Eide, 2006).
In mammals, it has been demonstrated that high levels of zinc are detected in
several tissues and intracellular organelles. Synaptic vesicles in neuronal cells (Palmiter
et al., 1996b), insulin granules in pancreatic β-cells (Chimienti et al., 2004) and secretory
vesicles in mammary cells display high levels of zinc (Kelleher and Lonnerdal, 2003).
Studies using zinc-specific fluorescent dyes have demonstrated that zinc is detected in
punctate vesicles in a variety of cell types, which are putatively termed as zincosomes
and may be endosomal or lysosomal compartments (Eide, 2006). However, the role of
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these zinc-containing organelles in zinc storage and mobilization in response to
fluctuating dietary zinc at organism levels has not been well characterized.
The nematode C. elegans has been a relevant model organism for the study of
metal biology, including iron and heme metabolism, metal toxicity, and zinc signaling
(Bruinsma et al., 2002; Gourley et al., 2003; Liao and Freedman, 1998; Rajagopal et al.,
2008; Vatamaniuk et al., 2001; Yoder et al., 2004). We are using C. elegans to study zinc
metabolism, because this animal has conserved mechanisms of zinc metabolism,
powerful genetics and culture system (Bruinsma et al., 2002; Bruinsma et al., 2008;
Davis et al., 2009). We demonstrated that C. elegans exposed to a high zinc diet
accumulate substantial amounts of zinc, indicating that these animals store excess zinc.
(Davis et al., 2009). In this study, we sought to identify the site of zinc storage by
developing methods to visualize zinc in C. elegans using a zinc-specific fluorescent dye,
FluoZin-3. Labile zinc was detected in gut granules in intestinal cells. Gut granules have
been classified as lysosome-related organelles based on the presence of lysosomal
proteins and staining with lysosome-specific fluorescent dyes such as LysoTracker
(Clokey and Jacobson, 1986; Hermann et al., 2005; Kostich et al., 2000). To assess the
function of gut granules, we analyzed gut-granule-loss (Glo) mutant animals. These
animals displayed zinc storage defects and zinc hypersensitivity, indicating that gut
granules are critical for zinc storage and detoxification. The cation diffusion facilitator
protein CDF-2 plays a critical role in the mechanism of zinc storage. CDF-2 localized to
the membrane of gut granules, and cdf-2 loss-of-function mutant animals were defective
in zinc storage and hypersensitive to high levels of dietary zinc. We demonstrated that
zinc stored in gut granules can be mobilized in zinc deficient conditions. Finally, we
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characterized a novel morphology of gut granules, asymmetric bilobed vesicles, in
response to high dietary zinc, and glo genes are necessary for the morphological change.
These findings identify the site of zinc storage in an animal and demonstrate a key role
for a CDF protein during zinc storage.

RESULTS

Gut Granules Contain Labile Zinc
By using inductively coupled plasma-mass spectrometry (ICP-MS) to measure
total zinc content in worm extracts, we previously demonstrated that culturing C. elegans
with high dietary zinc results in elevated levels of total zinc, suggesting that excess zinc
is stored (Davis et al., 2009). To elucidate the spatial distribution of zinc and identify the
site of zinc storage, we used zinc-specific fluorescent dyes to visualize zinc. We
conducted pilot studies with several dyes and selected FluoZin-3 based on its high zincsensitivity and specificity (Gee et al., 2002). Hermaphrodites were cultured on noble agar
minimal medium (NAMM) dishes (Bruinsma et al., 2008) containing FluoZin-3, and live
animals were analyzed by fluorescence microscopy. Wild-type animals cultured without
supplemental zinc displayed green fluorescence in vesicles in the intestinal cells (Figure
2.1A). To test if the FluoZin-3 fluorescence is due to zinc binding, we manipulated
dietary zinc using supplemental zinc and the zinc chelator, N,N,N′,N′-Tetrakis (2pyridylmethyl) ethylenediamine (TPEN). FluoZin-3 fluorescence intensity displayed
significant, dose-dependent enhancement and diminishment in worms cultured with
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supplemental zinc and TPEN, respectively (Figures 2.1A and 2.1B). These results
indicate that FluoZin-3 fluorescence monitors labile zinc in live worms, and zinc is
concentrated in vesicles of intestinal cells.
To investigate the relationship between FluoZin-3 fluorescent vesicles and
intestinal gut granules, we performed costaining experiments using LysoTracker
(Hermann et al., 2005). With no supplemental zinc, the patterns of FluoZin-3 and
LysoTracker fluorescence were highly overlapping in intestinal cells (Figure 2.1C and
Supplemental Figure 2.1), indicating that zinc detected by FluoZin-3 is stored in gut
granules. Because gut granules contain birefringent and autofluorescent materials, we
determined how autofluorescence compares to FluoZin-3 fluorescence by comparing
animals cultured with FluoZin-3 to control animals cultured with no dye. Animals
cultured with FluoZin-3 displayed 2.6, 3.5 and 4.3-fold higher signal than control
animals when cultured with 0μM, 100μM and 200μM supplemental zinc, respectively
(Supplemental Figure 2.2). These results indicate that the signal is primarily due to
FluoZin-3 binding zinc with a minor contribution from autofluorescence.

Gut Granules are the Major Site of Zinc Storage
To characterize the function of gut granules in zinc storage, we analyzed Glo
mutant animals that have reduced numbers of gut granules due to defects in lysosome
biogenesis (Hermann et al., 2005). We analyzed three genes, pgp-2, glo-1 and glo-3,
because well characterized loss-of-function mutations in these genes cause Glo
phenotypes of different severities; wild-type animals contain hundreds of gut granules,
whereas pgp-2(kx49) animals contain 10~100 gut granules, and glo-1(zu391) and glo23

3(zu446) animals contain less than 10 gut granules (Hermann et al., 2005; Rabbitts et al.,
2008; Schroeder et al., 2007). pgp-2 encodes an ABC transporter that is localized to the
membrane of gut granules, glo-1 encodes a predicted Rab GTPase that localizes to gut
granules, and glo-3 has not been molecularly identified. All of the Glo animals displayed
reduced FluoZin-3 fluorescence compared to wild-type animals at 0μM and 100μM
supplemental zinc (Figure 2.2A). Consistent with the severity of Glo phenotype, pgp-2
mutant animals contained a small number of FluoZin-3 positive granules, and glo-1 and
glo-3 mutant animals displayed very few granules stained with FluoZin-3. These results
support the conclusion that gut granules are the site of labile zinc detected by FluoZin-3.
To quantify zinc storage defects in Glo animals, we used ICP-MS as an
independent method to measure total zinc content. In culture conditions with 0μM and
200μM supplemental zinc, pgp-2 mutants displayed a moderate reduction of total zinc
content, and glo-1 mutants displayed a severe reduction of total zinc content compared to
wild-type animals (Figure 2.2B). The total zinc content of the Glo animals was well
correlated with the severity of the Glo phenotype. With 200μM supplemental zinc, glo-1
mutants contained approximately 50% of the total zinc content of wild-type animals.
These results indicate that gut granules are the major site of zinc storage in C. elegans
that contains about half of the total zinc in the body.
To determine whether gut granules are also used to store additional metals, we
analyzed the total metal content of four additional physiological metals from Glo animals
using ICP-MS. Glo animals did not exhibit a consistent change in total levels of
magnesium, iron, manganese or copper compared to wild-type animals (Supplemental
Figure 2.3). These results indicate that gut granules are specifically involved in zinc
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storage.

High Dietary Zinc Induces CDF-2 Expression, and CDF-2 Promotes Zinc Storage in
Gut Granules
cdf-2 mRNA levels are increased by high dietary zinc, and CDF-2 is expressed
specifically in intestinal cells and localized to autofluorescent vesicles (Davis et al.,
2009). To analyze the regulation of CDF-2 protein expression by dietary zinc, we used
transgenic animals expressing CDF-2::GFP. The level of CDF-2::GFP was induced in a
concentration-dependent manner by approximately 3-fold and 4-fold at 100 and 200μM
supplemental zinc, respectively, compared to 0μM supplemental zinc (Figures 2.3A and
2.3B). These results suggest that high levels of CDF-2 play an important role in the
response to high dietary zinc. To elucidate the relationship between CDF-2 and zinc
storage, we cultured transgenic animals expressing CDF-2::mCherry on NAMM dishes
containing FluoZin-3. In animals cultured with no supplemental zinc, FluoZin-3 and
CDF-2::mCherry fluorescence overlapped almost completely (Supplemental Figure 2.4,
left), indicating that CDF-2 is localized to the gut granules that concentrate zinc.
To determine the function of CDF-2 in zinc storage in gut granules, we analyzed
animals with reduced or increased levels of CDF-2 activity. Activity was reduced by the
cdf-2(tm788) deletion mutation that causes a strong loss-of-function, whereas activity
was increased by generating transgenic animals that contain multicopy,
extrachromosomal arrays expressing CDF-2::mCherry in the cdf-2(tm788) background.
cdf-2(tm788) mutant animals displayed significantly lower FluoZin-3 fluorescence at
both 0μM and 100μM supplemental zinc compared to wild-type animals (Figures 2.3C
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and 2.3D). ICP-MS analysis revealed that cdf-2(tm788) mutant animals had a severe
reduction of total zinc content, similar to glo-1 mutant animals (Figure 2.2B), consistent
with our previous studies (Davis et al., 2009). These results indicate that CDF-2 is
necessary to concentrate zinc into gut granules. Since cdf-2(tm788) mutant animals
displayed slightly increased FluoZin-3 fluorescence at 100μM compared to 0μM
supplemental zinc, a CDF-2 independent mechanism might concentrate zinc in gut
granules. One possibility is that an alternative zinc transporter is induced in cdf-2 mutant
animals, and differences were observed in mRNA levels of other cdf genes in cdf-2
mutants animals compared to wild-type animals (data not shown). Transgenic animals
that overexpress CDF-2::mCherry displayed higher FluoZin-3 fluorescence at 0μM and
100μM supplemental zinc compared to cdf-2 mutants and wild-type animals (Figures
2.3C and 2.3D). Thus, overexpression of CDF-2 was sufficient to concentrate zinc into
gut granules.
Transgenic animals containing extrachromosomal arrays display mosaic
expression of transgenes spontaneously and at a low frequency. To determine whether
CDF-2 functions cell-autonomously, we analyzed mosaic animals that lack transgene
expression in specific intestinal cells. Because these animals contain the cdf-2(tm788)
mutation, an intestinal cell that lacks transgene expression lacks all CDF-2 function. The
intestinal cells lacking CDF-2::mCherry expression displayed lower FluoZin-3
fluorescence compared to the flanking cells that express CDF-2::mCherry (Figure 2.3E).
These results indicate that CDF-2 functions cell-autonomously in intestinal cells to
promote zinc concentration in gut granules.
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High Dietary Zinc Alters Gut Granule Morphology
To characterize how the intracellular localization of CDF-2 responds to high
dietary zinc, we examined the colocalization of CDF-2 and LysoTracker. In the absence
of supplemental zinc, CDF-2::GFP colocalized completely with LysoTracker (Figure
2.4A, left). This observation demonstrates directly that CDF-2 localizes to the membrane
of gut granules. In the presence of 200μM supplemental zinc, CDF-2::GFP expression
remained restricted to gut granules, but gut granules displayed altered morphology. Many
vesicles had a bilobed appearance, and the two lobes displayed distinct staining patterns;
one side was positive for both CDF-2 and LysoTracker, whereas the other side was
positive for CDF-2 and negative for LysoTracker (Figure 2.4A, right). Since LysoTracker
labels acidic organelles, these results indicate that one lobe may lack the determinants
that concentrate the LysoTracker or the LysoTracker dye may be present but not
fluorescent due to high pH. To examine a possible pH difference, we used LysoSensor
Green DND-153, which is highly fluorescent in neutral compartments (Zhang et al.,
2010). Colocalization analysis with CDF-2::mCherry demonstrated that LysoSensor
Green strain only one side of the bilobed gut granules (Supplemental Figure 2.5), similar
to LysoTracker staining. These results suggest that asymmetric staining of bilobed
vesicles may reflect an asymmetric distribution of the molecules that bind these
fluorescent probes.
To characterize additional differences between the two dies of bilobed gut
granules, we first investigated the distribution of zinc. Zinc was visualized with FluoZin3, and gut granules were visualized with LysoTracker. With 100μM supplemental zinc,
FluoZin-3 and LysoTracker fluorescence displayed asymmetric staining in the bilobed
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gut granules. The LysoTracker-positive side displayed relatively weak FluoZin-3 staining,
whereas the LysoTracker-negative side displayed relatively strong FluoZin-3 staining
(Figure 2.1C, right). To examine the relationship between zinc levels and CDF-2 protein
in the bilobed gut granules, we visualized zinc using FluoZin-3 and CDF-2::mCherry.
Whereas FluoZin-3 fluorescence was asymmetric and strong in only one side of bilobed
granules, CDF-2::mCherry was localized to both sides (Supplemental Figure 2.4, right).
These results indicate that while the distribution of labile zinc may be asymmetric in
bilobed gut granules, CDF-2 protein may be symmetric.
C. elegans has been used to identify and characterize genes that are localized to
specific endosomal and lysosomal compartments. To define the molecular properties of
bilobed gut granules, we examined the localization of several of these marker proteins.
The GTPase Rab-5 is localized to early endosomes in mammalian cells (Zerial and
McBride, 2001), and C. elegans RAB-5 expressed in intestinal cells localizes to small
punctate structures that appear to be early endosomes (Chen et al., 2006; Hermann et al.,
2005). RAB-5 did not colocalize with LysoTracker or CDF-2 (data not shown),
indicating that CDF-2 does not accumulate in early endosomes. C. elegans RAB-7::GFP
appears to stain early endosomes and late endosomes, similar to the localization patterns
in other systems (Chen et al., 2006; Zerial and McBride, 2001). Lysosome associated
membrane proteins (LAMPs) are localized predominantly in lysosomes in vertebrates,
and C. elegans LMP-1 localizes to specific gut granules of intestinal cells (Kostich et al.,
2000). A subset of LMP-1 and RAB-7 colocalized with LysoTracker in gut granules
(Figure 2.4B and Supplemental Figure 2.6A). In high zinc, LMP-1 and RAB-7 were
localized on only one side of the bilobed vesicles that were visualized using CDF28

2::mCherry (Figure 2.4C and Supplemental Figure 2.6B). These results indicate that the
gut granules that contain CDF-2 also contain the late endosomal/lysosomal proteins
RAB-7 and LMP-1. The bilobed granules displayed an asymmetric distribution of RAB7 and LMP-1, indicating that one lobe has typical lysosomal characteristics whereas the
other lobe lacks lysosomal proteins.
C. elegans PGP-2 is an ABC transporter that localizes specifically to the gut
granule membrane (Schroeder et al., 2007). With no supplemental zinc, CDF-2::mCherry
and PGP-2::GFP colocalized completely in gut granules; these gut granules also
displayed autofluorescence (Supplemental Figure 2.7, left). In the presence of 100μM
supplemental zinc, CDF-2 and PGP-2 fully colocalized on both sides of the bilobed gut
granules. Autofluorescence displayed an asymmetric pattern and was only prominent on
one side, similar to the LysoTracker staining pattern (Supplemental Figure 2.7, right).
These results indicate that bilobed gut granules contain proteins that are symmetrically
distributed on both lobes, such as PGP-2 and CDF-2, and proteins that are
asymmetrically localized, such as RAB-7 and LMP-1.

Glo Genes are Required for the Formation of Bilobed Gut Granules
To identify mechanisms that are important for the formation of bilobed gut
granules, we examined the gut granule morphology in mutant animals by colocalization
experiments of PGP-2::GFP, LysoTracker and FluoZin-3. cdf-2 mutant animals displayed
bilobed vesicles that contain PGP-2::GFP symmetrically on both lobes and LysoTracker
asymmetrically on one lobe (Supplemental Figure 2.8A). As expected, bilobed gut
granules did not stain with FluoZin-3 in cdf-2 mutant animals (Supplemental Figure
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2.8B). These results indicate that the formation of bilobed vesicles does not require cdf-2
activity, but acculumation of zinc in these vesicles does require cdf-2.
To dissect the molecular process involved in the bilobed gut granule formation,
we blocked lysosome biogenesis and endocytosis pathways by RNAi knockdown of rab7 and rme-8, respectively, and examined its effect on gut granule morphology. Bilobed
vesicles were detected in rab-7 and rme-8 RNAi fed animals (Figure 2.5), indicating that
neither lysosome biogenesis nor endocytosis is required for the formation of bilobed gut
granule. Since only gut granule-specific proteins were found on both sides of bilobed
vesicles, we hypothesized that bilobed vesicle formation may be also regulated by gut
granule-specific processes. To test the hypothesis, we knockdowned glo genes, pgp-2 and
glo-3. In pgp-2 and glo-3 RNAi fed animals, bilobed morpholgy was not detected, and
there were separate compartments which display CDF-2:GFP but not LysoTracker
(Figure 2.5). These results indicate that Glo genes that function in gut granule formation
are required for the formation of bilobed morphology in response to high zinc.

Gut Granules are Necessary for Zinc Detoxification
To investigate whether storage in gut granules is a protective mechanism that
promotes zinc detoxification, we analyzed the growth rate of animals in response to
increasing levels of dietary zinc. Animals were synchronized at the first larval (L1) stage,
cultured on NAMM dishes supplemented with zinc for a specific time period, and
analyzed individually to measure length as an indicator of growth. Wild-type animals
displayed a dose-dependent decrease in growth rate, indicating that high dietary zinc
inhibits growth (Figure 2.6A). pgp-2, glo-1 and glo-3 mutant animals displayed
30

significantly lower growth rates than wild-type animals with all supplemental zinc
(Figure 2.6A). The severity of the zinc sensitivity phenotype correlated with the severity
of Glo phenotype; pgp-2 mutants were moderately zinc sensitive whereas glo-1 and glo-3
mutants were strongly zinc sensitive. These results indicate that gut granules play an
important protective role in response to zinc toxicity. To determine the role of CDF-2 in
this mechanism of zinc detoxification, we examined a cdf-2 loss-of-function mutant that
is defective in zinc storage. Similar to Glo animals, cdf-2 mutants were hypersensitive to
dietary zinc compared to wild-type animals (Figure 2.6B). Since cdf-2 mutants have
normal formation of gut granules shown by LysoTracker staining (Supplemental Figure
2.8B), these findings indicate that CDF-2 mediated zinc transport into gut granules is a
critical mechanism for zinc detoxification.
To investigate whether gut granules have a general role in metal detoxification,
we examined the sensitivity of Glo animals to the toxic effects of additional metals. Glo
animals were similar to wild-type animals in sensitivity to dietary cadmium (Figure
2.6C) and copper (data not shown), indicating that gut granules are not necessary to
detoxify these metals. The growth of cdf-2(tm788) mutant animals was also similar to
wild-type animals in the presence of supplemental cadmium (Figure 2.6D) and copper
(data not shown). These results indicate that CDF-2 function is specific to zinc and
support the conclusion that gut granules are not a general site of metal storage and may
be specific for zinc storage.

Gut Granules Provide a Source of Zinc that Can Be Mobilized in Response to
Deficiency.
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One possible function of storing zinc in gut granules is to provide a supply of
zinc that can be mobilized in response to zinc deficient conditions. To test this model, we
monitored the levels of zinc in gut granules using FluoZin-3 in the shift from high zinc to
different zinc conditions. Wild-type animals were first cultured with 200μM
supplemental zinc. There was approximately 2.5-fold increase in FluoZin-3 fluorescence
compared to the control animals cultured with no supplemental zinc, indicating that zinc
is stored in gut granules during the preculture with high zinc (Figures 2.7A and 2.7B).
Animals were then shifted to high (200μM supplemental zinc), normal (0μM
supplemental zinc) or low zinc (100μM TPEN) conditions, and analyzed to measure
FluoZin-3 fluorescence. When animals were continuously cultured with 200μM
supplemental zinc, FluoZin-3 fluorescence further increased (Figures 2.7A and 2.7B).
When animals were shifted to the normal zinc condition, FluoZin-3 fluorescence
increased by ~1.7-fold after 24h of the shift and then after 48h it slightly decreased.
When animals were shifted to the low zinc, FluoZin-3 fluorescence increased by ~1.4fold after 24h, but after 48h FluoZin-3 fluorescence dramatically decreased below the
initial fluorescence. These results indicate that zinc stored in gut granules can be
mobilized in response to low zinc conditions.
To independently investigate zinc mobilization, we analyzed the growth of
animals that were precultured with either normal or high zinc conditions and
subsequently cultured in low zinc conditions. Wild-type animals precultured with 50μM
supplemental zinc displayed a significantly increased growth rate in the presence of
TPEN compared to animals precultured with 0μM supplemental zinc (Figure 2.7C).
These results indicate that wild-type animals store zinc that can be used later to cope
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with zinc deficiency. cdf-2 mutant animals precultured with 0μM or 50μM supplemental
zinc displayed similar growth rates in the presence of TPEN (Figure 2.7C). These results
indicate that CDF-2 is necessary for preculturing with high zinc to promote the resistance
to subsequent zinc deficiency, probably because CDF-2 promotes the storage of zinc in
gut granules.
To test the model that gut granules are the source of zinc that is mobilized during
zinc deficiency, we examined Glo animals. glo-1, glo-3 and pgp-2 mutants precultured
with 0μM supplemental zinc displayed slower growth rates than wild-type animals when
challenged with zinc deficient conditions (Figure 2.7D). Furthermore, whereas wild-type
animals displayed a significant increase in growth when preincubated with 50μM
supplemental zinc, preincubation with supplemental zinc did not significantly affect the
growth of Glo animals (Figure 2.7D). Thus, glo-1, glo-3, pgp-2 and cdf-2 were necessary
for animals to respond to preincubation with supplemental zinc. These results indicate
that gut granules, which are the major site of zinc storage during dietary excess, are the
source of zinc mobilized during zinc deficiency.

DISCUSSION

Gut Granules in Intestinal Cells Function as a Zinc Storage Site
Zinc is essential, but zinc availability fluctuates. Thus, mechanisms to store and
mobilize zinc are important. We used C. elegans to characterize the site of zinc storage in
an animal by developing methods to visualize labile zinc using a zinc-specific
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fluorescent dye, FluoZin-3.

Labile zinc was detected primarily in lysosome-related

organelles in intestinal cells called gut granules. The biogenesis of gut granules has been
studied using Glo mutant animals that have reduced numbers of gut granules (Hermann
et al., 2005; Rabbitts et al., 2008; Schroeder et al., 2007). We used these mutants to
demonstrate that Glo animals have reduced levels of labile zinc and total zinc, and the
severity of the Glo phenotype correlated with the reduction in zinc levels. Glo animals
had wild-type levels of other metals such as copper. Thus, these results support the
conclusion that gut granules function specifically in zinc storage, and provide direct
evidence for the presence of a zinc-specific storage site in animals.
In the yeast Saccharomyces cerevisiae, the vacuole plays a central role in zinc storage
(Eide, 2006). In mammals, zinc storage has not been well defined. Kinetic studies using
zinc stable isotopes have suggested that exchangeable pools of zinc are limited (Krebs
and Hambidge, 2001). However, these studies have limitations because these studies
examined a very small fraction of total zinc pools and the range of dietary zinc that can
be tested was relatively narrow. Our studies using C. elegans with a wider range of
dietary zinc allowed the identification of a site of zinc storage. Since C. elegans has
conserved mechanisms of zinc metabolism, such as zinc transporter proteins and
metallothioneins, these results suggest that zinc storage mechanisms may be present in
higher animals.
C. elegans gut granules and yeast vacuoles both have lysosomal properties. This
similarity leads us to speculate that lysosome-related organelles may have a role in zinc
storage in higher animals. In fact, labile zinc is detected by zinc-responsive fluorescent
dyes in intracellular organelles called zincosomes in various types of mammalian cells,
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which have lysosomal properties (Eide, 2006). Furthermore, there are specialized
lysosome-related organelles that may function in zinc storage, similar to C. elegans gut
granules. For instance, secretory granules in paneth cells in the intestine contain zinc, and
paneth cell number and the granule morphology are affected by dietary zinc conditions
(Giblin et al., 2006). Acidocalcisomes are acidic organelles conserved from bacteria to
human that contain calcium and polyphosphate, and zinc is found in acidocalcisomes in
several species (Docampo et al., 2005). Thus, the roles of these lysosome-related
organelles in zinc storage and zinc homeostasis of animals will be intriguing future topics
to be studied.
The cation diffusion facilitator protein CDF-2 plays a critical role in zinc storage.
Colocalization experiments with gut granule markers demonstrated that CDF-2 is
localized to the membrane of gut granules. Reducing the activity of cdf-2 with a loss-offunction mutation and increasing the activity of cdf-2 by overexpression demonstrated
that cdf-2 is both necessary and sufficient for zinc storage in gut granules. Consistent
with the model that CDF-2 directly transports zinc into gut granules, CDF-2 functions
cell-autonomously in intestinal cells to promote zinc accumulation. C. elegans CDF-2 is
homologous to mammalian ZnT2 which plays a role in the secretion of zinc into breast
milk (Chowanadisai et al., 2006). Similar to CDF-2, ZnT2 is localized to intracellular
vesicles and upregulated by dietary zinc (Liuzzi et al., 2001), suggesting that ZnT2 may
be involved in zinc storage in mammals.

Zinc Storage in Gut Granules Promotes Detoxification and Provides a Source of
Zinc that is Mobilized During Deficiency
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We characterized two functions of zinc storage in gut granules. The first is detoxification.
Glo animals were hypersensitive to zinc toxicity, and the hypersensitivity correlated with
the severity of the Glo defect. These findings indicate that gut granules have a critical
role in zinc detoxification. cdf-2 loss-of-function mutants which had normal gut granules
were hypersensitive to dietary zinc, and CDF-2 was induced by dietary zinc, suggesting
that CDF-2 mediated transport of zinc into gut granules is an important mechanism to
detoxify high levels of dietary zinc. The yeast vacuole plays a role in zinc detoxification.
In multicellular animals, the protective role of zinc-containing organelles in the whole
body zinc homeostasis has not been demonstrated. Thus, these studies of C. elegans
document a novel role of lysosome-related organelles in zinc metabolism in animals.
High levels of dietary zinc induce changes in gene expression, such as induction of
metallothionein genes, and these alterations in gene expression may play a role in
detoxification (Lichtlen and Schaffner, 2001). An important direction for future research
will be to determine how zinc sequestration in lysosome-related organelles relates to
other mechanisms of zinc tolerance such as expression of zinc-binding proteins.
The second function of zinc storage in gut granules is to provide a source of zinc
that can be utilized during dietary deficiency. To test this process, we examined the zinc
level in gut granule using FluoZin-3 in the shift from high zinc to low zinc conditions.
For the first 24h after the shift, FluoZin-3 fluorescence slightly increased, but after 48h,
it significantly decreased. These results indicate that zinc stored in gut granules during
preculture in high zinc can be mobilized in the shift to low zinc conditions, and zinc
mobilization appeared to occur between 24h and 48h after the shift conditions. It is
possible that, within the 24h, gut granules keep taking up remaining excess zinc in the
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animal. Between 24h and 48h after the shift, animals perhaps experience zinc deficiency
and begin to mobilize zinc from gut granules.
As an independent approach, we also examined the growth of animals in the
shift from high zinc to low zinc conditions. Wild-type animals with a high level of zinc
storage grew better in zinc deficient conditions than animals with a low level of zinc
storage, indicating that stored zinc can be mobilized during zinc deficiency. An
alternative explanation for this observation is that exposure to high dietary zinc results in
another change, such as altered gene expression, that promoted growth in zinc deficient
conditions. The analysis of Glo animals and cdf-2 mutants suggests this is unlikely, since
gut granules and CDF-2 mediated zinc transport were necessary for effective storage and
mobilization. Therefore, we propose that zinc stored in gut granules during periods of
dietary excess can be mobilized to support growth during periods of zinc deficiency. This
process requires Glo genes that mediate biogenesis of gut granules and CDF-2 that
transports zinc into gut granules.
Mobilization of stored zinc has been analyzed in yeast. The ZIP protein Zrt3 is
localized to the vacuole and transports zinc into the cytoplasm in response to zinc
deficiency (MacDiarmid et al., 2000). In multicellular animals, although the loss of zinc
from zinc-containing organelles has been observed in the process of signal transduction
(Aydemir et al., 2009), zinc mobilization from a site of zinc storage in response to dietary
deficiency has been not demonstrated. The characterization of gut granules described
here is the first documentation of a specific site of zinc storage that is mobilized during
dietary deficiency. Mobilization is likely to require a transporter that shuttles zinc from
the lumen of gut granules to the cytoplasm, and future studies will focus on the
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identification of this transporter.

Gut Granules Change Morphology in High Dietary Zinc
Gut granules displayed novel morphological changes in response to high dietary zinc. In
standard culture conditions, gut granules were typically round in shape, autofluorescent,
stained with LysoTracker, LysoSensors, and FluoZin-3, and the membrane contained
CDF-2, RAB-7, LMP-1 and PGP-2 (Supplemental Figure 2.9). In high dietary zinc, gut
granules were frequently bilobed in shape. The bilobed vesicles displayed asymmetric
distribution of molecules; one side displayed almost the identical molecular properties to
normal state gut granules, whereas the other side contained only gut granule-specific
proteins, PGP-2 and CDF-2, and displayed strong FluoZin-3 staining (Supplemental
Figure 2.9). These results suggest that one side that has a high concentration of zinc may
have unique molecular properties and specialized functions in zinc metabolism.
We speculate that bilobed vesicles may have two functions. First, this structural
change may be a mechanism to promote zinc storage. Generating additional adjacent
vesicles which are devoted to storing zinc can improve the capacity of storage and
facilitate rapid sequestration. Second, bilobed vesicles may function in the secretion of
excess zinc beyond the gut granule capacity. When zinc is accumulated over the capacity
of gut granules in high zinc conditions, gut granules may undergo the structural changes
to make specialized secretory vesicles full of excess zinc. Thus, gut granules may play a
role in the balance between storage and excretion of zinc. Studies of the fate of bilobed
vesicles will be future research to understand the function of the structure.
To study the process of bilobed gut granule formation, we tested the role of
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CDF-2. Interestingly, cdf-2 mutants displayed bilobed vesicles containing PGP-2, but
these vesicles did not show strong FluoZin-3 fluorescence, indicating that there may be
other processes that sense zinc levels and induce this morphological changes
independently of CDF-2. To investigate this process, we tested lysosome biogenesis and
endocytosis process by RNAi of rab-7 and rme-8. RNAi of these genes did not block the
formation of bilobed morphology, indicating the general lysosome biogenesis or
endocytic pathways are not likely to be required for the process. On the other hand,
RNAi of glo genes, pgp-2 and glo-3 blocked the formation of bilobed morphology. These
results indicate that gut granule specific trafficking pathway is critical for the generation
of bilobed vesicles. The discovery of this novel structure raises important new questions
concerning the relationship between intracellular trafficking and zinc metabolism.

EXPERIMENTAL PROCEDURES

General Methods and Strains
C. elegans strains were cultured at 20℃ on nematode growth medium (NGM) seeded
with E. coli OP50 unless otherwise noted (Brenner, 1974). The wild-type C. elegans and
parent of all mutant strains was Bristol N2. The following mutations and transgenes were
used: pgp-2(kx48) I (Schroeder et al., 2007), unc-119(ed3) III (Praitis et al., 2001), cdf1(n2527) X (Bruinsma et al., 2002), cdf-2(tm788) X (Davis et al., 2009), glo-1(zu391) X
(Hermann et al., 2005), glo-3(zu446) X (Rabbitts et al., 2008), amIs4(cdf-2::GFP::unc119(+)) (Davis et al., 2009), pwIs50 (lmp-1:GFP) (Treusch et al., 2004), pwIs72 (Pvha39

6::GFP::rab-5) (Hermann et al., 2005), pwIs170 (Pvha-6::GFP::rab-7) (Chen et al.,
2006), and kxEx98(pgp-2::GFP;rol-6D) (Schroeder et al., 2007). amEx132(cdf2::mCherry;rol-6D), and amEx142(cdf-2::mCherry::unc-119(+)) are described here.
Double mutant animals were generated by standard methods, and genotypes were
confirmed by PCR or DNA sequencing.

Transgenic Strain Construction
We previously described amIs4, an integrated transgene generated by bombardment
transformation that expresses CDF-2::GFP from the cdf-2 promoter (Davis et al., 2009).
cdf-2(tm788);amIs4 animals were generated by standard methods and used to analyze
CDF-2::GFP expression. We generated pSC6 by inserting the coding sequence for
mCherry from pCJF104 (a gift from M. Nonet), the unc-54 3’UTR from pPD95.77 (a
gift from A. Fire), and the cdf-2 promoter region and coding sequences into pBluescript
SK+ (Stratagene). pSC6 and the marker pRF4 were microinjected into cdf-2(tm788)
animals (Mello et al., 1991). Two independently derived strains containing
extrachromosomal arrays were isolated, amEx129 and amEx132. We made pSC23 by
inserting CDF-2::mCherry coding sequences from pSC6 into plasmid pMM016 (a gift
from J. Austin) that contains unc-119(+) (Praitis et al., 2001). pSC23 was transformed
into unc-119(ed3) animals by bombardment to generate amEx142. For colocalization
analysis, amEx142 animals were crossed with animals containing pwIs72, pwIs170,
pwIs50 or kxEx98.

Metal Sensitivity Assays
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Gravid adult hermaphrodites were treated with NaOH and bleach, and eggs were
incubated in M9 solution overnight to allow hatching and synchronized arrest at the L1
stage. L1 animals were transferred to NAMM dishes supplemented with zinc sulfate
(ZnSO4), cadmium chloride (CdCl2) or copper sulfate (CuSO4), and seeded with
concentrated OP50. After 3 days, animals were washed twice in M9 containing 0.01%
Tween-20, paralyzed with 10mM sodium azide (NaN3) in M9, and mounted on a 2%
agarose pad on a microscope slide. Nomarski images were captured with a Zeiss
Axioplan 2 microscope equipped with a Zeiss AxioCam MRm digital camera. Length of
animals was measured using ImageJ software (NIH) by drawing a line from the nose to
the tail tip.

Quantitative Analysis of CDF-2::GFP Expression by Fluorescence Microscopy
cdf-2(tm788);amIs4 animals were synchronized at L1 stage and cultured on NGM dishes.
L4 stage hermaphrodites were then cultured for 24h on NAMM dishes supplemented
with ZnSO4 and seeded with concentrated OP50. Animals were paralyzed with 0.1%
tricaine and 0.01% tetramisole in M9, mounted on 2% agarose pads on microscope slides,
and imaged with a Zeiss Axioplan 2 microscope equipped with a Zeiss AxioCam MRm
digital camera using identical settings and exposure times. GFP fluorescence intensity
was quantified using ImageJ software (NIH). Briefly, the Spot Enhancing Filter 2D
plugin was used to amplify signals from gut granules, and then threshold settings were
used to specifically select the fluorescent regions of gut granules. The selected regions
were overlaid on the original images and analyzed for mean fluorescence intensity of the
area.
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Staining with FluoZin-3, LysoTracker and LysoSensors
FluoZin-3 acetoxymethyl (AM) ester (Molecular Probes F24195) was reconstituted in
dimethylsulfoxide (DMSO) to generate a 1mM stock solution, diluted in M9 and
dispensed on NAMM dishes to yield a final concentration of 3μM. L4 stage
hermaphrodites were cultured on these dishes for 12-24 h in the dark, transferred to
NGM dishes without FluoZin-3 for 30 min to reduce FluoZin-3 in the intestinal lumen,
and analyzed by fluorescence microscopy as described above. The intestine on the
anterior half of each animal was analyzed because this structure was typically observed
in the same focal plane. Residual fluorescence from the intestinal lumen was manually
removed and excluded from the analysis.
LysoTracker RED DND-99 (1mM, Invitrogen L7528), or LysoSensor Green
DND-153 (1mM, invitrogen L7534) were diluted in M9 and dispensed on NAMM dishes
to yield a final concentration of 2μM. L4 stage hermaphrodites were cultured for 12-24 h
in the dark, transferred to NGM dishes without dye for 30 min to reduce the dyes in the
intestinal lumen, and imaged as described above. Confocal microscopy was performed
using an Olympus FV500 confocal microscope system equipped with multi-line argon
(458/488/515nm) and krypton (568nm) lasers.

Metal Content Analysis by Inductively Coupled Plasma-Mass Spectrometry (ICPMS)
To obtain a large population of animals, we cultured hermaphrodites on multiple 100mm
NGM dishes, washed the animals three times in M9 containing 0.01% Tween-20,
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resuspended the animals in concentrated OP50 in M9, and cultured the animals on
multiple 100mm NAMM dishes supplemented with ZnSO4. After 24 h, animals were
washed three times in magnesium-free (Mg-free) M9 containing 0.01% Tween-20,
incubated in 1mM serotonin in Mg-free M9 for 30 min to remove bacteria from the
intestinal lumen, washed twice in Mg-free M9, and transferred to preweighed tubes and
frozen at -80℃. The metal content was determined as described by Davis et al. (2009).
Briefly, samples were freeze-dried, reweighed to obtain the dry pellet weight, and
digested by incubation in a hot block digester at 90℃ for 1.5h with concentrated nitric
acid (HNO3) and hydrogen peroxide (H2O2) solution. The solution was diluted to a
volume of approximately 10mL with deionized water, and internal standards were added
to correct for matrix effects. Instrument calibration standards were prepared from multielement stock solutions (High-Purity Standards) to generate a linear calibration curve,
and samples were analyzed using a VG Axiom high-resolution ICP-MS (Thermo Fisher
Scientific). The content of zinc, iron, copper, magnesium and manganese was determined
as a value in parts-per-million (ppm) by dividing metal weight by dry pellet weight
(μg/g).

Zinc Shift Assay
L4 stage animals were cultured for 12-16h on NAMM dishes with FluoZin-3 containing
0 or 200μM ZnSO4, and then analyzed by fluorescence microscopy. Animals from the
NAMM dishes with 200μM ZnSO4 were washed, transferred to NAMM dishes with
FluoZin-3 containing 0 or 200μM ZnSO4 or 100μM TPEN with FluoZin-3, and analyzed
for fluorescence microscopy after 24h and 48h.
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To analyze growth assay, we cultured synchronized L1 stage animals on NAMM
dishes supplemented with 0 or 50μM ZnSO4 for 12h. We chose 50μM supplemental zinc
because it caused relatively mild toxicity as measured by subsequent growth, whereas
100 and 200μM supplemental zinc caused substantial toxicity (data not shown). Animals
were washed three times, incubated in M9 containing 0.01% Tween-20 for 30 min to
minimize residual bacteria, and washed one time in M9 containing 0.01% Tween-20.
Animals were cultured for 3 days on NGM dishes supplemented with TPEN and seeded
with concentrated OP50, and the length of each animal was determined.

RNA interference
RNAi feeding experiments were performed as described by Kamath et al. (2001) with
minor modifications using the Ahringer RNAi library (Geneservice). Briefly, bacteria
containing an RNAi clone were cultured in LB containing carbenicillin (50μg/ml)
overnight. The bacterial culture was diluted into LB containing carbenicillin and cultured
for ~6h, and the bacteria were seeded on NGM containing carbenicillin and IPTG (1mM)
and dried overnight. RNAi of rab-7 and rme-8 causes embryonic lethality (Kamath et al.,
2003) , and RNAi of pgp-2 and glo-3 causes the Glo phenotype (Rabbitts et al., 2008;
Schroeder et al., 2007). To avoid affecting embryonic development, we cultured cdf2(tm788);amIs4 animals at the L1 stage on NGM dishes seeded with RNAi bacteria. L4
stage animals were stained with LysoTracker and analyzed by fluorescence microscopy
as described above.

Statistics
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All data were analyzed by two-tailed unpaired Student’s t-test, and p <0.05 was
considered statistically significant.
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FIGURE LEGENDS

Figure 2.1. Zinc is stored in gut granules (A) Wild-type hermaphrodites cultured with
FluoZin-3 and the indicated levels of supplemental zinc and TPEN. Fluorescence images
of live animals were captured with identical settings and exposure times. Each panel
displays the anterior half of the intestine of a single animal with pharynx to the left and
tail to the right. Scale bar: 50μm. (B) Quantification of fluorescence images like those
shown in panel A using ImageJ software. The fluorescence intensity (shown in arbitrary
units, A.U.) was normalized by setting the value at 0μM supplemental Zn equal to 1.0.
Bars indicate mean values ± SEM (n=15) (** p<0.001; *** p<0.0001). (C) Fluorescence
images of live wild-type animals costained with FluoZin-3 (green) and LysoTracker (red).
Boxed regions are magnified in the right panels. Animals cultured with 100μM
supplemental zinc displayed bilobed gut granules with asymmetric staining; one side was
strongly positive for FluoZin-3 (arrow), and the other side was strongly positive for
LysoTracker (arrowhead). Scale bars: 10μm and 2μm (boxed regions) (see also
Supplemental Figure 2.1 and 2.2).

Figure 2.2. Gut granules are the major site of zinc storage (A) Fluorescence
microscope images of live wild-type, pgp-2(kx48), glo-1(zu391) and glo-3(zu446)
animals cultured with FluoZin-3 and the indicated levels of supplemental zinc. Images
show the intestine with pharynx to the left and tail to the right. All images had identical
exposure times and settings. Scale bar: 50μm. (B) Total zinc content of wild-type, pgp2(kx48), glo-1(zu391) and cdf-2(tm788) animals. Populations of animals consisting of a
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mixture of developmental stages were cultured on NAMM dishes with the indicated
levels of supplemental zinc, and total zinc content was determined by ICP-MS and
calculated in parts-per-million (ppm). Bars indicate mean values ± SEM of two
independent experiments (see also Supplemental Figure 2.3).

Figure 2.3. CDF-2 functions cell autonomously to promote zinc storage in gut
granules (A) Fluorescence microscope images of live transgenic animals containing an
integrated array, amIs4, expressing CDF-2::GFP, and the cdf-2(tm788) mutation. L4
stage hermaphrodites were cultured with the indicated levels of supplemental zinc, and
images were captured with the identical settings and exposure times. Each panel displays
one representative animal oriented with pharynx to the left and tail to the right. Scale bar:
100μm. (B) Quantification of fluorescence images like those shown in panel A. The
fluorescence intensity (shown in arbitrary units, A.U.) was normalized by setting the
value at 0μM supplemental zinc equal to 1.0. Bars indicate mean values ± SEM (n=15)
(*** p<0.0001). (C) Fluorescence microscope images of wild-type, cdf-2(tm788), and
transgenic cdf-2(tm788) animals containing a multicopy extrachromosomal array,
amEx132, expressing CDF-2::mCherry. Images show the intestine (pharynx to the left,
tail to the right) of live animals cultured with FluoZin-3 and the indicated levels of
supplemental zinc. Scale bar: 50μm. (D) Quantification of fluorescence images like those
shown in panel A. The fluorescence intensity (shown in arbitrary units, A.U.) was
normalized by setting the value of wild-type animals at 0μM supplemental Zn equal to
1.0. Bars indicate mean values ± SEM (n=15) (* p<0.01; ** p<0.001; *** p<0.0001). (E)
Images of a live cdf-2(tm788);amEx132 animal that displayed mosaic expression of the
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CDF-2::mCherry. The animal was cultured with FluoZin-3 and no supplemental zinc,
and the intestine was imaged by fluorescence microscopy (pharynx to the left, tail to the
right). The intestinal cell lacking CDF-2::mCherry expression is marked with a star (*).
Scale bar: 50μm (see also Supplemental Figure 2.4).

Figure 2.4. High zinc induces the formation of asymmetric bilobed gut granules (A)
Fluorescence images of live transgenic animals expressing CDF-2::GFP cultured with
LysoTracker and the indicated levels of supplemental zinc. The differential interference
contrast (DIC) image shows the intestinal lumen (triangle) and adjacent intestinal cells
with pharynx to the left and tail to the right. Boxed regions are magnified in the right
panels. With 200μM supplemental zinc, many gut granules appear to be bilobed and
asymmetric; one side is positive for CDF-2::GFP and LysoTracker (arrowhead), whereas
the other side is positive for CDF-2::GFP and negative for LysoTracker (arrow). Scale
bars: 10μm and 2μm (boxed regions) (see also Supplemental Figure 2.5). (B) Confocal
microscope images of live transgenic animals expressing LMP-1::GFP cultured with
LysoTracker and the indicated levels of supplemental zinc. Images show intestinal cells
with pharynx to the left and tail to the right. Scale bar: 10μm and 2μm (insets). (C)
Confocal microscope images of live transgenic animals expressing LMP-1::GFP and
CDF-2::mCherry cultured with 200μM supplemental zinc. Images show intestinal cells
with pharynx to the left and tail to the right. Insets are magnified images of the boxed
regions. Scale bar: 10μm and 2μm (insets) (see also Supplemental Figures 2.6 and 2.7).

Figure 2.5. Bilobed gut granule formation is dependent on Glo genes. Fluorescence
48

microscope images of live transgenic animals expressing CDF-2::GFP transgenic
animals stained with LysoTracker. L1 stage animals were fed RNAi bacteria to reduce
expression of the indicated genes, L4 stage animals were cultured with LysoTracker and
200μM supplemental zinc for ~16h and visualized. Images shows intestinal cells with
pharynx to the left and tail to the right, Boxed regions are magnified in the bottom panels.
Scale bar: 10μm and 2μm (bottom) (see also Supplemental Figure 2.8).

Figure 2.6. Zinc storage in gut granules promotes detoxification. Wild-type, pgp2(kx48), glo-1(zu391), glo-3(zu446) and cdf-2(tm788) hermaphrodites were synchronized
at the L1 stage and cultured on NAMM dishes for 3 days with the indicated levels of
supplemental zinc (A, B) or supplemental cadmium (C, D). The length of individual
animals was measured using microscopy and ImageJ software. To compare strains that
have different growth rates under optimal conditions, we normalized the length of worms
by setting the value at 0μM supplemental zinc equal to 1.0 for each strain. Each point
indicates mean values ± SD (n=10 for Zn, and n=20 for Cd).

Figure 2.7. Zinc in gut granules can be mobilized in response to zinc deficiency (A)
FluoZin-3 staining of animals in the shift from high zinc to different zinc conditions.
Wild-type L4 stage hermaphrodites were first cultured on NAMM dishes containing
FluoZin-3 with 0 or 200μM supplemental zinc. Next, animals from 200μM supplemental
zinc were transferred to NAMM dishes containing the indicated levels of zinc or TPEN.
After 24h and 48h of subsequent culture, FluoZin-3 fluorescence was analyzed by
fluorescence microscopy. (B) Quantification of fluorescence images like those shown in
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panel A. The fluorescence intensity (shown in arbitrary units, A.U.) was normalized by
setting the value at 0μM supplemental Zn before the shift equal to 1.0. Each point
indicates mean values ± SEM (n=10). (C) Wild-type and cdf-2(tm788) L1 stage
hermaphrodites were precultured for 12h on NAMM dishes containing 0 or 50μM
supplemental zinc, cultured for 3 days on NGM dishes with the indicated levels of TPEN,
and analyzed individually for length. Each point indicates mean value ± SD (n=20). (D)
Wild-type, glo-1(zu391), glo-3(zu446) and pgp-2(kx48) animals were analyzed as
described in panel C. The results with 100μM TPEN are presented, because this
concentration was the most informative with wild-type animals. The length of individual
worms at 100μM TPEN was divided by the average length at 0μM TPEN. Bars indicate
mean values ± SD (n=20). This ratio compares the growth of worms in deficient and
normal zinc conditions - lower values indicate more severely reduced growth in response
to zinc deficiency. Animals were precultured with 0 (black) or 50μM (white)
supplemental zinc. For each strain, the white bar was compared to the black bar (***
p<0.0001). All the mutant strain black and white bar values were significantly different
than the wild-type black and white bar values, respectively.

Supplemental Figure 2.1. FluoZin-3 and LysoTracker colocalize in gut granules of
intestinal cells Wild-type L4 stage hermaphrodites were cultured with the indicated
levels of supplemental zinc and costained with FluoZin-3 and LysoTracker. Images show
an entire live hermaphrodite from pharynx (upper left) to tail (bottom right): bright field
shows morphology, green displays FluoZin-3 fluorescence, red displays LysoTracker
fluorescence, and the merge shows green and red. FluoZin-3 fluorescence was captured
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with the identical settings and exposure times. Scale bar: 100μm.

Supplemental Figure 2.2. FluoZin-3 detects zinc in gut granules (A) Fluorescence
microscope images of live wild-type animals cultured with or without FluoZin-3. L4
stage hermaphrodites were cultured with the indicated levels of supplemental zinc.
Images were captured with the identical settings and exposure times. Images of animals
cultured with FluoZin-3 are identical to Figure 1A. Fluorescence of gut granules of
animals cultured with FluoZin-3, which is a combination of FluoZin-3 and
autofluorescence, was much brighter than fluorescence of gut granules of control animals,
which is entirely autofluorescence. (B) Quantification of fluorescence images like those
shown in panel A. The fluorescence intensity (shown in arbitrary units, A.U.) was
normalized by setting the value of animals cultured without FluoZin-3 at 0μM
supplemental Zn equal to 1.0. Bars indicate mean values ± SEM (n=15) (*** p<0.0001,
compared to no dye control at the same concentration of supplemental zinc).

Supplemental Figure 2.3. Gut granules are not a general site of metal storage Total
magnesium (Mg), iron (Fe), manganese (Mn) and copper (Cu) content of wild-type, pgp2(kx48), glo-1(zu391) and cdf-2(tm788) animals. Populations of animals consisting of a
mixture of developmental stages were cultured on NAMM dishes with the indicated
levels of supplemental zinc, and total metal content was determined by ICP-MS and
calculated in parts-per-million (ppm). Bars indicate mean values ± SEM of two
independent experiments. The same samples were used to measure total zinc content in
Figure 2B.
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Supplemental Figure 2.4. Colocalization of CDF-2 and zinc in gut granules
Fluorescence microscope images of intestinal cells of live transgenic animals expressing
CDF-2::mCherry cultured with FluoZin-3 and the indicated levels of supplemental zinc.
Green displays FluoZin-3 and red displays CDF-2::mCherry protein. Boxed regions are
magnified in the right panels. Animals cultured with 100μM supplemental zinc displayed
bilobed gut granules. CDF-2::mCherry localized symmetrically to the membrane of both
sides, whereas FluoZin-3 staining was asymmetric, with one side staining strongly
(arrow) and the other side staining weakly (arrowhead). The scale bars represent 10μm
and 2μm (boxed region).

Supplemental Figure 2.5. Neutral lysosomal pH indicators display similar staining
patterns to LysoTracker Confocal microscope images of live transgenic animals
expressing CDF-2::mCherry cultured with the indicated levels of supplemental zinc and
LysoSensor Green DND-153. Images show intestinal cells with pharynx to the left and
tail to the right, red displays CDF-2::mCherry, green displays LysoSensor Greens, and
the merge shows green and red. Insets are magnified images of the boxed regions. The
scale bars represent 10μm and 2μm (boxed region).

Supplemental Figure 2.6. Asymmetric distribution of molecules in bilobed gut
granules (A) Confocal microscope images of live transgenic animals expressing
GFP::RAB-7 cultured with LysoTracker and the indicated levels of supplemental zinc.
Images shows intestinal cells with pharynx to the left and tail to the right, green displays
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GFP::RAB-7, red displays LysoTracker, and the merge shows green and red. The scale
bar represents 10μm. (B) Confocal microscope images of live transgenic animals
expressing GFP::RAB-7 and CDF-2::mCherry cultured with 200μM supplemental zinc.
Images shows intestinal cells with pharynx to the left and tail to the right, green displays
GFP::RAB-7, red displays CDF-2::mCherry, and the merge shows green and red. The
scale bar represents 10μm.

Supplemental Figure 2.7. CDF-2 and PGP-2 colocalize on the membrane of gut
granules Fluorescence microscope images of live transgenic animals expressing CDF2::mCherry and PGP-2::GFP cultured with the indicated levels of supplemental zinc. Red
displays CDF-2::mCherry, green displays PGP-2::GFP, and blue displays
autofluorescence. Images show a lateral view of intestinal cells, and boxed regions are
magnified in the right panels. In the presence of 100μM supplemental zinc, gut granules
appear to be bilobed and asymmetric. CDF-2::mCherry and PGP-2::GFP proteins fully
colocalized on the membrane of gut granules at both 0μM and 100μM supplemental zinc
(arrow). Autofluorescence fully colocalized with CDF-2::mCherry and PGP-2::GFP with
0μM supplemental zinc (triangle), but autofluorescence was detected only on one side of
bilobed granules with 100μM supplemental zinc (arrowhead). The scale bars represent
10μm and 2μm (boxed regions).

Supplemental Figure 2.8. Bilobed gut granules formation is independent of CDF-2
activity (A) Fluorescence microscope images of live transgenic animals expressing PGP2::GFP in the background of the cdf-2(tm788) mutation cultured with 200μM
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supplemental zinc. Images show a lateral view of intestinal cells, green displays PGP2::GFP, red displays LysoTracker, and merge displays green and red. The scale bar
represents 10μm. (B) Fluorescence microscope images of wild-type and cdf-2(tm788)
mutant animals costained with FluoZin-3 and LysoTracker and cultured with the
indicated levels of supplemental zinc. Images show intestinal cells, green displays
FluoZin-3, red displays LysoTracker, and merge displays green and red. While wild-type
animals display bilobed morphology of gut granules with an asymmetric staining of
FluoZin-3 and LysoTracker, cdf-2 mutants display single round shape of gut granules.
The scale bar represents 10μm.

Supplemental Figure 2.9. Molecular properties of gut granules in normal and high
zinc conditions In normal zinc conditions, gut granules are round vesicles that are
autofluorescent and stained by LysoTracker, LysoSensors, and FluoZin-3 staining. Gut
granule membrane contains late endosomal or lysosomal proteins, RAB-7 and LMP-1,
and gut granule-specific proteins, CDF-2 and PGP-2, not an early endosomal protein,
RAB-5. In high zinc conditions, gut granules are bilobed in shape, and the bilobed
granules display different distribution of molecules. One side displays autofluorescence,
staining of LysoTracker, LysoSensors, and FluoZin-3, and the localization of RAB-7,
LMP-1, CDF-2 and PGP2 proteins, identical to regular state gut granules. The other side
contains PGP-2 and CDF-2 and displays strong FluoZin-3 staining. The plus (+) and
minus (-) signs indicate the presence and absence of the molecules, respectively. The low
and high indicate the relative levels of the molecule.
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CHAPTER 3

The Cation Diffusion Facillitator TTM-1
Functions in Zinc Excretion in C. elegans

[The work in Chapter 3 is in preparation for submission with the following authors: Hyun
Cheol Roh, Sara Collier, James Guthrie, J. David Robertson, and Kerry Kornfeld.
H.C.R designed and performed all experiments and analyses except: S.C. performed
quantitative RT-PCR (Figures 3.2, 3.5B, 3.5C), and J.G. and J.D.R. performed the ICPMS (Figure 3.5A).]
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ABSTRACT

Zinc is the most widely used essential trace metal element. Organisms have
evolved precise mechanisms to maintain zinc homeostasis, and zinc transporters play an
important role in this process. Although many zinc transporters have been studied, how
multiple zinc transporters act in a coordinated manner is not well defined. Here we
characterize a C. elegans cdf gene, ttm-1, and its two isoforms, ttm-1a and ttm-1b. TTM1A localized to intracellular compartments of the intestine and hypodermis, and
expression was not induced by dietary zinc. TTM-1B localized to the apical membrane
of intestinal cells, and expression was induced by dietary zinc. Analyses of loss-function
mutations demonstrated that TTM-1 is involved in zinc excretion and is important for
zinc detoxification in the absence of CDF-2. These findings indicate that TTM-1 plays a
role in zinc detoxification and excretion in concert with CDF-2 in C. elegans.
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INTRODUCTION

Zinc is an essential trace element that is required for a wide range of biological
processes and implicated in a variety of human diseases (Vallee and Falchuk, 1993).
Since zinc deficiency and excess zinc are deleterious (Fosmire, 1990; Hambidge, 2000),
organisms have evolved mechanisms to achieve zinc homeostasis. As positively charged
zinc ions cannot move across the membrane of lipid bilayers, transmembrane zinc
transporter proteins are necessary for the movement of zinc in the cell (Eide, 2006).
Zinc transporters are divided into two major families, cation diffusion facilitator
(CDF/ZnT/SLC30) and Zrt-, Irt-like protein (ZIP/SLC39) (Kambe et al., 2006). CDF
proteins have six conserved transmembrane motifs, and they transport cytoplasmic zinc
out of the cell or into intracellular organelles, resulting in the decrease in the cytoplasmic
zinc concentrations. In contrast, ZIP proteins have eight conserved transmembrane
motifs, and they move zinc either from the outside of the cells or from intracellular
compartments into the cytoplasm. In mammals, there are 10 members in the CDF family
and 14 members in the ZIP family. Each zinc transporter displays different tissue
distributions and intracellular localizations (Lichten and Cousins, 2009), and the
cooperation of zinc transporters at multiple locations contributes to the regulation of zinc
homeostasis in the cell and in the whole organism. For example, in intestinal epithelial
cells, ZIP-4 localizes to the apical membrane while ZnT-1 localizes to the basolateral
membrane. These proteins function antagonistically to modulate intracellular zinc levels,
and the interaction between these zinc transporters is critical for the uptake of zinc from
the diet and the distribution of zinc to other tissues of the body. However, although
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previous studies have identified many zinc transporters, our understanding of the
networks of zinc transporters in an entire individual is limited.
C. elegans is an excellent system to study zinc metabolism (Bruinsma et al.,
2008; Davis et al., 2009; Murphy et al., 2011). Unlike the yeast, C. elegans contains
multiple tissues such as an intestine, musculature, nervous system, reproductive tracts
and epithelia, which allows the study of networks of zinc transporters at multiple
locations. The powerful genetic techniques in C. elegans biology facilitate the analysis of
functional interaction between zinc transporters, which have been difficult in mammalian
system. In addition, culture conditions have been developed that allow precise control
over dietary zinc(Bruinsma et al., 2008; Davis et al., 2009).
Previous studies of C. elegans characterized three C. elegans CDF proteins
which function in the control of zinc metabolism in the intestine. CDF-1 is localized to
the plasma membrane of intestinal cells, probably on the basolateral side, and transport
zinc from the intestine to the body cavity similar to mammalian ZnT-1. Zinc transported
by CDF-1 is excreted from the body perhaps via the excretory cell (Bruinsma et al.,
2002). CDF-2 localizes to the membrane of lysosome-related organelles, termed gut
granules, which store excess zinc during high zinc conditions (Davis et al., 2009). SUR-7
is present in the ER/Golgi complex and appears to be involved in the excretion of zinc by
transporting it into secretory vesicles (Yoder et al., 2004). Therefore, the intestine is a
critical tissue for maintaining zinc homeostasis in C. elegans and multiple CDF proteins
contribute to this process.
Here, we characterize the C. elegans cdf gene, ttm-1 (toxin-regulated target of
p38MAPK). ttm-1 was identified as a downstream transcriptional target of p38 kinase in
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response to bacterial toxins (Huffman et al., 2004). TTM-1 is also involved in the
response to environmental cadmium (Cui et al., 2007a). We demonstrate that ttm-1 is
composed of two isoforms, ttm-1a and ttm-1b, that are specified by different
transcription start sites. Expression of ttm-1a was not responsive to dietary zinc and
TTM-1A localized to intracellular compartments. In contrast, ttm-1b was strongly
induced by dietary zinc and TTM-1B localized to the apical membrane of intestinal cells.
Genetic analysis demonstrated that TTM-1B is involved in zinc excretion and is
important for zinc detoxification in combination with CDF-2. These results advance our
understanding of networks of zinc transporters for the regulation of zinc homeostasis in
animals.

RESULTS

Gene Structure of ttm-1
Based on the computational algorithm Gene Finder and the analysis of
expression sequence tags (ESTs), it was predicted that ttm-1 contained five exons and
encoded two variants, ttm-1a and ttm-1b (Figure 3.1A). To determine the molecular
mechanism that is responsible for the generation of the two isoforms, we performed 5’
rapid amplification of cDNA ends (5’ RACE). Using a primer specific to both predicted
isoforms of ttm-1, we detected two different mRNA products fused to the SL1 transspliced leader sequence at the 5’ end. While SL1 of ttm-1a mRNA is 3 bp apart from the
start codon, SL1 of ttm-1b mRNA is 4 bp apart from the start codon (data not shown).
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These results suggest that ttm-1 generates at least two isoforms using different
transcription start sites (Figure 3.1A).
BLAST searches indicated that TTM-1A/B are closely related to C. elegans
CDF-2 and human ZnT-2, but they are also similar to human ZnT-3, 4, and 8 (Figure
3.1B). TTM-1A and TTM-1B contain distinct N-terminal sequences (Figure 3.1B). Most
CDF proteins contain a conserved histidine motif, (HX)n in the loop between the fourth
and fifth transmembrane motifs, and this motif is presumed to regulate zinc transporter
activity (Gaither and Eide, 2001a; Kawachi et al., 2008).TTM-1B has a unique histidineand glycine-rich motif at its N-terminus which is similar to the (HX)n motif in the loop
between the fourth and fifth transmembrane motifs (Figures 3.1B and C). This Nterminal (HX)n motif is unique to C. elegans TTM-1B and may be an important
regulatory or functional domain.

Regulation of ttm-1b by Dietary Zinc
The expression of genes involved in zinc metabolism, such as mtl-1, mtl-2 and
cdf-2, are regulated by the level of dietary zinc (Davis et al., 2009; Freedman et al.,
1993). To determine whether ttm-1 expression is affected by dietary zinc levels, we
performed quantitative RT-PCR on animals grown with different levels of zinc. ttm-1a
mRNA levels were constant across all zinc concentrations. In contrast, ttm-1b mRNA
was strongly induced by 200μM supplemental zinc compared to 0μM supplemental zinc
(Figure 3.2). These results suggest that only ttm-1b is responsive to excess dietary zinc
and may be more important than ttm-1a for the response to high zinc conditions.
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Tissue Distribution of ttm-1
To determine the cell types expressing ttm-1a and ttm-1b, we generated
transgenic animals that express GFP under the control of the predicted ttm-1a and ttm-1b
promoters. For ttm-1a, the region between the ttm-1a start codon and the 3’ end of the
adjacent upstream gene was used to drive GFP expression (Figure 3.1A). Pttm-1a::GFP
transgenic animals displayed GFP expression in the hypodermis and the intestine (Figure
3.3A). For ttm-1b, because its transcription starts upstream of exon 3, intro 2 is likely to
function as a promoter region. The large size of intron 2 (~10kbp) suggests that it may
contain important promoter elements that drive ttm-1b expression. We built a construct
containing ~6kb upstream of the ttm-1b start codon (Pttm-1b(-6kb)::GFP) (Figure 3.1A).
Transgenic animals containing this construct displayed GFP expression in multiple
tissues including the intestine, head neurons, seam cells, hypodermis and the vulva
(Figure 3.3B). These results suggest that each ttm-1 isoform has the unique tissue
distribution.
To determine if the expression patterns observed in transgenic animals reflects
the endogenous ttm-1b expression pattern, we tested whether GFP expression was
induced in Pttm-1b(-6kb)::GFP transgnic animals (Figure 3.2). When incubated with
200μM supplemental zinc, these animals displayed a significant increase in intestinal
GFP expression (Figure 3.3C, a-b). This induction of GFP was restricted to the intestine.
GFP expression in head neurons, for example, was not affected by zinc (Figure 3.3C, cd). These results suggest that the 6kb fragment immediately upstream of the TTM-1B
start codon contains elements important for tissue specific and zinc-responsive
expression.
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To determine the location of the key promoter elements responsible for ttm-1b
expression, we built a truncated construct that contains ~2.4kb upstream of the ttm-1b
start codon (Pttm-1b(-2.4kb)::GFP) (Figure 3.1A). In Pttm-1b(-2.4kb)::GFP transgenic
animals, GFP expression was absent from intestinal cells but detected in the other tissues
where Pttm-1b(-6kb)::GFP was expressed (Supplemental Figure 3.1A). In addition, GFP
was not induced in response to high zinc levels in Pttm-1b(-2.4kb)::GFP transgenic
animals (Supplemental Figure 3.1B). These results suggest that the region between ~6kb
and ~2.4kb upstream of the ttm-1b start codon contains elements required for intestinal
and zinc-responsive expression of ttm-1b.

Intracellular Localization of TTM-1
To determine the intracellular localization of TTM-1A and TTM-1B proteins, we
generated transgenic animals that express TTM-1A or TTM-1B protein fused to GFP
under the control of each respective promoter (Figure 3.1A). In the head and body
hypodermis, TTM-1A::GFP localized to intricate intracellular networks (Figures 3.4A
and 3.4B). To identify the compartments containing TTM-1A::GFP, we performed
colocalization experiments using MitoTracker and autofluorescence from gut granules.
TTM-1A::GFP was not colocalized with MitoTracker (data not shown) or
autofluorescence from gut granules in the intestine (Figure 3.4C) These data suggest that
TTM-1A is not present in mitochondria or gut granules. We are currently testing
additional molecular markers to identify the TTM-1A intracellular localization.
In intestinal cells, TTM-1B::GFP localized to the apical plasma membrane,
whereas it localized to intracellular structures in other tissues such as hypodermis and
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neurons (Figure 3.4D), suggesting that the intracellular localization of TTM-1B may be
different depending on the type of tissues. To determine if TTM-1B levels are induced by
dietary zinc, we analyzed TTM-1::GFP expression in response to supplemental zinc.
Consistent with the induction of ttm-1b mRNA expression, TTM-1B::GFP on the apical
membrane of intestinal cells was increased in the presence of 100μM supplemental zinc
(Figure 3.4E), suggesting that high levels of TTM-1B proteins on the apical membrane of
intestinal cells may play an important role in the response to high levels of zinc. In the
other tissues such as neurons and hypodermis, TTM-1::GFP expression was not changed
(data not shown), consistent with the observation from Pttm-1b(-6kb)::GFP transgenic
animals. These results suggest that TTM-1B may have two distinct functions. In the
tissues including neurons and hypodermis, TTM-1B may be involved in the flow of zinc
into intracellular compartments. In the intestine, it may play a role in the excretion of
zinc by transporting it directly into the intestinal lumen in response to high levels of zinc.

Role of TTM-1 in Excretion of Zinc
To study the function of TTM-1 in zinc metabolism, we examined the mutant
allele ttm-1(ok3503) which was generated by the C. elegans Gene Knockout Consortium.
We analyzed the genomic sequence of the ttm-1 locus of the ok3503 strain and found that
the ok3503 allele is a deletion of 877 bp from exon 4 to intron 4 (Figure 3.1A). This
deletion is predicted to remove transmembrane motifs II through VI and may cause an
early translation termination due to a splicing site disruption and subsequent frame shift
(Figure 3.1B). Because of the loss of a large portion of the transmembrane region, we
predict ttm-1(ok3503) is a loss-of-function allele. Since the deleted region is common to
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both of ttm-1a and ttm-1b isoforms, the ttm-1(ok3503) is predicted to inactivate both
isoforms.
Based on the localization of TTM-1B, we hypothesized that one of the functions
of ttm-1 is to excrete zinc in high zinc conditions. To test the hypothesis, we measured
the total zinc content of ttm-1(ok3503) animals by using inductively coupled plasmamass spectrometry (ICP-MS). In normal conditions without supplemental zinc, the zinc
content of ttm-1(ok3503) animals was similar to wild-type animals. However, in the
presence of 200μM supplemental zinc, ttm-1(ok3503) animals displayed approximately
40% higher total zinc than wild-type animals, indicating more zinc had accumulated in
the mutant animals (Figure 3.5A). These results suggest that TTM-1 promotes the
excretion of zinc during high zinc conditions.
To examine the excretory role of TTM-1 by an independent approach, we
measured mRNA levels of metallothionein genes. Metallothionein gene expression is
upregulated by increased levels of cytoplasmic zinc (Davis and Cousins, 2000). In
normal conditions without supplemental zinc, ttm-1(ok3503) animals displayed
approximately 3-fold higher levels of mtl-1 compared to wild-type animals. In the
presence of 100μM and 200μM supplemental zinc, there was also approximately 2-fold
increase in mtl-1 mRNA levels in ttm-1(ok3503) animals compared to wild-type animals
(Figure 3.5B). Similar results were observed for mtl-2 mRNA expression (Figure 3.5C).
These results suggest that ttm-1 mutant animals contain higher levels of cytoplasmic zinc
both in normal and high zinc conditions. Furthermore, mtl-1/2 expression may be a more
sensitive measure of cytoplasmic zinc levels than ICP-MS.
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Role of ttm-1 in Zinc Detoxification
To determine the role of TTM-1 in zinc detoxification, we examined zinc
sensitivity by measuring growth rate in the presence of different concentrations of
supplemental zinc as described in Chapter 2. ttm-1(ok3503) animals grew similarly to
wild-type animals in under all zinc conditions (Figure 3.6A), suggesting that TTM-1 may
not be required for zinc detoxification. CDF-2 is the zinc transporter that is most similar
to TTM-1 in C. elegans. To determine if these proteins have overlapping functions, we
examined zinc sensitivity of ttm-1(ok3503);cdf-2(tm788) animals. ttm-1(ok3503);cdf2(tm788) animals displayed a reduced growth rate in normal zinc conditions and an
enhanced sensitivity to high levels of zinc compared to cdf-2(tm788) animals (Figure
3.6A). These data indicate that TTM-1 may play a role in zinc detoxification in the
absence of CDF-2.
To further explore the relationship between TTM-1 and CDF-2, we measured
mRNA levels of mtl-1/2 in ttm-1(ok3503);cdf-2(tm788) animals. Without supplemental
zinc, ttm-1 and cdf-2 single mutant animals displayed approximately 3-fold and 1.5-fold
increase in mtl-1 expression, while ttm-1(ok3503);cdf-2(tm788) animals displayed an
approximately 18-fold increase (Figure 3.5B). In the presence of 100μM supplemental
zinc, ttm-1(ok3503);cdf-2(tm788) animals also displayed a synergistic increase of mtl-1
expression. mtl-2 mRNA levels displayed similar patterns to mtl-1 mRNA (Figure 3.5C).
These results suggest that TTM-1 and CDF-2 function in parallel to detoxify cytoplasmic
zinc.
To test whether TTM-1 cooperates with other known CDF members, we
examined alleles of cdf-1 and sur-7. Animals carrying cdf-1(n2527) or sur-7(ku119) were
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hypersensitive to zinc (Bruinsma et al., 2002; Yoder et al., 2004) (Figure 3.6B and
Supplemental Figure 3.2). Both ttm-1(ok3503);cdf-1(n2527) and ttm-1(ok3503);sur7(ku119) animals were indistinguishable from cdf-1(n2527) and sur-7(ku119) animals,
respectively, in the growth-rate assay (Figure 3.6B and Supplemental Figure 3.2). These
results suggest that neither CDF-1 nor SUR-7 functionally interact with TTM-1.

Role of TTM-1B in Zinc Detoxification
To determine which isoform of TTM-1 is important for zinc excretion and
detoxification, we performed a rescue experiment by expressing each isoform. We
generated transgenic animals expressing either TTM-1A::GFP or TTM-1B::GFP in the
ttm-1(ok3503);cdf-2(tm788) animals, and measured zinc sensitivity. TTM-1A::GFP did
not rescue the zinc hypersensitivity of ttm-1(ok3503);cdf-2(tm788) animals, TTM1B:GFP expression displayed a partial rescue of the phenotype (Figure 3.6C). These
results suggest that TTM-1B, but not TTM-1A, plays a critical role in zinc detoxification
by promoting excretion of zinc from the intestine.

DISCUSSION

ttm-1 was originally identified as one of the downstream targets of p38 kinase
(Huffman et al., 2004). ttm-1 expression is increased in response to pore-forming
bacterial toxins via the p38 MAPK signaling pathway, and RNAi of ttm-1 causes
hypersensitivity to the same toxins. ttm-1 expression is also induced by cadmium
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exposure, and it is important for cadmium tolerance (Cui et al., 2007a). However, the
function of ttm-1 has not been determined.
We demonstrate that TTM-1 plays a role in zinc excretion and is important for
zinc detoxification in response to high levels of dietary zinc. Loss of ttm-1 results in
elevated zinc contents and mtl-1/2 mRNA levels. These data suggest that zinc
accumulates in ttm-1(ok3503) animals and TTM-1 functions in excretion of zinc in
response to high zinc. To study the action of TTM-1, we characterized the tissue
distribution and intracellular localization of TTM-1A/B. TTM-1A is localized to
intracellular compartments in intestinal and hypodermal cells. TTM-1B displayed two
different localizations; while TTM-1B is on the apical plasma membrane of intestinal
cells, it is localized to intracellular compartments in other tissues such as hypodermis and
neurons. These results suggest that TTM-1A/B has multiple functions depending on the
type of cells.
One function of TTM-1 may be to supply zinc to intracellular compartments via
the action of TTM-1A. Since ttm-1a expression is constant regardless of zinc status,
TTM-1A may mediate the flow of zinc into zinc-requiring intracellular compartments.
We demonstrated that the intracellular compartments containing TTM-1A are neither
mitochondria nor gut granules, and further experiments are required to determine the
localization of this protein. Additionally, we are conducting assays to determine the
function of TTM-1A.
Given that ttm-1 mutant animals displayed a zinc accumulation phenotype, the
major function of TTM-1 appears to be the excretion of zinc via the action of TTM-1B.
ttm-1b was most strongly expressed in the intestine which is a metabolically active tissue
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in C. elegans. TTM-1B was localized on the apical plasma membrane of intestinal cells,
and its expression was strongly induced by high levels of dietary zinc. Additionally,
TTM-1B::GFP rescued the zinc hypersensitivity phenotype of ttm-1(ok3503);cdf2(tm788) animals. Taken together, these results suggest that TTM-1B promotes excretion
of zinc from intestinal cells into the lumen during high zinc conditions. To further define
the role of TTM-1B, we will use tissue-specific promoters to determine the site of TTM1B action.
TTM-1 functions with CDF-2 in zinc detoxification. Although TTM-1 plays a
role in zinc excretion, it was not required for efficient zinc detoxification. TTM-1 was,
however, critical for zinc detoxification in the absence of CDF-2. These results raise two
possibilities. First, zinc excretion by TTM-1 plays a minor role in zinc detoxification,
and its role is detectable only in sensitized strains that are hypersensitive to zinc. Second,
TTM-1 communicates with CDF-2 to control the flow of intracellular zinc. To test these
possibilities, we tested the role of TTM-1 in other zinc hypersensitive strains including
cdf-1 and sur-7 mutant animals. In contrast to ttm-1;cdf-2 double mutant animals, neither
ttm-1;cdf-1 nor ttm-1;sur-7 double mutant animals displayed additive phenotypes,
suggesting a specific functional interaction between TTM-1 and CDF-2.
As TTM-1 was important in the absence of CDF-2, it is likely that CDF-2 is
sufficient for zinc detoxification, and only when CDF-2 is not functional does the role of
TTM-1 become critical. Zinc is a valuable nutrient to animals. When exposed to zinc
abundant environments, animals store excess zinc rather than excrete it. Therefore, it is
natural that zinc storage by CDF-2 in gut granules has the priority for zinc detoxification
over zinc excretion by TTM-1 in high zinc conditions. This study demonstrates that
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functional interaction between zinc transporters is an important mechanism to control
zinc metabolism in an efficient manner. For the molecular mechanism by which CDF-2
has priority over TTM-1, it is possible that CDF-2 has higher affinity for zinc than TTM1B so that excess zinc is mainly transported into gut granules. Alternatively, TTM-1B has
a unique histidine-rich motif at its N-terminus, which may receive a signal to attenuate
TTM-1B transporter activity. The interaction between multiple zinc transporters will be
an important future research topic to be addressed in zinc physiology.

MATERIALS AND METHODS

General Methods and Strains
C. elegans strains were cultured at 20℃ on nematode growth medium (NGM) and the E.
coli OP50 strain was used for food (Brenner, 1974). The wild-type C. elegans and parent
of all mutant strains was Bristol N2. The following mutations were used: cdf-1(n2527)
(Bruinsma et al., 2002), cdf-2(tm788) (Davis et al., 2009) and sur-7(ku119) (Yoder et al.,
2004). ttm-1(ok3503) was generated by the C. elegans Gene Knockout Consortium and
obtained from the Caenorhabditis Genetics Center. ttm-1(ok3503) was backcrossed five
times before analysis. The molecular lesion of ttm-1(ok3503) was determined by
sequencing of the PCR-amplified ttm-1 locus using the following primers:
cccgccaaaaattattcaga and accgtaatgggacagacagc. Double mutant animals were generated
by standard methods, and genotypes were confirmed by PCR or DNA sequencing.
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5’ Rapid Amplification of cDNA Ends (RACE)
To determine the presence of ttm-1a and ttm-1b isoform transcripts and to study the
mechanism by which those isoforms were encoded by the ttm-1 genomic locus, we
performed 5’ RACE using the 5’ RACE System for Rapid Amplification of cDNA Ends
Version 2.0 according to the manufacturer’s protocol (Invitrogen, Carlsbad, CA). Briefly,
RNA was purified from wild-type adult animals using TRIzol and reverse-transcribed
using a gene specific primer (GSP1) which hybridizes to exon 4. Next, cDNA was tailed
with oligo(dC) and amplified by PCR using Abridge Anchor Primer and another gene
specific primer (GSP2) which is ~30bp 5’ of GSP1. Two different PCR products were
observed after agarose gel electrophoresis and then purified and sequenced. GSP1 is
gtaaccgaatgaaagacgct, and GSP2 gagaattcaagacgtgcacaacgaatcg.

Quantitative real-time PCR
To generate samples of synchronized adult animals, eggs were isolated from gravid adult
hermaphrodites by bleaching, hatched in M9 overnight, and the worms were cultured on
NGM dishes for approximately 2.5 days. Synchronized animals at L4/young adults were
washed off and then cultured on noble agar minimum medium (NAMM) dishes
supplemented with zinc sulfate (ZnSO4) and seeded with concentrated OP50. After 1624hr, animals were washed off and collected for RNA purification. RNA analysis was
performed as described by Davis et al. (2009) with modifications. Briefly, RNA was
purified using TRIzol and treated with DNase I, and cDNA was synthesized using the
High-Capacity cDNA Reverse Transcription kit according to the manufacturer’s protocol
(Applied Biosystems, Foster City, CA). PCR was performed using a BioRad MyiQ
86

Single Color Real-Time PCR Detection System thermocycler and iQ SYBR Green
Supermix (BioRad Laboratories, Hercules, CA). Fold change was determined by
comparing the changes in target gene expression between different conditions to the
changes in reference gene expression (ama-1 and rps-23) under the same conditions.

Transgenic Strain Construction & Microscopy
To generate promoter fusion constructs, we inserted the putative promoter region of ttm1a or ttm-1b, coding sequence of GFP and the unc-54 3’UTR into pBluescript SK+
(Stratagene, Santa Clara, CA). For ttm-1a, the region between the ttm-1a start codon and
the 3’ end of the adjacent upstream gene (~1.2kb) was amplified by PCR using wild-type
genomic DNA and used to make pSC27 [Pttm-1a::GFP]. For ttm-1b, ~6kb and ~2.4kb
regions upstream of exon 3 were amplified by PCR using wild-type genomic DNA and
used to make pHR6 [Pttm-1b(-6kb)::GFP] and pSC28 [Pttm-1b(-2.4kb)::GFP],
respectively. To generate translational fusion constructs, ttm-1a cDNA was amplified by
PCR using the EST clone, yk1572h06, which was obtained from the National Institutes
of Genetics in Japan. ttm-1b cDNA was generated by combining the exon 4-5 fragment
PCR-amplified from the EST clone, yk1572h06, and the exon 3 fragment PCR-amplified
from wild-type genomic DNA. Next, the promoter, cDNA of ttm-1a or ttm-1b without
the stop codon, coding sequence of GFP and the unc-54 3’UTR were inserted into
pBluescript SK+ to build pSC29 [TTM-1A::GFP] and pHR7 [TTM-1B::GFP].
Transgenic animals were generated by coinjecting each plasmid construct and the
coinjection marker pCJF104 [Pmyo-3::mCherry].
For fluorescence microscopy, animals were paralyzed in a drop of 10mM
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levamisole in M9 on 2% agarose pads on microscope slides. Images were captured using
a Zeiss Axioplan 2 microscope equipped with a Zeiss AxioCam MRm digital camera.

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
Metal content analysis was performed as described by Davis et al. (2009) with
modifications. For the preparation of samples, large populations of animals were
generated by culturing on multiple 100mm NGM dishes. Animals were then washed off
and cultured on multiple 100mm NAMM dishes supplemented with ZnSO4 and seeded
with concentrated OP50. After ~24 h, animals were washed three times in magnesiumfree (Mg-free) M9 containing 0.01% Tween-20, incubated in 1mM serotonin in Mg-free
M9 for 30 min to remove bacteria from the intestinal lumen, washed twice in Mg-free
M9, and transferred to preweighed tubes and frozen at -80°C. For ICP-MS, samples were
freeze-dried, reweighed to obtain the dry pellet weight, and digested by incubation in a
hot block digester with concentrated nitric acid and hydrogen peroxide solution. The
solution was diluted with water, and internal standards were added to correct for matrix
effects. Instrument calibration standards were prepared from multi-element stock
solutions (High-Purity Standards) to generate a linear calibration curve, and samples
were analyzed using a VG Axiom high-resolution ICP-MS (Thermo Fisher Scientific).
The content of zinc, iron, copper, magnesium and manganese was determined as a value
in parts-per-million (ppm) by dividing metal weight by dry pellet weight (μg/g).

Zinc Sensitivity Assays
Eggs were isolated from gravid adult hermaphrodites by treating with NaOH and bleach
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and hatched in M9 overnight. Synchronized L1 animals were then cultured on noble agar
minimum medium (NAMM) dishes supplemented with ZnSO4 and seeded with
concentrated OP50. After about 3 days, animals were washed off, paralyzed with 10mM
sodium azide (NaN3) in M9, and then mounted on a 2% agarose pad on a microscope
slide. Images were captured as described above. Length of animals was measured using
ImageJ software (NIH) by drawing a line from the nose to the tail tip.
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FIGURE LEGENDS

Figure 3.1. Gene structure and protein sequence of ttm-1. (A) ttm-1 encodes two
isoforms, ttm-1a and ttm-1b using different transcription start sites near exon 1 and exon
3, respectively, as indicated by arrows. Both ttm-1a and ttm-1b mRNA contain SL1 at
their 5’ ends. The ok3503 allele is a deletion of 877bp in the region between exon 4 and
intron 4. Transgene constructs used for expression pattern analysis are depicted. (B)
TTM-1A/B protein sequence alignment with C. elegans CDF-2 and human orthologs.
Identical and similar amino acids are displayed in black and gray, respectively. Blue
boxes indicate six predicted transmembrane motifs (labeled I-VI) conserved in the CDF
family. The pair of red triangles indicates the region deleted by the ok3503 allele. The
red bar indicates the region containing the unique N-terminal histidine-rich motif of
TTM-1B, the green bar indicates the conserved (HX)n motif of CDF proteins in the loop
between the fourth and fifth transmembrane motifs. (C) The unique N-terminal histidinerich motif (red bar) and the conserved (HX)n motif in the loop between the fourth and
fifth transmembrane motif (green bar) are compared. Histidine residues are displayed in
red.

Figure 3.2. Expression of ttm-1a and ttm-1b mRNA by high dietary zinc. mRNA levels
of indicated genes were analyzed by quantitative RT-PCR. The Y-axis represents the fold
changes of relative mRNA levels between 0 and 200μM supplemental zinc, and the bars
indicate the average ± SEM of two independent experiments. While ttm-1a displays the
constant mRNA levels, ttm-1b displays significant induction of mRNA expression by
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200μM supplemental zinc. ama-1 is a reference gene which is not responsive to zinc, and
cdf-2 is a positive control which is induced by zinc.

Figure 3.3. Fluorescence microscope images of transgenic animals expressing GFP
under the control of ttm-1a or ttm-1b promoter. (A) ttm-1a expression in the hypodermis
and intestine. (B) ttm-1b expression in the head neurons, intestine, hypodermis including
seam cells and vulva. (C) (a-b) ttm-1b expression is induced in the intestine by 200μM
supplemental zinc. The arrows indicate either end of the intestine. (c-d) The head of an
animal including the first pair of intestinal cells is displayed (anterior to the right and
posterior to the left). While intestinal cells (triangles) display induction of ttm-1b by
200μM supplemental zinc, ttm-1b expression is not responsive to zinc in the head
neurons (arrows).

Figure 3.4. Fluorescence microscope images of transgenic animals expressing TTM-1A
or TTM-1B translationally fused to GFP. Localization of TTM-1A::GFP to intracellular
compartments in the head hypodermis (A), body hypodermis (B), and intestine (C). In
the intestine, green displays TTM-1A::GFP, and blue display autofluorescence from gut
granules. TTM-1A::GFP does not colocalize with gut granule autofluorescence. (D)
Localization of TTM-1B::GFP on the apical membrane of intestinal cells (top) and to
intracellular compartments of the tail hypodermis (bottom). The arrows indicate the
lumen of the intestine. (E) Induction of TTM-1B::GFP on the apical membrane of
intestinal cells by 100μM supplemental zinc. The arrows indicate the lumen of the
intestine.
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Figure 3.5. (A) Total zinc contents of wild-type (WT) and ttm-1(ok3503) animals
measured by ICP-MS. (B-C) mRNA levels of mtl-1 (B) and mtl-2 (C) in wild-type (WT),
ttm-1(ok3503), cdf-2(tm788), and ttm-1(ok3503);cdf-2(tm788) animals. mRNA levels
were analyzed by quantitative RT-PCR.

Figure 3.6. (A) Zinc sensitivity of wild-type (WT), ttm-1(ok3503), cdf-2(tm788), and
ttm-1(ok3503);cdf-2(tm788) animals. Animals synchronized at the L1 stage were
cultured with the indicated levels of supplemental zinc for 3 days. The length of
individual animals was measured using microscopy and ImageJ software. The values
indicate the average of the length of animals ± SD (n=20). (B) Zinc sensitivity of wildtype (WT), ttm-1(ok3503), cdf-1(c2527), and ttm-1(ok3503);cdf-1(n2527) animals. (C)
Zinc sensitivity of wild-type (WT), ttm-1(ok3503), cdf-2(tm788), ttm-1(ok3503);cdf2(tm788), and transgenic animals expressing TTM-1A::GFP or TTM-1B::GFP in the ttm1(ok3503);cdf-2(tm788) mutation.

Supplemental Figure 3.1. Fluorescence microscope images of transgenic animals
expressing GFP under the control of the short ttm-1b promoter. (A) GFP is observed in
the head neurons, hypodermis and vulva. (B) GFP is not induced by 200μM
supplemental zinc.

Supplemental Figure 3.2. Zinc sensitivity of wild-type (WT), ttm-1(ok3503), sur7(ku119), and ttm-1(ok3503);sur-7(ku119) animals.
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CHAPTER 4

Conclusions, Discussions and Future Directions
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Identification of zinc storage site in animals
Organisms have evolved homeostatic mechanisms to regulate uptake,
consumption, excretion and storage of nutrients. In these processes, storage of nutrients
is critical for survival of organisms in particular in natural environments where nutrient
availability fluctuates. When nutrients are replete, excess nutrients are stored so that they
can be mobilized under nutrient deficient conditions. For example, carbohydrates and
lipids are stored in the forms of glycogen and triacylglycerols in the liver and adipocytes
which are specialized tissues for fat storage. In response to nutrient deficiency, the stored
nutrients are mobilized to meet the need for energy. In the wild, the availability of metal
is also variable, so organisms have mechanisms for metal storage and mobilization. For
instance, iron is essential in mammals for erythropoietic function and oxidative
metabolism, and iron is stored in the liver in the forms of ferritin or hemosiderin (Munoz
et al., 2009).
Mechanisms of zinc storage have been described in the yeast Saccharomyces
cerevisiae. The vacuole plays a role as a zinc storage site where CDF and ZIP proteins
shuttle zinc across the membrane in response to zinc level changes (Eide, 2006).
However, zinc storage in multicellular animals has not been well defined. It has been
thought that zinc is unlikely to be stored in higher animals, such as mammals, based on
kinetic studies using stable zinc isotopes (Krebs and Hambidge, 2001). However, these
studies need to be interpreted with caution because they examined a small fraction of the
total zinc pools and the range of testable dietary zinc levels was relatively narrow. Our
studies of C. elegans using a variety of experimental approaches and wider ranges of
dietary zinc, described in Chapter 2 and Appendix A, identified a site of zinc storage in
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the animal. Lysosome-related organelles in intestinal cells, called gut granules, play a
critical role in zinc storage in C. elegans, and this discovery suggests a possibility that
zinc storage mechanisms may be present in higher animals.
Given that both the yeast vacuole and C. elegans gut granules have lysosomal
properties, we can hypothesize that lysosome-related organelles may have an
evolutionary conserved role in zinc storage. In fact, labile zinc is detected by zincspecific fluorescent dyes in intracellular organelles which have lysosomal properties and
often called zincosomes in various types of mammalian cells (Eide, 2006). There are also
specialized lysosome-related organelles in mammals that may be involved in zinc
homeostasis. For instance, paneth cells located in the bases of the small intestine contain
a large number of secretory granules that have lysosomal proteins and high levels of zinc.
The number of paneth cells and their secretory granule morphology are affected by
dietary zinc levels (Giblin et al., 2006), suggesting that these cells and the granules might
play a role in zinc storage in mammals. Therefore, the investigation of zinc storage in
lysosome-related organelles in higher animals will be an important research topic in zinc
physiology.

Physiological functions of zinc storage in gut granules
Zinc storage in gut granules has two functional roles in the control of zinc
metabolism. One function is zinc detoxification in response to high zinc conditions.
When there are defects in gut granule biogenesis or zinc transport into gut granules,
animals become hypersensitive to high levels of dietary zinc and suffer severely from
zinc toxicity. In yeast, the vacuole functions in zinc detoxification. However, in
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multicellular animals, zinc-containing organelles have not been demonstrated to protect
organisms from zinc toxicity. Thus, our studies of C. elegans document a novel role of
lysosome-related organelles in zinc detoxification in animals. Metal detoxification
processes are also mediated by many other genes such as metallothionein genes. An
important direction for future research can be to study how zinc sequestration in
lysosome-related organelles cooperates with other genes such as zinc-binding proteins.
The second function of zinc stored in gut granules is to provide a source of zinc
that can be utilized during dietary deficiency. Our studies demonstrated that stored zinc is
mobilized from gut granules to meet the need for zinc by visually monitoring gut granule
zinc levels and measuring growth rates of animals in the shift from high to low zinc
conditions. Mobilization process of stored zinc has been well studied in the yeast, but it
has not demonstrated in multicellular animals. Although zinc level changes in organelles
of mammalian cells have been detected, it is not a homeostatic process in response to
dietary zinc level changes. Our results here provide the first evidence of a site of zinc
storage in animals that is mobilized during dietary deficiency. In the yeast, a ZIP protein
Zrt3 play a critical role in zinc mobilization by moving zinc out of the vacuole in
response to zinc deficiency (MacDiarmid et al., 2000). In C. elegans gut granules,
mobilization is also likely to require a ZIP protein that shuttles zinc from the lumen of
gut granules to the cytoplasm, and future studies will focus on the identification of this
zinc transporter.

Function of CDF-2 in zinc storage
The initial study described in Appendix A proposed the role of CDF-2 in zinc
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storage based on its localization on gut granules and the phenotype of reduced total zinc
levels of cdf-2 mutant animals. Further thorough experiments described in Chapter 2
provide direct evidence of the role of CDF-2 in gut granule zinc storage. Colocalization
experiments using markers confirmed that CDF-2 is localized to the membrane of gut
granules. CDF-2 expression is induced by high levels of dietary zinc, suggesting its
functional importance during high zinc conditions. Most importantly, while zinc storage
was reduced by a loss-of-function mutation of cdf-2, it was elevated by overexpression of
CDF-2 proteins, suggesting that cdf-2 is necessary and sufficient for zinc storage in gut
granules. Consistent with the model that CDF-2 directly transports zinc into gut granules,
the action of CDF-2 is cell-autonomous in intestinal cells to promote zinc accumulation.
Intriguingly, we observed that a small amount of zinc is likely to be stored even in cdf-2
mutant animals, suggesting that there may be a CDF-2 independent mechanism that can
move zinc into gut granules such as using alternative zinc importer or vesicular
trafficking. C. elegans CDF-2 is homologous to mammalian ZnT-2. Similar to CDF-2,
ZnT-2 is also localized to intracellular vesicles and upregulated by high levels of zinc
(Liuzzi et al., 2001). This similarity proposes a possibility that ZnT-2 may be involved in
zinc storage in mammals and it can be one way to approach to zinc storage mechanisms
of higher animals.

Morphological changes of gut granules in high zinc
In normal conditions, gut granules are single round-shaped vesicles. However,
we observed that when exposed to high zinc conditions, gut granules undergo
morphological changes and display the shape of bilobed vesicles with asymmetric
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distribution of molecules. In particular, lysosomal markers were positive for one side,
whereas zinc was highly concentrated in the other side. These findings suggest that high
levels of zinc lead to the novel structural changes of gut granules that may have
important functions in zinc metabolism. First, it is possible that this structural change is a
mechanism to promote zinc storage. Generation of additional adjacent vesicles devoted
to storing zinc may improve the capacity of storage and facilitate rapid sequestration.
Second, bilobed vesicles may be utilized for the secretion of zinc which exceeds the
capacity of gut granule storage. Excess zinc is concentrated in one side of bilobed
vesicles, and this side is secreted via certain trafficking pathways to the extracellular
space. Thus, the bilobed structure may be imporant for the control of the balance
between zinc storage and excretion. These possible functions of the bilobed structure can
be studied by monitoring dynamic structures of gut granules in different zinc conditions
using time-lapse live imaging.
Genetic analysis to dissect pathways involved in bilobed vesicle formation
demonstrated that neither lysosome biogenesis process nor endocytosis is required for
this process. Bilobed vesicle formation was also independent of CDF-2 activity. In
contrast, Glo genes that are required for gut granule biogenesis during development such
as pgp-2 and glo-3 genes were are also necessary for this morphological change during
high zinc conditions. These results suggest that the formation of bilobed vesicles may be
mediated by processes specific to gut granules and that intracellular trafficking may play
a role in zinc metabolism. The mechanism by which intracellular trafficking regulates
zinc metabolism in the aspects of storage or secretion will be important topics to be
studied.
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Characterization of a cdf gene, ttm-1 in zinc metabolism
ttm-1 (toxin-regulated target of p38MAPK) is a cdf gene which is the most
similar to C. elegans cdf-2 and human ZnT-2. ttm-1 was originally identified as one of
downstream targets of p38 kinase in the response to bacterial toxins (Huffman et al.,
2004). ttm-1 expression is increased in response to pore-forming bacterial toxins via the
p38 MAPK signaling pathway, and RNAi of ttm-1 causes hypersensitivity to the the
same toxins. ttm-1 is also involved in cadmium toxicity (Cui et al., 2007a); ttm-1
expression is induced by cadmium, and it is important for cadmium tolerance. However,
the function of ttm-1 has not yet been studied.
The work presented in Chapter 3 describes the functional role of ttm-1 in zinc
metabolism in C. elegans. Unlike the C. elegans cdf genes previously characterized, ttm1 encodes two isoforms, ttm-1a and ttm-1b, suggesting that ttm-1 may have multiple
functions. First, TTM-1 may function in providing zinc into intracellular compartments
via the action of TTM-1A. Since TTM-1A is localized to intracellular compartments and
ttm-1a expression is not affected by zinc levels, it appears that TTM-1A mediates
constant influx of zinc into the intracellular compartments where it is needed for the
synthesis or activity of zinc-dependent proteins. Second, TTM-1 functions in the
excretion of zinc via action of TTM-1B. TTM-1B expression is strongly induced by high
levels of zinc and TTM-1B is localized on the apical membrane of intestinal cells where
it appears to move cytoplasmic zinc out to the lumen. It is important to note that no CDF
protein that mediates zinc efflux on the plasma membrane has been identified in the yeast.
In humans, ZnT-5 is reported to be localized on the apical membrane of small intestinal
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cells. However, it is not clear whether it promotes uptake or excretion of zinc (Cragg et
al., 2002; Cragg et al., 2005). Therefore, these findings demonstrate the first evidence
that there is a direct flow of zinc from intestinal cells into the lumen to regulate zinc
levels in animals and suggest that mammals may have similar mechanisms to control
zinc homeostasis.
Interestingly, ttm-1 functionally interacts with cdf-2. Although zinc excretion by
ttm-1 is not required for efficient zinc detoxification, it becomes critical in the absence of
cdf-2, suggesting that cdf-2 may suppress ttm-1 activity and thereby that zinc storage
process has priority over excretion process. This regulatory mechanism is important for
the efficient use of dietary zinc. Once zinc is transported into intestinal cells at the cost of
energy, it should be utilized by animals. Thus, ttm-1 may be fully activated only when
zinc excretion is necessary. For example, when zinc storage is saturated or defective due
to mutations, zinc excretion by ttm-1 can be an effective way to detoxify excess zinc.
These findings suggest that interactions between zinc transporters can be a key
mechanism to achieve the efficient control of zinc metabolism. The molecular
mechanism by which cdf-2 suppresses ttm-1 activity will be an interesting question to be
addressed in the future research. It is possible that CDF-2 has a significantly higher
affinity for zinc than TTM-1B so it has the biochemical priority to zinc. This possibility
can be tested by comparing zinc transporter activity of CDF-2 and TTM-1. Another
possible mechanism is that the unique histidine- and glycine-rich motif at its N-terminus
of TTM-1B may receive a signal from CDF-2 and regulate its activity. This possibility
can be tested by analyzing engineered TTM-1B protein that has deletions or mutations in
the motif.
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Action of multiple CDF proteins in the intestine
Previous studies and this work have identified and characterized four C. elegans
cdf genes, cdf-1, cdf-2, sur-7 and ttm-1, all of which contribute to the control of zinc
metabolism (Bruinsma et al., 2002; Davis et al., 2009; Yoder et al., 2004). The intestine
is the major site for the regulation of zinc metabolism in C. elegans, where the CDF
proteins act at multiple locations (Figure 4.1). CDF-1 moves zinc through the basolateral
membrane into the body cavity, and it functions in the distribution of zinc from the
intestine to other tissues of the body and the indirect excretion of zinc perhaps via the
excretory cell. SUR-7 moves zinc into the ER/Golgi complex, and it is probably involved
in the distribution of zinc via secretory vesicles. Since cdf-1 and sur-7 expressions are
not affected by dietary zinc levels, they appear to play an important role in the constant
flow of zinc throughout the body. CDF-2 moves zinc into gut granules for storage, and
its expression is strongly induced by high levels of dietary zinc. Zinc storage in the
intestine mediated by CDF-2 is critical to survive in the wild where zinc levels fluctuate
by functioning in detoxification and mobilization. TTM-1 moves zinc across the apical
membrane to the intestinal lumen, and its expression is also induced by zinc similar to
CDF-2. However, TTM-1 activity appears to be partially suppressed by CDF-2 for the
efficient use of zinc via unknown mechanisms. In the condition when CDF-2 is not
functional, TTM-1 promotes direct excretion of zinc out of the body to deal with zinc
toxicity. Therefore, this network of CDF proteins plays a key role in zinc metabolism
from the distribution of zinc to the response to unfavorable zinc conditions. There may
be other zinc transporters acting in the intestine that have not been identified yet. For
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example, ZIP proteins acting on the apical membrane like mammalian ZIP-4 have not
been identified. Identification and characterization of these zinc transporters should be an
important research topic in the C. elegans zinc biology.

Analysis of other zinc transporters
To expand our knowledge of zinc transporters, the work described in Appendix
B conducted the initial studies of unknown 8 zip genes and 1 cdf gene. While many zinc
transporters displayed similar expression patterns to their mammalian counterparts,
others displayed differences, suggesting that C. elegans zinc transporters have conserved
functions, but some of them may be specific to C. elegans or other nematodes. In the
analysis of mutant animals, it is not surprising that many mutant animals had no
phenotype, because there are a large number of zinc transporters and some of them may
be functionally redundant with one another. In addition, the assays used in this study
were limited to identify complicated phenotypes. Thus, the analysis of genetic
interactions between multiple zinc transporters and the development of various types of
assays are necessary in the study of zinc transporters. In this regard, the zinc transporters,
F55F8.9 and F28F3.3 are interesting to follow up for further studies. F55F8.9 and
F28F3.3 mutant animals displayed the vulva positioning defect phenotype and the
sperm-related sterility phenotype, respectively. Further analysis of these mutant animals
may reveal novel functions of zinc and/or zinc transporters in biological processes.

Identification of novel proteins in zinc metabolism: Future studies
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All the studies presented here are based on the reverse genetic approaches and
have been successful to characterize C. elegans zinc transporters. However, in our effort
to expand the knowledge of zinc metabolism, this type of reverse genetic approach has
limitations; it is impossible to identify novel proteins involved in zinc metabolism.
Therefore, different approaches should be considered for further studies.

Identification of zinc-responsive transcription factors
Regulation of gene expression in response to the changes in zinc levels is an
important mechanism to control zinc metabolism. The yeast Zap1 and the mammalian
MTF-1 proteins play a key role in this process by acting as a zinc-responsive
transcription factor. However, in C. elegans, zinc-responsive transcription factors have
not yet been identified. There is no candidate protein that is homologous to Zap1 or
MTF-1. Therefore, reverse genetic approaches are not feasible here, and other unbiased
methods are needed.
To identify zinc-responsive transcription factors, we can use traditional forward
genetic screens. To set up the screens, we generated a zinc-responsive reporter system
which is a transgenic animal containing an integrated array that expresses GFP under the
control of the cdf-2 promoter. As cdf-2 expression is responsive to zinc, GFP expression
was induced by high levels of zinc (Figure 4.2A). Using the transgenic animals, we can
perform forward genetic screens for mutations that cause defects in the gene expression
induction in response to high zinc levels. These screens may identify zinc-responsive
transcription factors which directly control gene expression similar to Zap1 and MTF-1.
It is also possible that other proteins which respond to zinc and transmit the signals to the
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gene expression machinery would be identified from the screens. These studies may
contribute to dissecting of the molecular processes that regulate the gene expression in
zinc metabolism.
For the identification of zinc-responsive transcription factors, we can take
another approach using the zinc-responsive gene promoters. We first analyzed the
promoter sequences of the four known zinc-responsive genes, mtl-1/2, cdf-2 and ttm-1.
Using computational analysis, we identified a DNA element that is found in the promoter
of all the four genes (Figure 4.2B). DNA mutagenesis analysis demonstrated that this
element is necessary for the induction of mtl-1/2 (Deshmukh and Dimitrov, unpublished
observation). We can identify candidate zinc-responsive transcription factors that bind to
the element using the yeast-one-hybrid system or protein pull-down assays using biotinlabeled DNA element.

Identification of novel proteins involved in zinc metabolism
In addition to forward genetic screens, microarray experiments can be a useful
and unbiased approach to identify novel proteins that play a role in zinc metabolism. We
previously conducted microarray experiments to compare gene expression profiles across
different zinc conditions. We identified numerous genes whose expression is induced in
response to high levels of zinc (Deshmukh and Kornfeld, unpublished observation). In
the list of the genes, there were the genes previously known to be induced by zinc, such
as mtl-1/2 and cdf-2 (data not shown), suggesting that the microarray results are reliable.
There were many other genes that have not been implicated in zinc or metal metabolism.
Studies of these genes, therefore, may identify novel genes important for zinc
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metabolism. For example, we found that RNAi of one of the genes, B0218/clec-52,
which encodes a C-type lectin, resulted in mild zinc hypersensitivity, suggesting that this
gene may be involved in the zinc detoxification. These studies will broaden our
knowledge of the mechanism that controls zinc metabolism.

Final Thoughts
Zinc was first recognized as a mineral essential for the growth of a fungus more
than a hundred years ago, and it has since been demonstrated that zinc is also an essential
micronutrient for humans. However, it is just over the past few decades that we have
started to understand the molecular aspects of zinc metabolism and its implication in
human diseases. We have just begun to appreciate the complexity of zinc metabolism and
its significance in human health. There are much more important biological functions of
zinc metabolism that remain to be uncovered.
A major obstacle to the studies of zinc metabolism has been its complexity that
involves numerous proteins across multiple tissues. In this work, our approach using C.
elegans was useful to overcome this problem. We have established the functional
networks of CDF proteins in the intestine to control the whole body zinc metabolism and
proposed possible physiological functions of zinc or zinc transporters. Therefore, I
believe that as C. elegans has been powerful in a variety of fields of biology, it will
advance our understanding of zinc, zinc transporters and/or zinc metabolism.
Furtheremore, studies of zinc metabolism using C. elegans may lead to new medical and
pharmaceutical approaches for dieases implicated in abnormal zinc metabolism.
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FIGURE LEGENDS

Figure 4.1. Action of multiple CDF proteins in the intestine. CDF-1 (blue) is localized
on the basolateral membrane and transports zinc into the body cavity. CDF-2 (red) is
localized on the membrane of gut granules and transports zinc into the lumen of gut
granules. SUR-7 (green) is localized in the ER and transports zinc into the lumen of the
ER. TTM-1 (yellow) is localized on the apical membrane and transport zinc out to the
intestinal lumen.

Figure 4.2. Future studies to identify of zinc-responsive transcription factors. (A)
Fluorescence microscope images of live transgenic animals containing an integrated
array, amIs4, which expresses GFP under the control of the cdf-2 promoter [Pcdf2::GFP]. Whole animals at the adult stage are displayed with the pharynx to the bottom
left and the tail to the upper right. GFP expression is highly increased in 200μM
supplemental zinc. (B) DNA element present in the known zinc-responsive genes: mtl-1,
mtl-2, cdf-2 and ttm-1b. The bottom panel displays its location and sequence of the
promoter region of each gene. This element was identified using the MEME module
(Bailey and Elkan, 1994).
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APPENDIX A
The cation diffusion facilitator gene cdf-2
mediates zinc metabolism in Caenorhabditis
elegans

[This work in Appendix A has been published with the following citation: Diana E. Davis,
Hyun Cheol Roh, Krupa Deshmukh, Janelle J. Bruisma, Daniel L. Schneider, James
Guthrie, J. David Robertson, and Kerry Kornfeld (2009) The cation diffusion facilitator
gene cdf-2 mediates zinc metabolism in Caenorhabditis elegans. Genetics 182: 10151033.
H.C.R. conducted and analyzed the expression pattern experiments (Figure A.6). D.E.D.
designed, performed and analyzed the majority of the experiments, K.D. assisted in the
qRT-PCR experiments (Figure A.5), J.G. and J.D.R. performed the ICP-MS analysis
(Figures A.3 and A.9, Supplemental Table A.1), D.L.S. provided technical Assistance, J.J.
provided intellectual contributions, and K.K. designed and analyzed experiments. D.E.D.
and K.K. wrote the manuscript.]
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ABSTRACT

Zinc is essential for many cellular processes. To use C. elegans to study zinc
metabolism, we developed culture conditions allowing full control of dietary zinc and
methods to measure zinc content of animals. Dietary zinc dramatically effected growth
and zinc content; wild-type worms survived from 7 µM to 1.3 mM dietary zinc, and zinc
content varied 27 fold. We investigated cdf-2, which encodes a predicted zinc transporter
in the cation diffusion facilitator family. cdf-2 mRNA levels were increased by high
dietary zinc, suggesting cdf-2 promotes zinc homeostasis. CDF-2 protein was expressed
in intestinal cells and localized to cytosolic vesicles. A cdf-2 loss-of-function mutant
displayed impaired growth and reduced zinc content, indicating that CDF-2 stores zinc
by transport into the lumen of vesicles. The relationships between three cdf genes, cdf-1,
cdf-2, and sur-7, were analyzed in double and triple mutant animals. A cdf-1 mutant
displayed increased zinc content, whereas a cdf-1 cdf-2 double mutant had intermediate
zinc content, suggesting cdf-1 and cdf-2 have antagonistic functions. These studies
advance C. elegans as a model of zinc metabolism and identify cdf-2 as a new gene that
has a critical role in zinc storage.
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INTRODUCTION

Zinc plays many roles in biological systems, including binding to proteins and
promoting specific conformations, such as the zinc finger, and contributing to the active
site of enzymes (Vallee and Falchuk, 1993). Reflecting its multiple uses, organisms that
do not obtain adequate dietary zinc display a wide range of defects (Chowanadisai et al.,
2005; Cole et al., 1999; Dufner-Beattie et al., 2007; Herbig et al., 2005; Kambe et al.,
2004). For example, humans that are zinc deficient have abnormalities of multiple
systems including the skin and immune system (Chowanadisai et al., 2006; Hambidge
and Krebs, 2007; Hambidge, 2000; Maverakis et al., 2007). Excess dietary zinc can also
cause defects as a result of zinc toxicity (Koh et al., 1996; Nies, 2007). The mechanisms
underlying zinc toxicity have not been clearly defined but may involve the substitution of
zinc for other metals such as copper (Zhao and Eide, 1997). Animals have evolved
sophisticated mechanisms to regulate zinc metabolism to ensure an adequate supply of
zinc but avoid zinc toxicity. Zinc metabolism involves uptake of zinc from dietary
sources into intestinal cells, distribution of zinc throughout the body to supply nonintestinal cells, insertion of zinc into zinc-requiring proteins and excretion of excess zinc
from cells and the animal. An essential aspect of zinc metabolism is adapting to changing
levels of dietary zinc. Homeostasis is likely to involve sensors that monitor available zinc
and effector mechanisms that adjust intake, storage, and excretion of zinc (Tapiero and
Tew, 2003). These important processes are not well characterized.
Zinc in biological systems is the Zn2+ ion, and Zn2+ does not diffuse across lipid
bilayers (Stryer, 1995). In metazoans, two families of transmembrane proteins play
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critical roles in transporting zinc, the cation diffusion facilitator (CDF/SLC30) family
(Palmiter and Huang, 2004) and the Zrt-, Irt- like protein (ZIP/SLC39) family (Eide,
2004; Eng et al., 1998; Guerinot, 2000). The CDF family evolved in prokaryotes and has
been conserved in fungi, plants, and animals. Yeast contain multiple CDF proteins, which
are localized to specific membrane compartments (Eide, 2006). Vertebrates contain 10
predicted CDF proteins (Liuzzi and Cousins, 2004; Palmiter and Huang, 2004; Seve et
al., 2004). Mutations in human ZnT-2 are implicated in diseases characterized by
inadequate zinc in breast milk, suggesting that CDF proteins play essential roles in zinc
metabolism in humans (Chowanadisai et al., 2006). Most CDF proteins are predicted to
contain six transmembrane regions, and the N- and C- termini are predicted to be
cytoplasmic. Recent crystallographic data suggest that the E. coli CDF protein YiiP
functions as a dimer (Lu and Fu, 2007), consistent with the results of cell biology studies
in yeast (Ellis et al., 2005). The energy source for CDF proteins appears to be ion
gradients, such as H+ and K+ (Chao and Fu, 2004; Guffanti et al., 2002).
Given that animals contain multiple CDF proteins, a critical question is how do
these proteins function in a coordinated manner to mediate zinc metabolism throughout
the animal? One mechanism is cell-type specific expression. For example, vertebrate
ZnT-3 is expressed primarily in neuronal cells, where it promotes zinc accumulation in
synaptic vesicles (Cole et al., 1999; Palmiter et al., 1996b). A second mechanism is
localization to specific membrane compartments. For example, vertebrate ZnT-8 is
localized to insulin granules (Chimienti et al., 2004), whereas vertebrate ZnT-1 is
localized to the plasma membrane (Palmiter and Findley, 1995). A third mechanism is
intrinsic differences in activity, which might include differences in affinity for zinc (Km),
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differences in the rate of zinc transport (Vmax), and differences in metal specificity. A
fourth mechanism is differences in regulation that adjust protein abundance and activity
in response to fluctuating dietary zinc, which might include transcriptional, posttranscriptional, and post-translational regulation. These mechanisms are not mutually
exclusive, and additional mechanisms may also be utilized. An understanding of how
multiple CDF proteins function coordinately in an animal will require a genetically
tractable model system that can be used to dissect the complementary, redundant, and
antagonistic activities of multiple CDF proteins.
The nematode Caenorhabditis elegans has been a powerful model system to
study many biological processes, but studies of nutrient biology have been limited. The
use of C. elegans to study metal biology has included analyses of heme, magnesium, zinc,
and cadmium (Bruinsma et al., 2002; Bruinsma et al., 2008; Dong et al., 2008a; Kemp et
al., 2009; Rajagopal et al., 2008). The fully sequenced C. elegans genome contains 14
predicted genes that encode CDF proteins (Kambe et al., 2004, K. Deshmukh and K.
Kornfeld unpublished observation). Two of these genes have been analyzed genetically,
cdf-1 and sur-7 (Bruinsma et al., 2002; Yoder et al., 2004). Loss-of-function mutations of
cdf-1 and sur-7 were identified in forward genetic screens for modifiers of abnormal
vulval cell fates caused by constitutively activated Ras. In addition to promoting Rasmediated signal transduction, cdf-1 and sur-7 promote survival in high dietary zinc, since
loss-of-function mutations of these genes cause sensitivity to high dietary zinc (Bruinsma
et al., 2002; Yoder et al., 2004). cdf-1 is expressed in intestinal cells and vulval cells, and
CDF-1 protein is localized to the plasma membrane (Bruinsma et al., 2002). sur-7 is
expressed in non-intestinal cells, and SUR-7 protein is diffusely localized to the cytosol,
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suggesting it is localized to an internal membrane (Yoder et al., 2004). The functions of
the remaining predicted cdf genes in C. elegans have not been determined.
To use C. elegans as a model system to study zinc metabolism and CDF protein
function, we developed culture conditions that allow full control of dietary zinc. Here we
show that worms are sensitive to both low and high dietary zinc and that sensitivity to
dietary zinc can be used to assay zinc metabolism. We developed methods to measure the
zinc content of C. elegans and demonstrated that dietary zinc strongly influences zinc
content of wild-type animals. These methods advance the utility of C. elegans as a model
system to study zinc metabolism. We investigated the function of a new predicted cdf
gene, which we named cdf-2. CDF-2 is most similar to vertebrate ZnT-2, which is
localized to vesicles and implicated in human diseases of zinc deficiency (Chowanadisai
et al., 2006). The cdf-2 transcript abundance was increased at high levels of dietary zinc,
suggesting that cdf-2 is involved in zinc homeostasis. CDF-2 protein was expressed in
intestinal cells and localized to cytosolic vesicles. A strong loss-of-function mutation of
cdf-2 was characterized; mutant animals displayed growth defects and reduced zinc
content compared to wild-type animals, indicating that cdf-2 functions in zinc storage. To
explore the relationship between the functions of multiple cdf genes, we analyzed double
and triple mutant animals with mutations in cdf-1, cdf-2, and sur-7. The results indicate
that cdf-1 and cdf-2 have antagonistic functions in mediating zinc content and cdf-2 plays
an important role in zinc storage by sequestering zinc in the lumen of cytosolic vesicles.

MATERIALS AND METHODS
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General methods and strains: C. elegans were cultured at 20º on nematode growth
medium (NGM) dishes with live E. coli as described by Brenner (1974) or in C. elegans
maintenance medium (CeMM, described below) (Szewczyk et al., 2003). The wild-type
strain and parent of all mutant strains was Bristol N2. The following mutations were used.
unc-119(ed3 R113Stop) is a loss-of-function mutation that causes a strong uncoordinated
phenotype and an inability to form dauer larvae (Maduro and Pilgrim, 1995). let60(n1046 G13E) is a semi-dominant, gain-of-function allele of the Ras gene (Beitel et al.,
1990). cdf-1(n2527 Q156Stop) is a strong loss-of-function allele caused by a nonsense
change in exon four (Bruinsma et al., 2002). sur-7(ku119) is a partial loss-of-function
allele caused by a single nucleotide change near the splice donor of exon three (Yoder et
al., 2004). cdf-2(tm788) has an 804 bp deletion with a 68 bp insertion that removes the
first 34 codons and is likely to cause a strong loss-of-function (described here). cdf-1,
cdf-2, and sur-7 are located on chromosome X, and we generated cdf-1 cdf-2, cdf-1 sur-7,
and cdf-2 sur-7 double mutant animals using standard techniques and confirmed the
genotypes by PCR and gel electrophoresis (cdf-2) and DNA Pyrosequencing (cdf-1 and
sur-7; PSQ 96 MA, Biotage, Charlottesville, VA). A cdf-1 cdf-2 sur-7 triple mutant was
generated from cdf-1 cdf-2 and cdf-2 sur-7 double mutant animals using standard
techniques.

Preparation of CeMM and culturing worms in CeMM: 2x CeMM was prepared as
described by Szewczyk et al. (2003) with minor modifications. Briefly, we prepared five
solutions (amino acids, nucleic acids, water-soluble growth factors and vitamins,
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triethanolamine-soluble growth factors and vitamins, and trace metal salts without zinc
chloride), combined these to yield 2x CeMM with no added zinc, adjusted the pH to 5.9
with 10% (w/v) NaOH, filtered the medium through a 0.22 µm cellulose acetate filter
(Corning Inc. Life Sciences, Lowell, MA), and stored the medium in the dark at 4º for up
to 8 months. To use the CeMM, we diluted with water from a Milli-Q Synthesis A10
machine (Millipore, Billerica, MA) to yield 1x CeMM. To achieve the final zinc
concentration of 1x CeMM, we added the appropriate volume of 1 mm, 10 mm, 100 mm,
or 1 m zinc chloride (Z0152, Sigma-Aldrich, St. Louis, MO) diluted in 40 mm HCl. To
equalize the amount of HCl diluent added to each medium sample, we added the
appropriate volume of 40 mm HCl with no added zinc. The 1x CeMM with added zinc
was used promptly and not stored.
To introduce worms that were growing on NGM with live E. coli into CeMM,
we collected adults and treated the animals with NaOH and bleach to generate eggs free
of bacterial contamination (Wood, 1988). Subsequent procedures were performed in a
tissue culture hood using sterile technique. Eggs were transferred to 25 cm2 T-flasks (TPP,
Trasadingen, Switzerland) containing 5 mL M9 buffer (85 mm NaCl, 22 mm KH2PO4,
42 mm Na2HPO4, 1 mm MgSO4) and 10 µL/mL Antibiotic-Antimycotic solution (10,000
units penicillin, 10 mg streptomycin, and 25 µg amphotericin B per milliliter, SigmaAldrich). Eggs were cultured at 20º for 2-3 days to allow the hatching and developmental
arrest of L1 larvae. Larvae were washed 2x in M9 buffer, transferred to a 25 cm2 T-flask
in 5 mL CeMM containing 30 µm zinc chloride, and cultured at 20º with no agitation for
3-4 weeks until visual inspection revealed significant growth of the population. Worms
were collected using Pasteur pipets, pelleted by centrifugation at 1,000 rpm for 5 min at
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15º, washed 2x in M9 buffer, resuspended in 15 mL CeMM containing 30 µm zinc
chloride and transferred to 75 cm2 T-flasks (TPP).

Maturity Analysis: Worms were grown on NGM with live E. coli and treated with
NaOH and bleach to collect eggs. For experiments scored with a dissecting microscope,
eggs were diluted in CeMM (19 zinc concentrations), seeded in 24-well plates (TPP) at a
concentration of 100 eggs in 500 µL, and incubated at 20º in a box containing moist
paper towels to increase humidity. After nine days, animals were collected, examined
using a dissecting microscope, and scored as larval (less than 1 mm and larval
morphology) or adult (greater than 1 mm and adult morphology). For experiments using
the COPAS BIOSORT (Union Biometrica, Holliston, MA), eggs were added to 5 mL M9
buffer containing 10 µL/mL Antibiotic-Antimycotic solution (Sigma-Aldrich) and
incubated for 2-3 days at 20º. Resulting L1 larvae were diluted in CeMM (18 zinc
concentrations), seeded in 24-well plates at a concentration of 100 L1 larvae in 500 µL,
and incubated at 20º in a box containing moist paper towels. After 12 days, animals were
transferred to 96-well plates and analyzed using the REFLEX option of a COPAS
BIOSORT.

Population growth rate analysis: To prepare 15-16 cultures for a comparative analysis,
we generated a large population of worms growing in CeMM containing 30-75 µm zinc
chloride. We counted an aliquot to determine the number of worms in the sample,
collected the worms by centrifugation, washed 2x in M9 buffer, and resuspended at
10,000 worms/mL in CeMM with no added zinc. For cultures scored using a dissecting
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microscope, 2.5 mL of worms were transferred to a 25 cm2 T-flask containing 2.5 mL of
CeMM with added zinc to generate final zinc concentrations that ranged from 0 to 2 mm.
For cultures scored using the COPAS BIOSORT, 7.5 mL of worms were transferred to a
75 cm2 T-flask containing 7.5 mL of CeMM with added zinc to generate final zinc
concentrations that ranged from 0 to 2.5 mm. In both cases, the initial worm
concentration was 5,000 worms/mL. The cultures were incubated at 20º for up to 22 days.
To determine the number of worms in the sample using a dissecting microscope, we
removed 100 µL of the culture, diluted the sample with M9 buffer containing 0.01%
Triton X-100 to yield an approximate worm concentration of 1 worm/µL, spotted 100 µL
onto an NGM dish, and counted the number of larvae and adults. Each sample was
scored three times. To determine the number of worms in the sample using the COPAS
BIOSORT, we employed 45 µm fluorescent beads (Fluoresbrite beads, Poly Sciences,
Inc., Warrington, PA) as a counting standard. Beads were diluted to a concentration of
approximately 20 beads/µL. We combined a known number of beads with a sample of
worms in ~8 mL M9 buffer with 0.01% Triton X-100, used the COPAS BIOSORT to
count the number of beads and the number of worms, calculated the ratio of worms to
beads, and then calculated the concentration of worms in the initial culture. The use of
the fluorescent beads allowed us to determine the total number of worms in an aliquot
even though not all of the aliquot flowed past the detector. To determine the population
growth rate, we plotted the number of worms per milliliter versus the number of days in
culture and performed a linear regression analysis using Microsoft Excel (Microsoft Co.,
Redmond, WA). The linear portion of the plot was from day 7 to day 17 (Figure A.2B
and data not shown), and we defined this slope as the population growth rate. To
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determine the population growth rates that were half the maximal population growth rate
(EC50 and IC50), we analyzed the 16 population growth rates determined during a single
growth trial using GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA). The
EC50 and IC50 were determined from the population growth rates at dietary zinc
concentrations from 1 µm to 120 µm and 60 µm to 2.5 mm, respectively, by fitting these
data to a dose-response curve with the bottom constrained to zero and a variable Hill
slope. Two to three independent EC50 and IC50 values were determined for each strain,
and the average, standard deviation, and p-values were calculated using Microsoft Excel
(Microsoft Co.).

Determination of zinc content of C. elegans using radioactive 65Zn: 65ZnCl2 was
purchased from Perkin Elmer (Waltham, MA), and the initial specific activity varied
from ~1 to 3 µCi/µg. To culture worms with 65Zn, we determined the concentration of
worms in a large starting culture, pelleted the worms, washed the worms 2x in M9 buffer,
resuspended the worms in CeMM with no added zinc, dispensed 30,000 worms in 300
µL into 24-well plates, and added 300 µL of CeMM with added zinc to yield final zinc
concentrations of 6 µm, 10 µm, 30 µm, 75 µm, 350 µm, 1 mm, and 2 mm. To generate
CeMM with zinc concentrations of 6 µm, 10 µm, and 30 µm, we used undiluted 65ZnCl2
with a specific activity of ~1µCi/µg. To generate CeMM with zinc concentrations of 75
µm, 350 µm, 1 mm, and 2 mm, we combined 65ZnCl2 (~1µCi/µg) with non-radioactive
ZnCl2 to yield samples where the specific activity of the 65Zn was reduced by the dilution
factors 2.5, 11, 33, and 67, respectively. Samples were incubated at 20º for 12-15 days.
To minimize evaporative loss, we placed samples in plastic bags with moist paper towels.
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Worms were collected in a 0.2 µm Nanosep MF filtration device (Pall Scientific, East
Hills, NY) by centrifugation and washed 2x in M9 with 100 mm EDTA to chelate
unincorporated zinc. To eliminate 65Zn in the intestinal lumen, we incubated the worms
for 30 min in CeMM with the corresponding unlabeled zinc concentration and 1 mm
serotonin (Sigma-Aldrich) to stimulate pharyngeal pumping and defecation (Horvitz et
al., 1982). Thirty minutes was sufficient time for worms to expel 65Zn from the intestinal
lumen (data not shown). Worms were collected in a 0.2 µm Nanosep filtration device by
centrifugation and washed 2x in M9 with 100 mm EDTA. Serial dilutions of 65ZnCl2
were measured with a Beckman gamma 4000 (Beckman Coulter Inc., Fullerton, CA) to
generate a standard curve that was used to determine the amount of 65Zn in each worm
sample. The samples were stored at -80º. To determine the amount of protein in each
worm sample, we added 100 mm NaCl containing Complete Mini Protease Inhibitor
Cocktail tablets (Roche, Basel, Switzerland) to each sample, sonicated to disrupt the
cuticle using a Digital Sonifer 450-D (Branson Ultrasonics Corporation, Danbury, CT),
and determined the amount of protein using the Micro BCA Protein Assay Reagent Kit
(Pierce, Rockford, IL) according to the manufacturer’s instructions. The zinc content of
worms (ng zinc/µg protein) was calculated using the formula: [65Zn (µCi)/sample ÷
specific activity (µCi/µg) x 1000 ng/µg] ÷ [protein (µg)/volume x volume/sample].

Determination of zinc content of C. elegans using inductively coupled plasma-mass
spectrometry (ICP-MS): A large population of worms growing in CeMM containing 30
µm zinc chloride was generated to initiate seven cultures for a comparative analysis. We
determined the number of worms in the sample, collected the worms by centrifugation,
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and washed the worms 2x in M9 buffer. The worms were resuspended at 20,000
worms/mL in CeMM with no added zinc, and 7.5 mL of worm solution was transferred
to a 75 cm2 T-flask containing 7.5 mL of CeMM with added zinc to yield the zinc
concentrations 6 µm, 10 µm, 30 µm, 75 µm, 350 µm, 1 mm, and 2 mm, and an initial
worm concentration of 10,000 worms/mL. Samples were cultured at 20º for 16-18 days.
Worms were collected by centrifugation and washed 2x in M9 buffer. To eliminate zinc
in the intestinal lumen, we incubated the worms for 30 min in M9 buffer with 1 mm
serotonin. Worms were washed 2x in M9 buffer, transferred to pre-cleaned and preweighed 15 mL polypropylene tubes (Stockwell Scientific, Scottsdale, AZ) and frozen at
-80º. The metal content of the sample was determined using ICP-MS as described by
Dong et al. (2008b). Briefly, the sample was desiccated, weighed, digested with
concentrated nitric acid and hydrogen peroxide solution (HNO3, Fisher OPTIMA Grade,
Thermo Fisher Scientific, Wilmington, DE; 30% H2O2, Fluka TraceSELECT Ultra,
Sigma-Aldrich) in an ultrasonic bath at 60º for 1 hour, diluted with ultra-pure 18.2
MΩ·cm deionized water, re-weighed, mixed by repeated inversion, and diluted with 2%
HNO3 in H2O. Empty tubes were processed identically to the samples as a control. An
internal standard was added to each sample and control to correct for matrix effects in the
instrument. Weights were recorded at each step so that exact gravimetric dilution factors
could be calculated for all samples and controls. The copper, iron, manganese, and zinc
content of each sample and control was determined using a VG Axiom high-resolution
ICP-MS (Thermo Fisher Scientific). Instrument calibration standards were prepared by
diluting ICP-MS Multielement calibration standards (High-Purity Standards, Charleston,
SC), which are manufactured following National Institute of Standards and Technology
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Standard Reference Materials procedures. The instrument limit of detection (LOD) was
calculated as three times the standard deviation of the concentration of a given analyte
measured in ten runs of a zero point standard (2% HNO3 solution with internal standard).
The sample LOD was calculated by multiplying the instrument LOD by the total sample
dilution factor. The metal content of the worms was calculated using the following
formula: [zinc/sample ÷ sample weight].
One consideration with using CeMM is the possibility that worm metabolism
during the culture period significantly changes the medium composition. Szewczyk et al.
(2003) monitored pH during a two week incubation and demonstrated that the starting
pH of 6 gradually increases to about 7. We confirmed these results and observed that
after ~25 days in culture the pH begins to increase significantly; therefore, worms were
not cultured for longer than 22 days. To monitor changes in media zinc concentrations,
we used radioactive 65Zn to determine the fraction of total zinc incorporated into worms
in 109 independent samples with zinc concentrations ranging from 6 µm to 2mm and
initial worm concentrations of 50 worms/µL. The fraction of total zinc incorporated into
worms that were cultured for 12-15 days varied from 0.02% to 2.4%. There was a trend
towards lower fractional zinc incorporation as the dietary zinc concentration increased.
These results indicate that worm metabolism has a minimal effect on the concentration of
dietary zinc in the medium during the course of these experiments.

Analysis of cdf-2 transcripts: RNA was isolated from wild-type animals cultured on
NGM dishes with live E. coli. Mixed-staged animals were collected, washed in M9
buffer, and solubilized in TRIzol (Invitrogen, Carlsbad, CA). The RNA concentration and
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quality was determined using a NanoDrop 100 (Thermo Fisher Scientific). cDNA was
generated using the SuperScript III First-Strand Synthesis System for RT-PCR
(Invitrogen) using either an oligo(dT) primer or random hexamer oligonucleotide primers.
PCR and DNA sequencing were performed according to standard methods. Primers
annealing in exon 1 and exon 8 amplified the expected 959 bp product and did not
amplify any shorter products, suggesting that any alternatively spliced transcripts are of
low abundance. A primer annealing in exon 7 and an oligo(dT) primer amplified an ~425
bp product. DNA sequencing demonstrated a ~30 bp adenosine tract immediately
following the sequence ACAGC, indicating the addition of a poly-adenosine tail 120 bp
downstream of the stop codon.

Quantitative, real-time PCR analysis: To generate cultures for a comparative analysis,
we began by generating a large population of worms growing in CeMM containing 30
µm zinc chloride. Worms were collected by centrifugation, washed 2x in M9 buffer,
resuspended in CeMM with 2 µm, 10 µm, 30 µm, 250 µm, 500 µm, 1 mm, or 2 mm zinc
chloride, transferred to 25 cm2 T-flasks, and incubated at 20º for six days. To collect a
synchronous population of adult worms, we diluted the culture in 50 mm Tris HCl, pH
6.4 containing 2 µm, 10 µm, 30 µm, 250 µm, 500 µm, 1 mm, or 2 mm zinc chloride,
respectively, and used the COPAS BIOSORT to select 1,000 adults from a mixed-stage
population. RNA was purified using TRIzol, resuspended at a concentration of ~250
ng/µL, and treated with DNase I (Turbo DNA Free Kit, Applied Biosystems, Foster, CA).
cDNA was synthesized using the High-capacity cDNA Reverse Transcription Kit from
Applied Biosystems according to the manufacturer’s instruction using random hexamer
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oligonucleotide primers. Quantitative, real-time PCR was performed using a BioRad
MyiQ Single Color Real-Time PCR Detection System thermocycler and iQ SYBR Green
Supermix (BioRad Laboratories, Hercules, CA). Forward and reverse amplification
primers were: ama-1, atcggagcagccaggaactt and ggactgtatgatggtgaagctgg; cdf-1,
gcattaaaatcgctactcgcc and ccgtacacataaagattccgttg; cdf-2, atagcaatcggagagcaacg and
tgtgacaattgcgagtgagc; rps-23, aaggctcacattggaactcg and aggctgcttagcttcgacac; sur-7,
ctttatcgaaccgctggaac and cgagtgggtcgctgaattg. The amplified products were confirmed
by DNA sequencing. The efficiency (E) of each primer pair was determined using cDNA
from mixed-stage worms as template. The average primer pair efficiency was calculated
from three independent experiments and ranged from 87% and 109%. To calculate the
change in transcript abundance between two conditions, we used the approach of Pfaffl
(2001) by calculating the relative expression ratio (R) using the formula, R=
[Etarget^(ΔCPtarget)] ÷ [Ereference^(ΔCPreference)], where ΔCP=Ctcontrol-Ctsample. The Ctcontrol
was the Ct value at 2 µm dietary zinc, and the Ctsample was the Ct value at 2 µm to 2 mm
dietary zinc. The relative expression ratio was determined independently for two
reference genes, and the average of these values is represented as Fold Change (Figure
A.5) according to Vandesompele et al. (2002).

Analysis of CDF-2::GFP: To determine the expression pattern of cdf-2, we generated
the plasmid pDG222 as follows: Beginning with pBluescript SK+ (Stratagene, Santa
Clara, CA), we inserted the ~3.4 kb genomic region containing cdf-2 from 1,371 bases
upstream to 2,006 bp downstream of the ATG (eliminating the stop codon) in frame to
the coding region for green fluorescent protein (GFP) and the unc-54 3´ UTR, both
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amplified from pPD95.77, a gift from A. Fire (Stanford University, Palo Alto, CA).
Transgenic animals were generated by co-injecting pDG222 and the dominant
transformation marker pRF4 (Mello et al., 1991) into wild-type animals, selecting F1 Rol
progeny, and selecting three independently-derived strains that transmitted the Rol
phenotype. For each of these strains, the Rol phenotype was transmitted to only a subset
of self-progeny, indicating that these three transgenes are extra-chromosomal, and we
designated these arrays amEx1032, amEx1033, and amEx1201. To generate plasmid
pDP15 for biolistic transformation, we modified the plasmid pMM016, a gift from J.
Austin (Praitis et al., 2001), that contains unc-119(+) by digesting it with Acc651 and
HincII and inserting a ~4.8 kb EagI/Acc651 fragment of pDG222 containing the cdf-2
promoter and coding region, gfp, and the unc-54 3´ UTR. Biolistic transformation was
used to introduce pDP15 into unc-119(ed3) mutant animals (Praitis et al., 2001). Three
independently-derived transgenic animals that were non-Unc and segregated only nonUnc progeny were isolated. Since the unc-119 transgenes were transmitted to all the
progeny of these three strains, the transgenes are likely to be integrated in the genome
and were designated amIs2, amIs4, and amIs5.
To analyze the distribution of GFP using an anti-GFP antibody, we followed the
protocol described by Duerr (2006). Briefly, we cultured animals on NGM with live E.
coli, collected mixed-stage animals, washed in M9 buffer, fixed in methanol and acetone,
rehydrated through 90%, 60%, 30% and 10% acetone, blocked in 5% bovine serum
albumin in phosphate-buffered saline with 0.5% Triton X-100, stained with 1:100
dilution of Molecular Probes rabbit anti-GFP primary antibody (A11122, Invitrogen) and
1:200 dilution of Molecular Probes Alexa Fluor 488 goat anti-rabbit secondary antibody
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(A11008, Invitrogen), and visualized the fluorescence using a Zeiss Axio Imager Z1
(Oberkochen, Germany). GFP localization in live animals was analyzed using the same
culture conditions by directly visualizing GFP fluorescence.

Analysis of cdf-2(tm788): cdf-2(tm788) was a gift of the Mitani laboratory (National
Bioresource Project, Tokyo Women’s Medical University, Japan). cdf-2(tm788) was
backcrossed to wild type four times. To eliminate potential mutations linked in cis to cdf2(tm788) on chromosome X, we created a triple mutant of cdf-1(n2527) cdf-2(tm788)
sur-7(ku119), crossed the strain to wild type and selected cdf-1(+) cdf-2(tm788) sur-7(+)
animals. The cdf-2(tm788) molecular lesion was analyzed by determining the DNA
sequence of the PCR amplified cdf-2 locus.

RESULTS

The use of completely-defined, axenic medium to manipulate dietary zinc: The most
commonly used culture medium for C. elegans is nematode growth medium (NGM) that
is dispensed in a Petri dish and seeded with a bacterial lawn of E. coli (Brenner, 1974).
NGM provides nutrients for E. coli growth, and the worms obtain nutrients by eating the
E. coli. In these growth conditions, worms develop from egg to adult in approximately
3.5 days at 20º and generate about 300 self-progeny in the first five days of adulthood
(Riddle et al., 1997). In our initial attempts to manipulate dietary zinc, we supplemented
NGM with zinc sulfate and seeded this medium with E. coli (Bruinsma et al., 2002). cdf134

1(n2527) mutant animals displayed dose-dependent impairment of growth, indicating
these medium conditions resulted in increased dietary zinc. However, zinc was not
highly soluble in NGM, limiting the utility of this approach. To address the limitation of
zinc solubility, we developed a culture medium that allowed effective supplementation
with zinc sulfate, which we named noble agar minimal media (NAMM) (Bruinsma et al.,
2008). Culture conditions involving NGM and NAMM have two significant limitations.
First, the worms consume E. coli, which is a food source with a level of zinc that is
undefined and difficult to manipulate. Second, while these cultures can be supplemented
with zinc, these conditions do not permit depletion of dietary zinc. To overcome these
limitations, we used C. elegans maintenance medium (CeMM), a completely-defined,
axenic, liquid medium (Szewczyk et al., 2003). CeMM is formulated from purified
vitamins, growth factors, amino acids, nucleic acids, heme, β-sitosterol, sugar, salts, and
trace metals. CeMM provides adequate nutrition for indefinite propagation of C. elegans
cultures (Szewczyk et al. 2003). Compared to worms cultured on NGM with live E. coli,
worms cultured in CeMM display phenotypes suggestive of mild nutrient deprivation,
such as delayed development, an extended life-span, diminished self-fertile brood sizes,
and a thin adult body morphology. However, the proportion of the life cycle spent in each
larval stage is similar in both media conditions (Szewczyk et al., 2003; Szewczyk et al.,
2006).
Standard CeMM contains 75 µm zinc chloride (Szewczyk et al., 2003). To use this
medium to manipulate dietary zinc, we prepared CeMM with no added zinc chloride
(See Materials and Methods). To determine the level of zinc contamination in the
medium components, we used inductively coupled plasma-mass spectrometry (ICP-MS)
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to measure zinc. Medium that was formulated with no added zinc contained
approximately 30 ± 18 parts per billion by weight zinc (mean of seven independent
medium preparations). This corresponds to approximately 0.25 µm zinc, indicating that
there is minimal zinc contamination in the medium components.

Maturation and population growth of wild-type worms required a minimal level of
dietary zinc and were inhibited by high dietary zinc: To determine how dietary zinc
affects the development and maturation of worms, we cultured worms on NGM dishes
with live E. coli and transferred eggs to CeMM with 18-19 different concentrations of
zinc, ranging from no added zinc to 2 mm zinc (Figure A.1A). Development was
monitored after 80% of wild-type animals matured to adulthood with optimal
concentrations of zinc, which required nine to twelve days in culture (Figure A.1B).
Initially, maturation was monitored using a dissecting microscope, and animals were
scored as larvae or adults. To automate the analysis, we employed a COPAS Biosort
instrument that evaluates each animal with a laser microbeam and measures time of
flight (TOF) and extinction (EXT). Time of flight measures the time necessary for the
animal to flow past the laser, which is an indication of the length of the animal.
Extinction measures the percent of light transmission that is blocked during the time of
flight, which is an indication of the width and optical density of an animal. Time of flight
and extinction are highly correlated, and both measurements indicate the size and
maturity of an animal, with high values indicating a larger, more mature animal (Pulak,
2006). Figures 1B and C show that maturation is strongly affected by dietary zinc. At
concentrations of 0 and 1 µm zinc, worms displayed minimal maturation. At
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concentrations from 2 µm to 15 µm zinc, worms displayed measurable but impaired
maturation. Worms displayed maximal maturation in 30 µm to 200 µm zinc and did
nearly as well up to ~500 µm zinc. At zinc concentrations greater than 500 µm, worms
displayed concentration-dependent impairment of growth.
The maturation assay evaluates development and growth from the egg or L1
larva to the adult stage. To examine the complete life cycle, including reproductive
performance, we analyzed the growth rate of a population (Figure A.2A). Worms were
cultured in CeMM containing 30-75 µm zinc for multiple generations, since these
concentrations are in the range for maximal growth. Worms were transferred to CeMM
containing 16 different zinc concentrations ranging from no added zinc to 2.5 mm zinc.
To determine the maximum growth rate for the population, we counted the number of
worms in the population at several times after transfer to the new medium. Population
growth was approximately linear between 7 and 17 days in culture (Figure A.2B).
Overall the results were similar to the maturation assay. With no added zinc, there was no
significant population growth (Figure A.2C, D). With 1 µm to 2 µm added zinc, there
was measurable but severely impaired population growth. From 2 µm to 30 µm zinc,
there was a dose-dependent increase in population growth. To quantify these data, we
determined the effective concentration (EC50) of zinc that resulted in a population growth
rate that was half the maximal population growth rate. The EC50 for wild-type animals
was 6.8 ± 1.1 µm zinc (Table A.1). From 30 µm to 1 mm zinc, there was relatively
optimal population growth (Figure A.2C, D). Concentrations greater than 1 mm caused a
reduction of population growth rates. We determined the inhibitory concentration (IC50)
of zinc, and the IC50 for wild-type animals was 1.3 ± 0.3 mm zinc (Table A.1). These
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results indicate that worms require dietary zinc for efficient maturation and reproduction,
thrive in a wide-range of dietary zinc concentrations from 30 µm to 1 mm, and are
susceptible to zinc toxicity at concentrations above 1 mm.

Zinc content of wild-type worms is correlated with dietary zinc: To complement the
analysis of how dietary zinc affects maturation and population growth, we developed two
methods to measure the zinc content of animals. The first method utilized radioactive
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Zn. Animals were cultured with a range of dietary zinc and a trace amount of 65Zn, the

amount of internalized 65Zn was determined using a gamma counter, and the sample size
was determined by measuring the protein concentration. The second method utilized
ICP-MS, a technique that can measure the concentration of several different elements in
a single sample, including zinc. Worms were cultured with a range of dietary zinc, the
metal content was determined by ICP-MS, and the dry weight was determined to
establish the sample size. Both methods demonstrated that the zinc content of wild-type
C. elegans was strongly influenced by the level of dietary zinc (Figure A.3A and
Supplemental Table A.1). Worms cultured in 6 µm zinc had a zinc content of ~40 parts
per million (ppm), whereas worms cultured in 2 mm zinc had a zinc content of ~1,000
ppm, a 27-fold difference. By contrast, the content of three other physiologic metals, iron,
copper, and manganese, was not strongly affected by dietary zinc (Figure A.3B). The iron
content displayed minimal change, and copper and manganese contents declined less
than 2-fold. Figure A.3C shows that when the zinc content of wild-type animals
increased above ~400 ppm there was a corresponding decrease in population growth rate
that was caused by high concentrations of dietary zinc.
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While an increase in dietary zinc always resulted in an increase in total zinc content, the
quantitative relationship between the change in zinc content and the change in dietary
zinc (the slope) displayed an interesting pattern. Figure A.3D shows that at the lowest
concentrations of dietary zinc (6-10 µm), the zinc content displayed the greatest change
in response to increased dietary zinc (3.4 ppm/µm). As the dietary zinc concentration was
increased to an optimal level (75-350 µm), the rate of change of zinc content
progressively decreased to 0.6 ppm/µm. As the dietary zinc concentration was increased
to toxic levels (1-2 mm), the rate of change of zinc content was relatively stable (0.4-0.5
ppm/µm). These results indicate that worms cultured in low concentrations of zinc
undergo robust changes in zinc content when additional dietary zinc is provided, whereas
worms cultured in high concentrations of zinc are resistant to changes in zinc content
when challenged with additional dietary zinc. However, wild-type worms continued to
accumulate zinc even at toxic concentrations of dietary zinc greater than 1 mm.

C. elegans cdf-2 encodes a member of the cation diffusion facilitator family:
Vertebrates contain CDF proteins localized to the plasma membrane, ZnT-1, and to
vesicular membranes, ZnT-2, ZnT-3, ZnT-4, and ZnT-8 (Gaither and Eide, 2001a; Kambe
et al., 2004; Palmiter and Findley, 1995). We demonstrated previously that C. elegans
CDF-1 is most similar to the vertebrate ZnT-1 sub-family by sequence criteria and by the
experimental observation that ZnT-1 can functionally substitute for CDF-1 (Bruinsma et
al., 2002). To investigate a C. elegans cation diffusion facilitator protein that is closely
related to the ZnT-2, ZnT-3, ZnT-4, and ZnT-8 sub-family, we initiated an analysis of
the predicted gene T18D3.3. The computer algorithm Gene Finder predicted that the
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T18D3.3 gene contains 8 exons and encodes a protein of 360 amino acids, and we
experimentally validated the predicted gene structure (Figure A.4A and Materials and
Methods). The predicted T18D3.3 protein contains hallmarks of the CDF family
including six transmembrane-spanning segments and two histidine motifs, (HX)3, in the
loop between the fourth and fifth transmembrane segments (Figure A.4B), and we thus
named it CDF-2. Compared to vertebrate proteins, CDF-2 is most similar to ZnT-2,
which is localized to intracellular vesicles and is involved in zinc secretion into breast
milk (Chowanadisai et al., 2006; Palmiter et al., 1996a). While these sequence
similarities indicate that CDF-2 functions as a zinc transporter, the biochemical activity
of CDF-2 has not yet been demonstrated experimentally.

cdf-2 transcript levels were regulated by dietary zinc: To investigate how dietary zinc
regulates the expression of cdf-2, we used quantitative, real-time PCR to monitor the
abundance of cdf-2 mRNA. Wild-type worms were cultured in CeMM with added zinc
chloride for six days to achieve stable gene expression. Adult animals were collected,
and the abundance of cdf-2 transcripts was determined. For comparison, the abundances
of cdf-1 and sur-7 transcripts were also determined. The abundances of transcripts from
these genes were normalized to the abundance of two genes that displayed stable
expression over a range of zinc concentrations, ama-1 and rps-23 (data not shown).
At the low concentration of 2 µm zinc, cdf-1 transcripts were most abundant, cdf-2
transcripts were intermediate in abundance, and sur-7 transcripts were least abundant
(data not shown). As the concentration of dietary zinc was increased, the abundance of
cdf-2 transcripts increased progressively, displaying about 2-fold induction at 30 µm zinc
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and 3-4 fold induction at 250 µm to 2 mm zinc (Figure A.5). By contrast, the abundances
of cdf-1 and sur-7 transcripts were not increased. At the high concentration of 2 mm zinc,
cdf-2 transcripts were more abundant than cdf-1 or sur-7 transcripts. These findings
suggest that cdf-2 has an important function in the response to increased dietary zinc.

CDF-2 localized to vesicles in intestinal cells: To determine the cells that express CDF2 and the subcellular localization of the protein, we expressed a cdf-2::gfp fusion protein
under the control of the predicted cdf-2 promoter in transgenic worms. In an attempt to
include all the relevant promoter elements that might mediate cell type specific
expression, we designed the reporter construct to include 1,371 bp upstream of the
predicted initiation codon, the entire open reading frame, and all of the introns. To
include all of the relevant protein domains that might mediate subcellular localization,
we included the entire CDF-2 protein sequence. The plasmids were introduced into wildtype animals by microinjection to yield extra-chromosomal arrays (Mello et al., 1991)
and into unc-119(ed3) mutant animals by biolistic bombardment to yield integrated
arrays (Praitis et al., 2001). To determine the reproducibility of the observed expression
patterns, we identified six independently derived transgenic lines. The expression pattern
of CDF-2::GFP was similar in all six independently-derived transgenic lines, indicating
that this pattern is not influenced by the genomic integration sites or by rearrangements
that may have occurred during the formation of extrachromosomal arrays. In wild-type
animals, the intestinal cells contain granules that display autofluorescence.
Autofluorescence is first detected in embryos and becomes progressively more intense as
animals mature. Live CDF-2::GFP transgenic worms appeared to display enhanced
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fluorescence in embryos compared to wild-type worms. As animals matured and the
intestinal granules displayed more intense autofluorescence, we could no longer observe
enhanced fluorescence in live CDF-2::GFP transgenic worms. Because autofluorescence
of intestinal granules made it difficult to observe CDF-2::GFP, we fixed embryos and
animals, a process that eliminates autofluorescence, and visualized CDF-2::GFP using an
anti-GFP antibody. CDF-2::GFP was expressed in embryos (Figure A.6E-L), larvae
(Figure A.6M-P), and adults (Figure A.6Q-T). The CDF-2::GFP protein was expressed in
intestinal cells in a punctate pattern that appears to be the membrane of small vesicles
(Figure A.6U). To investigate the relationship between the punctate pattern of CDF2::GFP and the punctate pattern of autofluorescent intestinal granules, we analyzed
fluorescence in live adult worms (Figure A.6A-D). These results indicate that CDF2::GFP is only expressed in puncta that are autofluorescent. These data are consistent
with the possibilities that all or only some of the autofluorescent puncta contain CDF2::GFP, and suggest that CDF-2::GFP is not expressed outside of autofluorescent puncta.
A CDF-1::GFP fusion protein is also expressed in intestinal cells, but it is localized to the
plasma membrane (Bruinsma et al., 2002), and it is not localized to the vesicles that
contain CDF-2. Therefore, the subcellular localization of CDF-2::GFP is unlikely to be
mediated by the GFP fusion partner and appears to be specific for CDF-2. While the
CDF-2::GFP fusion protein was designed to indicate the expression pattern of
endogenous CDF-2, the function of the CDF-2::GFP fusion protein has not been
analyzed, and it is possible that endogenous CDF-2 is expressed in a broader or more
restricted pattern than the CDF-2::GFP reporter. These results indicate that CDF-2 is
localized to vesicular membrane compartments similar to the related vertebrate proteins
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ZnT-2, ZnT-3, Znt-4, and ZnT-8 (Gaither and Eide, 2001a; Kambe et al., 2004).

A cdf-2 loss-of-function mutation resulted in delayed population growth and
decreased zinc content: To investigate the function of cdf-2, we obtained the tm788
deletion allele from the Mitani laboratory (National Bioresource Project, Tokyo, Japan).
We determined the sequence of the cdf-2 locus and confirmed that tm788 is an 804 base
pair deletion that removes 594 base pairs upstream of the ATG, exon 1, intron 1, and 69
base pairs of exon 2 (Figure A.4A). In addition, there is a 68 base pair insertion at the site
of the deletion. The deleted DNA encodes the first 34 predicted amino acids of the CDF2 protein. The tm788 deletion is predicted to affect the cdf-2 transcript in two important
ways. First, tm788 is predicted to reduce the abundance of cdf-2 transcripts by removing
the 5' upstream region that might contain promoter elements and the transcription
initiation site. Second, any cdf-2 transcripts that are produced must have an abnormal
structure, since exon 1 and part of exon 2 are absent. Such abnormal transcripts would
definitely lack the codons for the first 34 predicted amino acids and might lack additional
codons. The first methionine codon in the cdf-2 open reading frame that remains in the
tm788 mutant is codon 65, and a protein that initiated at codon 65 would lack half of the
highly conserved first transmembrane domain.
To determine how the cdf-2(tm788) mutation affects the abundance of the cdf-2
transcript, we used the sensitive method of reverse transcription-PCR. The abundance of
the cdf-2 transcript was dramatically reduced by approximately 1,000-fold in the cdf2(tm788) mutant compared to wild type, and the residual cdf-2 transcript was not induced
by dietary zinc (Supplemental Figure A.1). These findings indicate that the cdf-2(tm788)
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deletion eliminates sequences that are critical for transcript initiation and/or sequences in
the transcribed region that are critical for transcript stability. These results suggest that
the cdf-2(tm788) mutation causes a strong loss-of-function.
To analyze the phenotype of the cdf-2(tm788) mutant, we first backcrossed the strain to
wild-type animals to remove extraneous mutations. cdf-2(tm788) mutant animals
appeared to have normal morphology and body movement. cdf-2(tm788) did not cause
significant lethality, and cdf-2(tm788) hermaphrodites and males were fertile (data not
shown). The cdf-2(tm788) mutation did not suppress the multi-vulval phenotype caused
by constitutively activated let-60(n1046) Ras (data not shown), by contrast to loss-offunction mutations of cdf-1 and sur-7 (Bruinsma et al., 2002; Yoder et al., 2004). To
carefully monitor the ability of cdf-2(tm788) mutant animals to grow and develop in a
wide range of dietary zinc conditions, we used CeMM to conduct maturity and
population growth assays. Figure A.7A shows that maturation from L1 to adult was
similar for cdf-2(tm788) mutant and wild-type animals in a wide range of dietary zinc.
By contrast, cdf-2(tm788) mutant animals displayed reduced population growth
compared to wild-type animals in 30 µm to 480 µm dietary zinc (Figure A.7B). In
extremely low and high dietary zinc conditions, cdf-2(tm788) mutant and wild-type
animals displayed similar population growth, and the EC50 and IC50 values for cdf2(tm788) mutant animals were 3.8 ± 1.0 µm zinc and 1900 ± 160 µm zinc, respectively
(Table A.1). These findings indicate that cdf-2 is necessary for wild-type levels of
population growth when dietary zinc is in the optimal range.
To determine how cdf-2 influences zinc content, we analyzed cdf-2(tm788)
mutant animals using ICP-MS. Figure A.7C shows that cdf-2(tm788) mutant animals
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displayed reduced zinc content at dietary zinc concentrations of 30 µm and higher
compared to wild-type animals (Supplemental Table A.1); at a dietary zinc concentration
of 75 µm, the zinc content of the cdf-2 mutant was reduced 2-fold, and at dietary zinc
concentrations of 350 µm, 1 mm, and 2 mm the zinc content of the cdf-2 mutant was
reduced 3-fold. In conjunction with the localization data, these results suggest that CDF2 functions to store zinc in vesicles of intestinal cells.
Loss-of-function mutations in cdf-1 and sur-7 affect sensitivity to dietary zinc and
zinc content: cdf-1 and sur-7 are critical for Ras-mediated signal transduction and
resistance to high levels of dietary zinc when animals are cultured with live E. coli
(Bruinsma et al., 2002; Yoder et al., 2004). The role of these genes in conditions of low
dietary zinc has not been determined. We used CeMM to analyze the functions of cdf-1
and sur-7 in a full range of dietary zinc. The strong loss-of-function cdf-1(n2527)
mutation is a nonsense change that is predicted to truncate the protein at amino acid 156
of 519, resulting in the absence of three highly conserved transmembrane domains
(Bruinsma et al., 2002). The partial loss-of-function sur-7(ku119) mutation affects a
predicted splice site and reduces but does not eliminate sur-7 transcripts (Yoder et al.,
2004). We cultured cdf-1 and sur-7 mutant animals in a wide range of dietary zinc and
measured the ability of L1 larvae to mature to adulthood. Both cdf-1 and sur-7 mutant
animals displayed reduced maturation at low and high concentrations of zinc, whereas
they displayed wild-type levels of maturation at intermediate zinc concentrations (Figure
A.8A, B). Both cdf-1 and sur-7 mutant animals displayed reduced population growth at
concentrations of dietary zinc from 10 µm to 2.5 mm (Figure A.8C, D). The EC50 for
population growth rate was similar for these mutant animals and wild type, whereas the
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IC50 was reduced for both cdf-1 and sur-7 mutant animals (Table A.1). These results
indicate that cdf-1 and sur-7 are necessary for optimal maturation in low dietary zinc, a
result that has not been previously reported. These genes are necessary for optimal
population growth in a wide-range of dietary zinc and are essential for survival at high
dietary zinc, consistent with previous reports (Bruinsma et al., 2002; Bruinsma et al.,
2008; Yoder et al., 2004).
To determine the role of cdf-1 and sur-7 in regulating zinc content, we analyzed
loss-of-function mutant animals using ICP-MS. cdf-1 mutant animals displayed increased
zinc content at dietary zinc concentrations of 30 µm and higher (Figure A.8E and
Supplemental Table A.1). sur-7 mutant animals displayed a zinc content similar to wild
type (Figure A.8F and Supplemental Table A.1). The finding that sur-7 mutant animals
displayed dramatic growth defects and relatively normal zinc content suggests that the
distribution of zinc is abnormal in mutant animals. This analysis shows that cdf genes can
have strikingly different effects on zinc content; cdf-2 promotes zinc accumulation,
whereas cdf-1 inhibits zinc accumulation.

Analysis of cdf-1, cdf-2, and sur-7 double and triple mutant animals: To investigate
the genetic interactions between these three genes, we generated the three possible
double mutant strains and the triple mutant strain and measured maturation, population
growth, and zinc content of each strain (Table A.1, Supplemental Tables A.1-3). The cdf1 cdf-2 and cdf-1 cdf-2 sur-7 mutant animals were particularly informative (Figure A.9).
Loss-of-function mutations in cdf-1 and cdf-2 have opposite effects on zinc content. The
cdf-1 cdf-2 double mutant displayed a zinc content that was intermediate between the
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two single mutant strains (Figure A.9E).

The cdf-1 cdf-2 double mutant had slightly

impaired maturation rates compared to the cdf-1 mutant (Figure A.9A), but had slightly
improved population growth rates compared to the cdf-1 mutant (Figure A.9C). These
results suggest that cdf-1 and cdf-2 have antagonistic functions with respect to zinc
content and the more normal zinc content of the cdf-1 cdf-2 mutant may account for the
increase in the population growth rate.
The cdf-1 cdf-2 sur-7 triple mutant was also intermediate between the cdf-1 and
cdf-2 single mutant animals with respect to zinc content; furthermore, the cdf-1 cdf-2 sur7 mutant had a zinc content that was similar to wild type (Figure A.9F). Figure A.9G
compares the change in zinc content as a function of dietary zinc for single and triple
mutant animals. The cdf-2 single mutant displayed smaller changes in zinc content
compared to wild type at all concentrations of dietary zinc. By contrast the cdf-1 single
mutant displayed larger changes compared to wild type in most intervals. Consistent with
the interpretation that cdf-1 and cdf-2 have antagonistic functions, the values for the
triple mutant were usually intermediate between cdf-1 and cdf-2 mutant animals.
Furthermore, at the highest concentrations of dietary zinc, cdf-1 and cdf-1 cdf-2 sur-7
mutant animals displayed a trend toward increasing values in contrast to wild-type
animals that displayed decreasing or stable values (Figure A.9H). These findings suggest
that cdf genes are necessary for animals to resist changes in zinc content when
challenged with the highest levels of dietary zinc. The cdf-1 cdf-2 sur-7 mutant had
increased population growth rates at optimal dietary zinc concentrations compared to the
cdf-1 mutant, but triple mutant animals were very sensitive to zinc toxicity and had an
IC50 of 220 µm (Figure A.9D and Table A.1). The failure of the cdf-1 cdf-2 sur-7 mutant
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to control zinc content at high dietary zinc may be responsible for the increased
sensitivity to zinc toxicity.

DISCUSSION

Zinc metabolism and homeostasis in wild-type C. elegans: C. elegans is typically
cultured with E. coli as a food source, which limits the ability to manipulate dietary
constituents such as zinc. Chemically defined media that support long term culture of the
related nematode C. briggsae have been developed (Buecher et al., 1966; Hieb and
Rothstein, 1968; Hieb et al., 1970; Lu et al., 1978). These culture conditions were
adapted for the study of C. elegans by Lu and Goetsch (1993), and the growth
characteristics of C. elegans in fully defined medium were described by Szewczyk et al.
(2003; 2006). To develop culture conditions that allow complete control of dietary zinc,
we analyzed worms using CeMM with no added zinc and a wide range of supplemental
zinc. These experiments revealed that C. elegans cannot mature or reproduce in CeMM
with no added zinc (approximately 0.25 µm zinc), demonstrating that dietary zinc is
essential for C. elegans survival. When dietary zinc was in the range of 1 µm to 10 µm,
C. elegans displayed impaired but measurable growth, and the EC50 for dietary zinc was
~7 µm. When dietary zinc was in the range of 30 µm to 1 mm, C. elegans displayed
optimal growth. The finding that optimal growth occurs over a 30-fold range in dietary
zinc indicates that C. elegans have evolved mechanisms to thrive in a relatively broad
range of dietary zinc. When dietary zinc was in the range of 1 mm to 2.5 mm, C. elegans
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displayed dose-dependent impairment of growth, and the IC50 for dietary zinc was ~1.3
mm. The EC50 and IC50 for dietary zinc differ by 190-fold and define the range of zinc
that permits C. elegans survival.
The culture conditions described here have important advantages compared to
the culture conditions that have been used previously to manipulate dietary zinc
(Bruinsma et al., 2002; Bruinsma et al., 2008; Dong et al., 2008a; Yoder et al., 2004). We
previously supplemented NGM or NAMM with zinc; these media conditions allowed for
supplemental dietary zinc but did not allow for depletion of dietary zinc, since E. coli is
the food source. The use of CeMM allowed us to quantitatively determine for the first
time the minimum, optimum, and maximum dietary zinc levels for C. elegans. Similar
quantitative measurements of levels have not been systematically established for other
animals, and these studies provide new information about the capacity of multicellular
animals to metabolize zinc.
An important method for analyzing zinc metabolism is the measurement of zinc
content. The zinc content of C. elegans has not been previously reported. We developed
two independent methods to measure zinc content. One method employed radioactive
65

Zn as a tracer and the second method utilized physical measurements of zinc performed

by ICP-MS. Our results indicate that total animal zinc content is proportional to the
concentration of dietary zinc. Over the ~30-fold range of dietary zinc that promotes
optimal growth (30 µm-1 mm), worms displayed an ~7-fold increase in zinc content.
However, the relationship between dietary zinc and zinc content displayed an interesting
pattern. At the lowest concentrations of dietary zinc, wild-type worms displayed the most
responsiveness to changes in dietary zinc, measured as the change in zinc content per
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change in dietary zinc. This responsiveness decreased as dietary zinc was increased to
the optimal range for population growth and then stabilized as dietary zinc increased to
high levels. These findings suggest that at low concentrations of dietary zinc, worms are
in a physiological state that promotes uptake of dietary zinc and/or minimizes zinc
excretion, so that the animals respond to an increase in dietary zinc with a robust increase
in zinc content. By contrast, at high concentrations of dietary zinc, worms are in a
physiological state that minimizes uptake of dietary zinc and/or maximizes zinc
excretion, so that animals respond to an increase in dietary zinc with a minimal increase
in zinc content. Because zinc content never appears to be independent of dietary zinc,
even at toxic levels of dietary zinc, it appears that worms do not have the capacity to
maintain a consistent zinc content when challenged with increasing dietary zinc. These
results support the model that excess zinc content is the cause of dietary zinc toxicity.
The analysis of metal content of worms indicated that there is a relationship
between zinc metabolism and the metabolism of other metals, specifically copper and
manganese. Wild-type worms displayed approximately two-fold decreases in copper and
manganese content as dietary zinc was increased. Interestingly, this effect was abrogated
in cdf-1 mutants. In humans, excess dietary zinc can cause copper deficiency (Prasad et
al., 1978; Vallee and Falchuk, 1993). Although the mechanisms have not been well
established, one possibility is that processes that are regulated to excrete excess zinc
and/or limit zinc uptake also act on other metals such as copper, perhaps due to
overlapping specificity. Our results suggest that similar events occur in C. elegans, and
raise the possibility that mechanisms that promote zinc excretion or limit zinc uptake
may also act on copper and manganese.
150

Studies of zinc in widely divergent species have led to the proposal that these
systems have similar concentrations of zinc and that there is a universal zinc quotient
(Eide, 2006; Outten and O'Halloran, 2001). The results of our studies indicate that zinc
content is dependent upon the concentration of dietary zinc and, therefore, highly
variable. These findings suggest that animals have a measurable but limited capacity to
moderate changes in zinc content in response to changing dietary zinc, and probably
have also evolved mechanisms to cope with a wide range of zinc content. Our studies
measured total zinc content of the animals, and it is possible that the distribution of zinc
within the animal is dynamic so that some cells or compartments maintain a relatively
constant zinc concentration. For example, zinc may be sequestered in specific cells or
compartments under conditions of high dietary zinc. Our analysis of cdf-2 suggests that
zinc is stored in vesicles of intestinal cells. The development of methods to localize zinc
will be important for elucidating how worms partition zinc to different compartments,
which may be an important aspect of zinc homeostasis.

cdf-2 encodes a predicted zinc transporter that is localized to vesicles in intestinal
cells: We investigated cdf-2 because it is predicted to encode a highly-conserved member
of the CDF family that is most similar to vertebrate ZnT-2 and is highly related to ZnT-3,
ZnT-4, and ZnT-8. ZnT-2 is expressed in the small intestine, kidney, seminal vesicle,
testis, and prostate and localized to the endosomal compartment (Palmiter et al., 1996a).
ZnT-4 is expressed ubiquitously and localized to the trans golgi network and endosomal
compartment (Murgia et al., 1999). ZnT-3 is expressed in neurons and localized to
synaptic vesicles (Palmiter et al., 1996b), and ZnT-8 is expressed in the pancreas and
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localized to insulin-containing vesicles (Chimienti et al., 2004; Chimienti et al., 2006).
We used a CDF-2::GFP fusion protein to demonstrate that CDF-2 is localized to vesicles
of intestinal cells. The vesicles that contain CDF-2::GFP co-localize with autofluorescent
intestinal granules. Autofluorescent intestinal granules have been characterized by
electron microscopy, leading to the conclusion that these structures are secondary
lysosomes (Clokey and Jacobson, 1986). Furthermore, autofluorescent intestinal granules
colocalize with LysoTracker Red-stained compartments and acidified, acridine orangestained comportments, strongly suggesting that these granules are components of
lysosome-related organelles (Hermann et al., 2005). In light of these studies, our results
indicate that CDF-2 resides on the membrane of secondary lysosomes/lysosome-related
organelles. Thus, CDF-2 resembles ZnT-3 and ZnT-8 since it is expressed in a specific
tissue and localized to specialized vesicles.
The discovery that CDF-2 is localized to lysosome-related organelles raises the
interesting question, what is the role of zinc in the lumen of this compartment? cdf-2
loss-of-function mutations caused impaired growth, indicating that the function of cdf-2
in lysosome-related organelles is critical for optimal zinc metabolism and growth. The
cdf-2 mRNA was significantly increased by high dietary zinc, indicating that cdf-2 may
mediate a response to zinc stress. Taubert et al. (2008) analyzed the MDT-15
transcriptional coregulator and showed that the increase in cdf-2 transcripts requires
MDT-15. In conditions of high dietary zinc, CDF-2 may function to reduce cytosolic
levels of zinc by sequestration in the lumen of lysosome-related organelles. Consistent
with this possibility, cdf-2 mRNA is induced by high dietary zinc and cdf-2 mutant
animals have reduced zinc content at high dietary zinc, suggestive of a storage defect.
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Strikingly, the zinc content of cdf-2 mutant animals is one-third the zinc content of wildtype animals at high dietary zinc, suggesting that two-thirds of the zinc content of wildtype animals is stored in the lumen of intestinal vesicles. Another possibility is that CDF2 functions to provide zinc for lysosomal enzymes. There are precedents for metal
transporters supplying proteins resident in vesicles, such as the recent demonstration that
ATP7A supplies copper to tyrosinase by functioning within specialized organelles called
melanosomes (Setty et al., 2008). The yeast CDF proteins Msc2 and Zrg17 transport zinc
into the ER to supply zinc to proteins in the secretory pathway (Eide, 2006; Ellis et al.,
2005), and vertebrate ZnT-3 and ZnT-8 transport zinc into synaptic vesicles and insulincontaining vesicles, respectively (Palmiter and Huang, 2004). Our studies lay the
foundation for further testing these hypotheses directly by establishing a model system to
study the function of a CDF protein that is localized to the vesicular membrane.

cdf-1 and cdf-2 function antagonistically to regulate zinc metabolism: Animals such
as C. elegans and vertebrates contain extensive families of CDF proteins (Eide, 2006;
Kambe et al., 2004; Liuzzi and Cousins, 2004; Palmiter and Huang, 2004). It is
important to determine the extent to which these proteins have independent, redundant,
or antagonistic functions. In vertebrates, loss-of-function mutations have been described
for ZnT-1, ZnT-3, ZnT-4 and ZnT-5 (Palmiter and Huang, 2004); only ZnT-1 is essential
for survival (Andrews et al., 2004). However, mutant animals that lack the function of
two or more vertebrate cdf genes have not been reported.
Three C. elegans genes encoding cation diffusion facilitator proteins have now
been characterized genetically and molecularly- cdf-1, cdf-2, and sur-7. cdf-1 encodes a
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protein whose most similar vertebrate homolog is ZnT-1. CDF-1 and ZnT-1 are localized
to the plasma membrane, ZnT-1 can functionally substitute for CDF-1 in C. elegans, and
both proteins modulate Ras-mediated signaling in vertebrates and C. elegans (Bruinsma
et al., 2002). cdf-1 is expressed in vulval precursor cells, and it appears to act cell
autonomously in these cells to affect Ras-mediated signaling. cdf-1 is also highly
expressed in intestinal cells, and cdf-1 appears to act non-autonomously in intestinal cells
to affect Ras-mediated signaling in vulval precursor cells. CDF-1 may transport zinc
from intestinal cells to the body cavity or intestinal lumen and thereby influence zinc
metabolism in vulval precursor cells. A cdf-1(lf) mutant was previously demonstrated to
be hypersensitive to high dietary zinc (Bruinsma et al., 2002). Here we confirmed this
result using fully defined CeMM. We determined that the maturation of a cdf-1(lf) mutant
was normal at optimal levels of dietary zinc but sensitive to low and high dietary zinc.
The population growth rate of cdf-1(lf) mutant animals was reduced at all concentrations
of dietary zinc, but the mutant animals were extremely sensitive to high dietary zinc. cdf1(lf) mutant animals displayed increased zinc content that was most pronounced at high
levels of dietary zinc. These results indicate that cdf-1 activity promotes zinc excretion
and/or limits zinc uptake. One model to explain this observation is that CDF-1 transports
zinc across the plasma membrane of intestinal cells and into the intestinal lumen, thus
directly promoting zinc excretion. Alternatively, CDF-1 may transport zinc from
intestinal cells into the body cavity, thereby indirectly promoting zinc excretion by
another cell such as the excretory cell. The findings that cdf-1 mutant animals cultured
with high dietary zinc displayed increased zinc content and decreased survival suggest
that the increased zinc content may cause the reduced survival.
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sur-7 encodes a CDF protein that does not have a closely related homolog in
vertebrates. Yoder et al. (2004) reported that a SUR-7::GFP fusion protein was expressed
in non-intestinal cells in a cytosolic pattern suggestive of endoplasmic reticulum,
indicating that sur-7 may provide zinc to proteins resident in this compartment and
promote excretion of zinc from cells through the secretory pathway. Here we
demonstrated that sur-7(lf) mutant animals displayed reduced maturation and population
growth rates in high dietary zinc, consistent with previous reports (Yoder et al., 2004).
Maturation was also reduced at low dietary zinc, whereas mutant and wild-type animals
displayed similar maturation at a narrow range of optimal dietary zinc. The zinc content
of sur-7 mutant animals was similar to wild-type animals. Because the growth defects of
sur-7 mutants are evidence for altered zinc metabolism, the finding that the overall zinc
content is similar to wild type indicates that the distribution of zinc in the sur-7(lf)
mutant animals is abnormal. The sur-7 phenotypes may be caused by reduced zinc in the
secretory pathway and/or increased zinc in another compartment.
Because CDF-1, CDF-2, and SUR-7 are all predicted to reduce the concentration
of zinc in the cytoplasm, it is possible that the functions of these proteins are redundant.
In this case, double or triple mutant animals might display phenotypes that are stronger
than any single mutant. In general, we did not observe this pattern, since most double and
triple mutant animals displayed similar phenotypes to one of the single mutants.
However, for the phenotype of controlling zinc content in high dietary zinc (Figure
A.9H), the triple mutant was much more impaired than any single mutant. This result
suggests that CDF-1, CDF-2, and SUR-7 might function redundantly to control zinc
content at high dietary zinc.
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By contrast to the similar effects that all CDF proteins are predicted to have on
the cytoplasmic zinc concentration, CDF-1 and CDF-2 are predicted to have distinct
effects on zinc concentrations in the extracellular space and lumen of intracellular
compartments. Whereas cdf-1(lf) mutant animals displayed increased zinc content in high
dietary zinc, suggesting cdf-1 is necessary to excrete zinc, cdf-2(lf) mutant animals
displayed reduced zinc content in high dietary zinc, suggesting cdf-2 is necessary to store
zinc. The cdf-1 cdf-2 double mutant displayed an intermediate zinc content, suggesting
that cdf-1 and cdf-2 function antagonistically. CDF-1 and CDF-2 are both expressed in
intestinal cells; CDF-1 is localized to the plasma membrane, whereas CDF-2 is localized
to vesicles. As shown in Figure A.10, we propose that CDF-1 and CDF-2 compete for
cytosolic zinc. If CDF-1 transports zinc across the plasma membrane, then the zinc
content of the animal is directly or indirectly decreased. If CDF-2 transports zinc into the
vesicle lumen, then the zinc content of the animal is increased. This model accounts for
the changes observed in the cdf-1 and cdf-2 mutant animals and explains why the cdf-1
cdf-2 double mutant animals have an intermediate phenotype. These findings
demonstrate the power of the C. elegans model system to dissect the relationships
between CDF family members.
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FIGURE LEGENDS

Figure A.1. The maturation of wild-type worms is affected by dietary zinc. A. To
monitor maturation, we cultured adults on NGM with live E. coli, transferred eggs or L1
larvae to CeMM (18-19 different zinc concentrations) in 24 well plates, cultured for 9-12
days, and evaluated maturation using a dissecting microscope (B) or a COPAS Biosort
(C). B. Wild-type worms were cultured in CeMM with added zinc, displayed on a
logarithmic scale. To calculate the percent of eggs that matured to an adult, we counted
immature and mature animals and calculated the percent mature. C. Maturation was
monitored using the COPAS Biosort to measure time of flight (TOF). TOF is a measure
of the time that the animal blocks light transmission and is shown in arbitrary units. The
TOF value of animals at the beginning of the experiment was approximately 80 units.
Values are the average (± standard deviation, SD) of four biological replicates.

Figure A.2. The population growth rate of wild-type worms is affected by dietary zinc. A.
To monitor the growth rate of the population, we cultured worms in CeMM with 30-75
µm zinc for multiple generations, transferred worms to flasks of CeMM (15-16 different
zinc concentrations), and counted the number of worms per mL of culture medium at
multiple times. Counting was performed using a dissecting microscope (B, C) or a
COPAS BIOSORT (D). B. Wild-type worms were cultured in CeMM with different
concentrations of added zinc shown in µm and indicated by colored lines. The numbers
of worms per mL were determined at culture days 1, 4, 7, 10, 14, 17, and 22. The
increase in population was maximal and approximately linear between days 7 and 17. C.
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The slopes of the lines defined by the linear range shown in panel B were used to
calculate population growth rates in worms/mL/day. The concentration of added zinc is
displayed on a logarithmic scale. The colors of the data points correspond to the colors of
the lines shown in panel B. Values are the average (± SD) of three independent
experiments, one of which is shown in panel B. D. Population growth rate was monitored
using the COPAS BIOSORT to measure the number of animals at four time points
between days 9 and 17. Values are the average (± SD) of three independent experiments.
The growth rates calculated from the COPAS BIOSORT data are somewhat higher than
the growth rates calculated from the dissecting microscope data, probably because
human observers are more stringent than the instrument in scoring objects as worms.
Nonetheless, the effect of zinc on population growth rate was similar when measured
using a dissecting microscope or the COPAS BIOSORT.

Figure A.3. Zinc content of mixed-stage wild-type animals. Worms were cultured in
CeMM with a range of added zinc, shown on a logarithmic scale. A. The zinc content
was determined by ICP-MS (parts per million, closed green circles), or radiolabeled 65Zn
(average ng zinc/µg protein ± SD, n=2, open green circles) in independent experiments.
B. ICP-MS was used to measure the content of copper (Cu, blue triangles), iron (Fe, red
squares), manganese (Mn, pink diamonds), and zinc (Zn, green circles) of each sample.
The dietary concentrations of copper, iron, and manganese in CeMM were 37.5 µm, 150
µm, and 112.5 µm, respectively, in all the samples. C. Zinc content was determined by
ICP-MS (green circles), and population growth rate was determined by COPAS
BIOSORT (black squares) in independent experiments. D. Bars indicate the change in
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zinc content (ppm) divided by the change in dietary zinc (µm) for the two dietary zinc
concentrations shown below. Values are the slope of the line defined by the ICP-MS data
in panel A.

Figure A.4. cdf-2 gene structure and predicted amino acid sequence. A. The line
represents genomic DNA, and boxes represent exons that are untranslated (open) or
translated (black). The green line indicates the extent of the tm788 deletion, and the
green triangle denotes the tm788 insertion. B. An alignment of the predicted CDF-2
protein with human ZnT-2 and C. elegans CDF-1.

Identical and similar amino acids are

highlighted in black and grey, respectively. Green lines indicate codons deleted in the
tm788 allele. Putative zinc binding motifs, (HX)n, are red. Predicted transmembrane
segments are boxed and labeled I to VI.

Figure A.5. cdf-2 transcript abundance was regulated by dietary zinc. Wild-type animals
were cultured in CeMM with added zinc, shown on a logarithmic scale. The abundance
of transcripts from cdf-1 (open circles), cdf-2 (black diamonds), and sur-7 (grey
triangles) was measured by performing quantitative, real-time PCR. The axis represents
the fold change in transcript abundance, which was calculated by comparing the
transcript abundance at 2 µm, 10 µm, 30 µm, 250µm, 500 µm, 1 mm, and 2 mm dietary
zinc to transcript abundance at 2µm dietary zinc. Values for transcript abundance were
corrected for RNA recovery and the efficiency of primer amplification (see Materials and
Methods). The fold change of each gene at 2 µm zinc was set equal to 1.0, and other
values were normalized relative to 2 µm zinc. Values are the average of four independent
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replicates (±SD). Compared to transcript abundance at 2 µm zinc, cdf-2 transcripts were
significantly higher at zinc concentrations of 250 µm to 2 mm zinc (~3-4 fold, p<0.05,
Welch’s t-Test), whereas cdf-1 and sur-7 transcripts were significantly decreased at 2 mm
zinc (~2-fold, p<0.05, Welch’s t-Test).

Figure A.6. CDF-2 was expressed in intestinal cells and localized to membrane-bound
vesicles. Transgenic animals expressing CDF-2::GFP were cultured on NGM with live E.
coli. Live adults were immobilized and mounted (A-D). Mixed-stage worms were fixed
and stained with an anti-GFP antibody (E-U). Differential interference contrast images
display organism morphology (A, E, I, M, Q), green displays CDF-2::GFP and
autofluorescence (B) or only CDF-2::GFP (F, J, N, R, U), red displays autofluorescence
(C, G, K, O, S), yellow displays overlap between CDF-2::GFP and autofluorescence (D),
and blue displays nuclear morphology using DAPI (H, L, P, T). Red in panel C shows a
punctate pattern of autofluorescence in intestinal cells, whereas red in panels G, K, O,
and S shows that there is no specific localization of autofluorescence following fixation,
and exposure times for red in these panels were at least 5-fold longer than for green.
CDF-2::GFP was first detected during embryogenesis at the E16-E20 stage (F), and
expression persisted throughout embryogenesis (J). CDF-2::GFP was expressed in a
punctate pattern in intestinal cells during all larval stages (N) and in adults (R). Puncta
appear to be membrane-bound vesicles (→, U).

Figure A.7. cdf-2 mutant phenotypes. Wild-type and mutant animals were cultured in
CeMM with a range of added zinc, shown on a logarithmic scale. A. Maturation of wild
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type (WT, black squares) and cdf-2(tm788) (open diamonds) was monitored using the
COPAS Biosort. Values are the average (± SD) of four biological replicates and are
representative of two independent experiments. B. Population growth rate was monitored
using the COPAS BIOSORT, and values are the average (±SD) of two to three
independent experiments. C. Zinc content was measured using ICP-MS.

Figure A.8. Maturation, population growth rate, and zinc content of cdf-1 and sur-7
mutant animals. Wild-type and mutant animals were cultured in CeMM with a range of
added zinc, shown on a logarithmic scale. A, B. Maturation of wild type (WT, black
squares), cdf-1(n2527) (open circles), and sur-7(ku119) (open triangles) was monitored
using the COPAS Biosort. Values are the average (± SD) of four biological replicates and
are representative of two independent experiments. C, D. Population growth rate was
monitored using the COPAS BIOSORT, and values are the average (± SD) of two to
three independent experiments. E, F. Zinc content was measured by ICP-MS.

Figure A.9. Maturation, population growth rate, and zinc content of double and triple
mutant animals. Wild-type and mutant animals were cultured in CeMM with a range of
added zinc, shown on a logarithmic scale. A, B. Maturation of wild type (black squares),
cdf-1(n2527) (open blue circles), cdf-2(tm788) (open red diamonds), sur-7(ku119) (open
green triangles), cdf-1(n2527) cdf-2(tm788) (grey squares), and cdf-1(n2527) cdf2(tm788) sur-7(ku119) (grey squares) was monitored using the COPAS Biosort. Values
are the average of four biological replicates. C, D. Population growth rates were
monitored using the COPAS Biosort. Values are the average of two to three independent
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experiments. Values (±SD) are shown in Supplemental Table A.2 (Maturation) and
Supplemental Table A.3 (Population growth rate). E-H. Zinc content was measured by
ICP-MS. The change in zinc content as a function of change in dietary zinc is displayed
in units of ppm/µm (panel G) or normalized by setting the values for 75-350 µm equal to
1.0 (panel H).

Figure A.10. A model of zinc distribution in wild-type and cdf mutant animals. Each
diagram shows a polarized intestinal cell. CDF-1 (blue) localizes to the plasma
membrane, and CDF-2 (red) localizes to the membrane of an intracellular compartment.
The absence of CDF-1 and CDF-2 in mutant animals is illustrated by an X (B-D). The
size of the Zn2+ indicates the concentration of zinc in a compartment. We propose that
CDF-1 and CDF-2 function as zinc transporters based on sequence similarity to wellcharacterized CDF proteins, and the size of the arrow indicates the amount of zinc flux.
A. In wild-type animals, CDF-1 and CDF-2 compete for cytosolic zinc, resulting in
intermediate levels of zinc in the cytosol, the extracellular space, and the vesicle lumen.
B. In cdf-1(lf) mutant animals, the level of cytosolic zinc increases, and CDF-2 transports
additional zinc into the vesicle lumen. C. In cdf-2(lf) mutant animals, the level of
cytosolic zinc increases, and CDF-1 transports additional zinc into the extracellular space.
D. In cdf-1(lf) cdf-2(lf) double mutant animals, zinc transport into the vesicle lumen and
extracellular space both decrease.

Supplemental Figure A.1. cdf-2 transcript levels were decreased ~1,000-fold in cdf2(tm788) mutant animals. Mixed-stage wild-type and cdf-2(tm788) animals were
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cultured on NAMM dishes containing E. coli (Bruinsma et al. 2008) and no
supplemental zinc (-) or 0.5 mm supplemental zinc (+) for 40 hours at 20º. Animals were
collected in M9 buffer and solubilized in TRIzol (Invitrogen). 590 ng of RNA was
reverse transcribed using random hexamer primers and the SuperScript III First-Strand
Synthesis System for RT-PCR (Invitrogen). cDNA was diluted in water and PCR
amplified using KlenTaq LA DNA Polymerase (Sigma-Aldrich). The amount of input
cDNA is indicated in arbitrary units (1, no dilution; 0.1, 10x dilution; 0.01, 100x
dilution), and the intensity of the amplified products demonstrates the semi-quantitative
nature of the assay. A 325 bp cdf-2 product was amplified using primers that annealed to
exon 5 and to the junction of exons 7 and 8. These exons are not affected by the tm788
deletion. A 330 bp cdf-1 product was amplified using primers that annealed to exons 3
and 4. As a control for contamination of individual reaction components, we substituted
water for the templates and either PCR amplified (W) or reverse transcribed and PCR
amplified (RT) the reaction mixes with each primer set. PCR products were separated on
a 2% TAE agarose gel containing ethidium bromide and visualized using UV light.
Molecular weight markers (M) are labeled (100 bp DNA ladder, New England Biolabs,
Ipswich, MA). The identities of the amplified products were verified by DNA sequencing.
In wild-type animals, cdf-2 transcripts were readily detected and induced by
supplemental zinc. In cdf-2(tm788) animals, cdf-2 transcript levels were reduced ~1,000fold compared to wild-type animals since they were barely detectable with 1 unit of input
cDNA. Furthermore, cdf-2 transcripts in the mutant animals were not induced by
supplemental zinc. The cdf-1 control demonstrates that equivalent levels of amplifiable
cDNA were present in all of the samples.
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APPENDIX B

Analysis of Uncharacterized C. elegans
Zinc Transporters
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INTRODUCTION

Zinc transporters play a major role in the control of zinc metabolism. There are
two families of zinc transporters, CDF and ZIP (Eide, 2006). CDF proteins move
cytoplasmic zinc out of the cell or into intracellular compartments, resulting in the
decrease in the cytoplasmic zinc level. In contrast, ZIP proteins uptake zinc from the
outside of the cells or move zinc from intracellular compartments to the cytoplasm,
leading to the increase in the cytoplasmic zinc level. Each zinc transporter family has
multiple members. For example, in mammals, there are 10 members in the CDF family
and 14 members in the ZIP family (Lichten and Cousins, 2009). Many zinc transporters
have been studied for their expression, regulation and function. Theses studies suggested
that each zinc transporter has its unique function but there are also networks of zinc
transporters to control biological processes and to regulate zinc homeostasis in the body.
However, due to the complexity caused by a large number of zinc transporters,
understanding of the function of zinc transporters in animals is still limited.
C. elegans can be useful to study the function of zinc transporters because it has
conserved multiple zinc transporters in its simple body, and thereby it can facilitate the
analysis of networks of zinc transporters. In addition, the genetic power of C. elegans
allows various and efficient approaches to study the function of zinc transporters.
Genomic sequence analysis revealed that C. elegans has 14 putative CDF and 14 ZIP
proteins (Table B.1) (Kambe et al., 2006; Krupa et al., unpublished data). Three CDF
proteins have been previously characterized (Bruinsma et al., 2002; Davis et al., 2009;
Yoder et al., 2004), but little is known about the other zinc transporters. Therefore, it is
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important to perform the comprehensive study of C. elegans zinc transporter to better
understand zinc metabolism and zinc-related physiological processes.
To characterize zinc transporters, we analyzed their expression patterns by
generating transgenic animals and examined the phenotypes of loss-of-function mutant
animals. Studying all C. elegans zinc transporters in this single study was practically
impossible. The priority of zinc transporters was thus determined by the criteria such as
the homology to human genes, implication in human heath, availability of mutant alleles
and easiness of gene cloning. A subset of zinc transporters was studied (Tables B.3 and
B.4). The results demonstrated that many C. elegans zinc transporters have similar
expression patterns to their mammalian counterparts but some have differences. Genetic
analysis identified new phenotypes of zinc transporter mutant animals, suggesting that
those zinc transporters may be involved in specific biological processes. This study
demonstrate that C. elegans is useful to study zinc transporter and zinc metabolism and
suggest novel functions of zinc and zinc transporters.

RESULTS AND DISCUSSION

Expression Pattern Analysis
Since the tissue distribution and intracellular localization of zinc transporters are
critical to understand their function in zinc metabolism, we performed expression pattern
analysis. To determine the cell types expressing zinc transporters and the intracellular
localization of zinc transporters, we generated transgenic animals expressing zinc
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transporters fused to GFP under the control of their predicted promoter region. Of the 9
target zinc transporters, we successfully expressed four of them in transgenic animals,
while one of them (C30H6.2) was made in multiple transgenic lines but its expression
was not detected. H13N06.5, which is the most close to mammalian ZIP-7, was mainly
expressed in the hypodermis and likely to be localized to the ER/Golgi (Figure B.1A).
F55F8.9, which is similar to mammalian ZIP-2, was expressed in the hypodermis and
highly in the intestine. F55F8.9 displayed cytoplasmic localization near apical membrane
of intestinal cells (Figure B.1B), suggesting that it may be localized to endosomal
vesicles. F59A3.4, which is C. elegans ortholog of mammalian ZIP-11 and close to the
yeast Zrt3, was expressed in the hypodermis, intestine and spermatheca and likely
localized to ER/Golgi (Figure B.1C). TOC-1, which is close to mammalian ZnT-6, was
expressed in the neurons, hypodermis and intestine. As TOC-1 displayed punctate
patterns in the cell, it is predicted to be localized to lysosomes (Figure B.1D). While
H13N06.5 and F55F8.9 displayed the intracellular localizations which are consistent
with their mammalian homologous proteins, F59A3.4 and TOC-1 displayed distinct
patterns. These results suggest that C. elegans zinc transporters have conserved functions
between species, but some of them may have C. elegans-specific unique functions.

Phenotype Analysis
To identify the physiological functions of zinc transporters, we analyzed mutant
animals containing loss-of-function mutations. We have requested the identification of
mutations in all C. elegans zinc transporters from the C. elegans knockout consortium.
To date, we have obtained at least one mutant allele in 8 zinc transporter genes (Table
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B.4). Of these, we tested the following strains: Y54G9A.4 (ok2094), F55F8.9 (ok2221),
C30H6.2 (ok745), T11F9.2 (ok875) and T28F3.3 (ok971). First, we tested whether these
mutant animals have phenotypes in zinc sensitivity. To determine zinc sensitivity, growth
rate of animals from L1 stage with different concentrations of supplemental zinc was
measured. All five strains tested displayed no significant difference from the wild
animals (Table B.4 and data not shown). These results suggest that these genes may not
be involved in the control of zinc toxicity or that there may be other genes functionally
redundant with them.
To investigate biological processes in which zinc transporters are involved, we
screened for phenotypes of mutant strains that are visibly noticeable based on growth,
morphology or behaviors. Y54G9A.4 (ok2094), C30H6.2 (ok745) and T11F9.2 (ok875)
displayed no phenotypes and appeared to be similar to wild type animals. F55F8.9
(ok2221) displayed scrawny body, slower growth rate, high larval lethality and smaller
brood size compared to wild type animals (Figure B.2A and data not shown). F55F8.9
(ok2221) also exhibited vulva positioning defects; while the vulva of wild type animals
was typically located in the middle of the body, its location in F55F8.9 (ok2221) was
slightly shifted to the posterior side (Figure B.2B). As vulval cell patterning are
controlled by the progeny of ventral hypodermal Pnp cells via the MAPK and Notch
signaling pathway (Sulston and Horvitz, 1977; Sundaram, 2004), these result suggest that
F55F8.9 zinc transporter may regulate those signaling pathways. In addition, a zebrafish
ZIP protein ZIP-6 is involved in cell migration process during gastrulation (Yamashita et
al., 2004), suggesting that F55F8.9 may function in the migration of ventral hypodermal
cells.
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F28F3.3 (ok971) strains were similar to wild type animals in growth rate and
morphology. However, F28F3.3 (ok971) strains displayed sterility phenotype with a
partial penetrance, and this phenotype was temperature sensitive. When eggs were
cultured at 15°C, ~92% (12/13) of them were sterile. At 20°C, ~54% (7/13) were sterile,
whereas none of the animals (0/12) were sterile at 25°C. While staying sterile, F28F3.3
(ok971) strains layed unfertilized oocytes (Figure B.3A), suggesting that the mutant
strains appear to have defects in the sperm formation or mating process, not in the oocyte
development. Consistently, while sterile F28F3.3 (ok971) strains displayed relatively
normal morphology of the gonad, their uterus appeared to be empty (Figure B.3B). To
examine whether F28F3.3 (ok971) strains have defects in the sperm formation, we mated
sterile F28F3.3 (ok971) mutant hermaphrodites with wild type males. After mating,
sterile F28F3.3 (ok971) hermaphrodites displayed wild type-like morphology of the
uterus full of eggs and became fertile (Figure B.3C). These results suggest that the sperm
development is likely to be defective in F28F3.3 (ok971) strains. As this sterility
phenotype is more severe at lower temperatures, it is possible that mutant sperm mobility
in the mutant is not as active as wild type so that increased mobility by high temperature
could rescue the phenotype.

MATERIALS AND METHODS

General Methods and Strains
C. elegans strains were cultured at 20°C on nematode growth medium (NGM) seeded
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with E. coli OP50 (Brenner, 1974). The wild-type C. elegans and parent of all mutant
strains was Bristol N2. The following mutations were used: Y54G9A.4 (ok2094),
F55F8.9 (ok2221), C30H6.2 (ok745), T11F9.2 (ok875), H13N06.5 (ok960), T28F3.3
(ok971), T01D3.5 (ok876). Before analyze the phenotypes, the following mutant animals
were backcrossed with N2 wild-type animals by standard methods, and the genotypes
were confirmed by PCR: Y54G9A.4 (ok2094) five times, F55F8.9 (ok2221) three times,
C30H6.2 (ok745) five times, and T28F3.3 (ok971) three times.

Transgenic Strain Construction
For the generation of GFP-fused zinc transporter constructs, I built plasmids with
pBluescript SK+ (Stratagene, Santa Clara, CA) by inserting the genomic fragment of
zinc transporter genes including promoter regions and coding sequence without the stop
codon, the coding sequence of GFP and the unc-54 3’UTR from pPD95.77 (a gift from A.
Fire). The genomic fragment of zinc transporter genes was amplified by PCR using the
primers listed in Table B.2 and fosmids as templates. To make mCherry-fused constructs,
the zinc transporter genomic regions were subcloned using enzyme digestion and ligation
from the GFP-fused plasmids into pSC3 which contains the coding sequence for
mCherry from pCJF104 (a gift from M. Nonet), and the unc-54 3’UTR. Transgenic
animals were generated by coinjecting each plasmid construct and the coinjection marker
pCJF104 (Pmyo-3::mCherry). All the plasmids and transgenic animals built are listed in
Table B.3.

Microscopy
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For differential interference contrast (DIC) and fluorescence microscopy, animals were
placed into a drop of 10mM levamisole in M9 on 2% agarose pads on microscope slides.
Images were captured using a Zeiss Axioplan 2 microscope equipped with a Zeiss
AxioCam MRm digital camera.

Zinc Sensitivity Assays
Eggs were isolated from gravid adult hermaphrodites by treating with NaOH and bleach
and were hatched in M9 overnight to obtain synchronized L1 animals. Animals were then
cultured on noble agar minimum medium (NAMM) dishes supplemented with zinc
sulfate (ZnSO4) and seeded with concentrated OP50. After about 3 days, growth rate was
determined by measuring length of animals cultured with different concentrations of zinc.

Brood Size Analysis
Ten hermaphrodite animals at L4 stages were individually cultured on NGM plates, and
transferred to new plates every 1-2 days until they stops laying eggs. When progenies
reached L3/L4 stage, the number of progenies was counted and the total progeny number
was determined as a brood size.
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FIGURE LEGENDS
Figure B.1
Fluorescence microscope images of transgenic animals expressing GFP-fused H13N06.5
(A), F55F8.9 (B), F59A3.4 (C), and TOC-1 (D). The type of cells and intracellular
organelles where each zinc transporter is localized are described on the right of the table.

Figure B.2
Phenotype analysis of F55F8.9 (ok2221) mutant strain. (A) Brood size analysis (B)
Vulva positioning defects. The wild type animal displays the vulva (arrow) in the middle
of the body (dotted line), whereas F55F8.9 (ok2221) strain displays the vulva (arrow)
which is shifted to the right, posterior, of the middle line (dotted line).

Figure B.3
Phenotype analysis of F28F3.3 (ok971) mutant strain. (A) A normal fertilized egg laid by
fertile F28F3.3 (ok971) (left, arrow head) and a string of unfertilized oocytes laid by
sterile F28F3.3 (ok971) (right, arrow). (B) DIC images of the reproductive tissue of a
sterile hermaphrodite. While the germline and the gonad appear to be normal, the uterus
(parenthesis) is empty. (C) A sterile hermaphrodite was mated with wild type males and
then became fertile. The uterus is full of eggs similar to wild type hermaphrodites
(parenthesis).

189

Table B.1

CDF family

ZIP family

C. elegans Gene

Human Ortholog

C. elegans Gene

cdf-1

ZnT-1, 10

Y54G9A.4
F55F8.9

cdf-2
ttm-1

Human Ortholog

ZnT-2,3,4,8

F30B5.7
ZIP-1,2,3

F19C6.5

C06G8.3

Y105E8A.3

ZnT-5,7

C18A3.2

toc-1

ZnT-6

F31C3.4

Y71H2AM.9

ZnT-9

C30H6.2

F41C6.7

T11F9.2

ZK185.5

Y55F3BL.2

K07G5.5

None

4,5,6,8,10,12,14

H13N06.5
ZIP-7

(Homologous to A.
PDB1.1

ZIP-

T28F3.3

thaliana AtMTPc3)

R02F11.3

T01D3.5

ZIP-9

F56C9.3

F59A3.4

ZIP-11

C14H10.1

ZIP-13

sur-7

None
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Table B.2

Gene
F55F8.9

C30H6.2

T11F9.2

H13N06.5

T28F3.3

T01D3.5

F59A3.4

toc-1

Forward Primer Sequence

Reverse Primer Sequence

ATA GGG CCC AGT CTG GTG ACT

TCG CCC GGG ATG TCC ATA

GCT TC

GTC ATC AAA AG

GGG GTA CCT GAA TCT CAT CGT

CCC CCC GGG GAT GTG AAA

TGC GGA

GCT ATA ATA

CGC AAG CTT CTG TGA AAT CTT

GCG ATA TCA AAG TCC ACA

ATA C

GAG TTC AC

GGG GTA CCT GAA CAT AGC CGC

CCC CCG GGC TCA TTG CTA

CTC GTT C

TTT ATG AG

CGG GTA CCG CAA TTC CTA AAT

GAG AAT TCC TCG ACC AAA

ACT TAC

CTG ACG

CCG GGT ACC GCC CTT ATA AAC

ATC CCG GGA TGA GAG TGA

TAT TC

CCA GAA G

GGG GTA CCT TCG GTC AAA TAT

CCG GAA TTC ACC CAA TCC

TTA GC

AAC ATC CAT G

ATA GGT ACC GAG AAC TAG ACG

CCG GAA TTC ATG ATA AAA

GAT ACG

AAC GCC GTC
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Table B.3

Human

GFP-fusion

mCherry-

Ortholog

plasmid

fusion plasmid

Y54G9A.4

ZIP-2

N/A

N/A

N/A

F55F8.9

ZIP-2

pSC4

pSC17

amEx128, amEx130

C30H6.2

ZIP-4

pSC2

pSC16

amEx125, amEx126

T11F9.2

ZIP-4

pSC13

pSC19

N/A

H13N06.5

ZIP-7

pSC1

pSC15

amEx123, amEx124

T28F3.3

ZIP-7

pSC14

pSC22

N/A

T01D3.5

ZIP-9

pSC12

pSC21

N/A

F59A3.4

ZIP-11

pSC11

pSC20

amEx134

toc-1

ZnT-6

pSC5

pSC18

amEx131

Gene
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Transgenic animals

Table B.4

Gene
Y54G9A.4

Human
Ortholog
ZIP-2

Mutant Alleles

Visible Phenotype

ok2094

None

Zinc
Sensitivity
WT-like

Slow growth, small brood
F55F8.9

ZIP-2

size, high larval lethality,

ok2221

WT-like

vulva positioning defects
C30H6.2

ZIP-4

None

WT-like

T11F9.2

ZIP-4

None

WT-like

H13N06.5

ZIP-7

ok960, gk256

N/A

N/A

T28F3.3

ZIP-7

ok971

Partial sterility

WT-like

T01D3.5

ZIP-9

ok876

N/A

N/A

F59A3.4

ZIP-11

N/A

N/A

N/A

toc-1

ZnT-6

tm4492

ok745, gk254
ok875, gk250,
gk251

embryonic lethal (clear
body color by RNAi)
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N/A

194

195

196

REFERENCES

Adlard, P.A., Parncutt, J.M., Finkelstein, D.I., and Bush, A.I. (2010). Cognitive loss in
zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory
deficits of Alzheimer's disease? J Neurosci 30, 1631-1636.
Andreini, C., Banci, L., Bertini, I., and Rosato, A. (2006). Counting the zinc-proteins
encoded in the human genome. J Proteome Res 5, 196-201.
Andrews, G.K., Wang, H., Dey, S.K., and Palmiter, R.D. (2004). Mouse zinc transporter
1 gene provides an essential function during early embryonic development.
Genesis 40, 74-81.
Aydemir, T.B., Liuzzi, J.P., McClellan, S., and Cousins, R.J. (2009). Zinc transporter
ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T
cells. J Leukoc Biol 86, 337-348.
Bailey, T.L., and Elkan, C. (1994). Fitting a mixture model by expectation maximization
to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2, 28-36.
Begum, N.A., Kobayashi, M., Moriwaki, Y., Matsumoto, M., Toyoshima, K., and Seya, T.
(2002). Mycobacterium bovis BCG cell wall and lipopolysaccharide induce a
novel gene, BIGM103, encoding a 7-TM protein: identification of a new protein
family having Zn-transporter and Zn-metalloprotease signatures. Genomics 80,
630-645.
Beighton, P., De Paepe, A., Steinmann, B., Tsipouras, P., and Wenstrup, R.J. (1998).
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos
National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med
Genet 77, 31-37.
Beitel, G.J., Clark, S.G., and Horvitz, H.R. (1990). Caenorhabditis elegans ras gene let60 acts as a switch in the pathway of vulval induction. Nature 348, 503-509.
Berg, J.M., and Shi, Y. (1996). The galvanization of biology: a growing appreciation for
the roles of zinc. Science 271, 1081-1085.
197

Beyersmann, D., and Haase, H. (2001). Functions of zinc in signaling, proliferation and
differentiation of mammalian cells. Biometals 14, 331-341.
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
Bruinsma, J.J., Jirakulaporn, T., Muslin, A.J., and Kornfeld, K. (2002). Zinc ions and
cation diffusion facilitator proteins regulate Ras-mediated signaling. Dev Cell 2,
567-578.
Bruinsma, J.J., Schneider, D.L., Davis, D.E., and Kornfeld, K. (2008). Identification of
mutations in Caenorhabditis elegans that cause resistance to high levels of dietary
zinc and analysis using a genomewide map of single nucleotide polymorphisms
scored by pyrosequencing. Genetics 179, 811-828.
Buecher, E.J., Jr., Hansen, E., and Yarwood, E.A. (1966). Ficoll activation of a protein
essential for maturation of the free-living nematode Caenorhabditis briggsae. Proc
Soc Exp Biol Med 121, 390-393.
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., and Prasher, D.C. (1994). Green
fluorescent protein as a marker for gene expression. Science 263, 802-805.
Chao, Y., and Fu, D. (2004). Kinetic study of the antiport mechanism of an Escherichia
coli zinc transporter, ZitB. J Biol Chem 279, 12043-12050.
Chausmer, A.B. (1998). Zinc, insulin and diabetes. J Am Coll Nutr 17, 109-115.
Chen, C.C., Schweinsberg, P.J., Vashist, S., Mareiniss, D.P., Lambie, E.J., and Grant, B.D.
(2006). RAB-10 is required for endocytic recycling in the Caenorhabditis elegans
intestine. Mol Biol Cell 17, 1286-1297.
Chimienti, F., Devergnas, S., Favier, A., and Seve, M. (2004). Identification and cloning
of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory
granules. Diabetes 53, 2330-2337.
Chimienti, F., Devergnas, S., Pattou, F., Schuit, F., Garcia-Cuenca, R., Vandewalle, B.,
Kerr-Conte, J., Van Lommel, L., Grunwald, D., Favier, A., et al. (2006). In vivo
expression and functional characterization of the zinc transporter ZnT8 in glucose-

198

induced insulin secretion. Journal of cell science 119, 4199-4206.
Chowanadisai, W., Kelleher, S.L., and Lonnerdal, B. (2005). Zinc deficiency is
associated with increased brain zinc import and LIV-1 expression and decreased
ZnT-1 expression in neonatal rats. J Nutr 135, 1002-1007.
Chowanadisai, W., Lonnerdal, B., and Kelleher, S.L. (2006). Identification of a mutation
in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in
transient neonatal zinc deficiency. J Biol Chem 281, 39699-39707.
Clokey, G.V., and Jacobson, L.A. (1986). The autofluorescent "lipofuscin granules" in the
intestinal cells of Caenorhabditis elegans are secondary lysosomes. Mech Ageing
Dev 35, 79-94.
Cole, T.B., Wenzel, H.J., Kafer, K.E., Schwartzkroin, P.A., and Palmiter, R.D. (1999).
Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption
of the ZnT3 gene. Proc Natl Acad Sci U S A 96, 1716-1721.
Costello, L.C., and Franklin, R.B. (2006). The clinical relevance of the metabolism of
prostate cancer; zinc and tumor suppression: connecting the dots. Molecular cancer
5, 17.
Coyle, P., Philcox, J.C., Carey, L.C., and Rofe, A.M. (2002). Metallothionein: the
multipurpose protein. Cell Mol Life Sci 59, 627-647.
Cragg, R.A., Christie, G.R., Phillips, S.R., Russi, R.M., Kury, S., Mathers, J.C., Taylor,
P.M., and Ford, D. (2002). A novel zinc-regulated human zinc transporter, hZTL1,
is localized to the enterocyte apical membrane. J Biol Chem 277, 22789-22797.
Cragg, R.A., Phillips, S.R., Piper, J.M., Varma, J.S., Campbell, F.C., Mathers, J.C., and
Ford, D. (2005). Homeostatic regulation of zinc transporters in the human small
intestine by dietary zinc supplementation. Gut 54, 469-478.
Cui, Y., McBride, S.J., Boyd, W.A., Alper, S., and Freedman, J.H. (2007a).
Toxicogenomic analysis of Caenorhabditis elegans reveals novel genes and
pathways involved in the resistance to cadmium toxicity. Genome Biol 8, R122.

199

Cui, Y., Vogt, S., Olson, N., Glass, A.G., and Rohan, T.E. (2007b). Levels of zinc,
selenium, calcium, and iron in benign breast tissue and risk of subsequent breast
cancer. Cancer Epidemiol Biomarkers Prev 16, 1682-1685.
Cummings, J.E., and Kovacic, J.P. (2009). The ubiquitous role of zinc in health and
disease. J Vet Emerg Crit Care (San Antonio) 19, 215-240.
Davis, D.E., Roh, H.C., Deshmukh, K., Bruinsma, J.J., Schneider, D.L., Guthrie, J.,
Robertson, J.D., and Kornfeld, K. (2009). The cation diffusion facilitator gene cdf2 mediates zinc metabolism in Caenorhabditis elegans. Genetics 182, 1015-1033.
Davis, S.R., and Cousins, R.J. (2000). Metallothionein expression in animals: a
physiological perspective on function. J Nutr 130, 1085-1088.
Docampo, R., de Souza, W., Miranda, K., Rohloff, P., and Moreno, S.N. (2005).
Acidocalcisomes - conserved from bacteria to man. Nat Rev Microbiol 3, 251-261.
Dong, J., Boyd, W.A., and Freedman, J.H. (2008a). Molecular characterization of two
homologs of the Caenorhabditis elegans cadmium-responsive gene cdr-1: cdr-4
and cdr-6. J Mol Biol 376, 621-633.
Dong, J., Robertson, J.D., Markesbery, W.R., and Lovell, M.A. (2008b). Serum zinc in
the progression of Alzheimer's disease. J Alzheimers Dis 15, 443-450.
Duerr, J.S. (2006). Immunohistochemistry. WormBook, 1-61.
Dufner-Beattie, J., Huang, Z.L., Geiser, J., Xu, W., and Andrews, G.K. (2006). Mouse
ZIP1 and ZIP3 genes together are essential for adaptation to dietary zinc
deficiency during pregnancy. Genesis 44, 239-251.
Dufner-Beattie, J., Kuo, Y.M., Gitschier, J., and Andrews, G.K. (2004). The adaptive
response to dietary zinc in mice involves the differential cellular localization and
zinc regulation of the zinc transporters ZIP4 and ZIP5. J Biol Chem 279, 4908249090.
Dufner-Beattie, J., Langmade, S.J., Wang, F., Eide, D., and Andrews, G.K. (2003).
Structure, function, and regulation of a subfamily of mouse zinc transporter genes.

200

J Biol Chem 278, 50142-50150.
Dufner-Beattie, J., Weaver, B.P., Geiser, J., Bilgen, M., Larson, M., Xu, W., and Andrews,
G.K. (2007). The mouse acrodermatitis enteropathica gene Slc39a4 (Zip4) is
essential for early development and heterozygosity causes hypersensitivity to zinc
deficiency. Hum Mol Genet 16, 1391-1399.
Eide, D.J. (2004). The SLC39 family of metal ion transporters. Pflugers Arch 447, 796800.
Eide, D.J. (2006). Zinc transporters and the cellular trafficking of zinc. Biochim Biophys
Acta 1763, 711-722.
Ellis, C.D., Macdiarmid, C.W., and Eide, D.J. (2005). Heteromeric protein complexes
mediate zinc transport into the secretory pathway of eukaryotic cells. J Biol Chem
280, 28811-28818.
Eng, B.H., Guerinot, M.L., Eide, D., and Saier, M.H., Jr. (1998). Sequence analyses and
phylogenetic characterization of the ZIP family of metal ion transport proteins. J
Membr Biol 166, 1-7.
Feeney, G.P., Zheng, D., Kille, P., and Hogstrand, C. (2005). The phylogeny of teleost
ZIP and ZnT zinc transporters and their tissue specific expression and response to
zinc in zebrafish. Biochim Biophys Acta 1732, 88-95.
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998).
Potent and specific genetic interference by double-stranded RNA in
Caenorhabditis elegans. Nature 391, 806-811.
Fosmire, G.J. (1990). Zinc toxicity. The American journal of clinical nutrition 51, 225227.
Frederickson, C.J., Koh, J.Y., and Bush, A.I. (2005). The neurobiology of zinc in health
and disease. Nature reviews 6, 449-462.
Frederickson, C.J., Maret, W., and Cuajungco, M.P. (2004). Zinc and excitotoxic brain
injury: a new model. Neuroscientist 10, 18-25.

201

Freedman, J.H., Slice, L.W., Dixon, D., Fire, A., and Rubin, C.S. (1993). The novel
metallothionein genes of Caenorhabditis elegans. Structural organization and
inducible, cell-specific expression. J Biol Chem 268, 2554-2564.
Fukada, T., Civic, N., Furuichi, T., Shimoda, S., Mishima, K., Higashiyama, H., Idaira, Y.,
Asada, Y., Kitamura, H., Yamasaki, S., et al. (2008). The zinc transporter
SLC39A13/ZIP13 is required for connective tissue development; its involvement
in BMP/TGF-beta signaling pathways. PLoS ONE 3, e3642.
Gaither, L.A., and Eide, D.J. (2001a). Eukaryotic zinc transporters and their regulation.
Biometals 14, 251-270.
Gaither, L.A., and Eide, D.J. (2001b). The human ZIP1 transporter mediates zinc uptake
in human K562 erythroleukemia cells. J Biol Chem 276, 22258-22264.
Gee, K.R., Zhou, Z.L., Ton-That, D., Sensi, S.L., and Weiss, J.H. (2002). Measuring zinc
in living cells. A new generation of sensitive and selective fluorescent probes. Cell
Calcium 31, 245-251.
Geraki, K., Farquharson, M.J., and Bradley, D.A. (2002). Concentrations of Fe, Cu and
Zn in breast tissue: a synchrotron XRF study. Phys Med Biol 47, 2327-2339.
Giblin, L.J., Chang, C.J., Bentley, A.F., Frederickson, C., Lippard, S.J., and Frederickson,
C.J. (2006). Zinc-secreting Paneth cells studied by ZP fluorescence. J Histochem
Cytochem 54, 311-316.
Giunta, C., Elcioglu, N.H., Albrecht, B., Eich, G., Chambaz, C., Janecke, A.R., Yeowell,
H., Weis, M., Eyre, D.R., Kraenzlin, M., et al. (2008). Spondylocheiro dysplastic
form of the Ehlers-Danlos syndrome--an autosomal-recessive entity caused by
mutations in the zinc transporter gene SLC39A13. American journal of human
genetics 82, 1290-1305.
Gourley, B.L., Parker, S.B., Jones, B.J., Zumbrennen, K.B., and Leibold, E.A. (2003).
Cytosolic aconitase and ferritin are regulated by iron in Caenorhabditis elegans. J
Biol Chem 278, 3227-3234.
Guerinot, M.L. (2000). The ZIP family of metal transporters. Biochim Biophys Acta

202

1465, 190-198.
Guffanti, A.A., Wei, Y., Rood, S.V., and Krulwich, T.A. (2002). An antiport mechanism
for a member of the cation diffusion facilitator family: divalent cations efflux in
exchange for K+ and H+. Mol Microbiol 45, 145-153.
Gunes, C., Heuchel, R., Georgiev, O., Muller, K.H., Lichtlen, P., Bluthmann, H., Marino,
S., Aguzzi, A., and Schaffner, W. (1998). Embryonic lethality and liver
degeneration in mice lacking the metal-responsive transcriptional activator MTF-1.
EMBO J 17, 2846-2854.
Hambidge, K.M., and Krebs, N.F. (2007). Zinc deficiency: a special challenge. J Nutr
137, 1101-1105.
Hambidge, M. (2000). Human zinc deficiency. J Nutr 130, 1344S-1349S.
Hantke, K. (2001). Bacterial zinc transporters and regulators. Biometals 14, 239-249.
Herbig, A., Bird, A.J., Swierczek, S., McCall, K., Mooney, M., Wu, C.Y., Winge, D.R.,
and Eide, D.J. (2005). Zap1 activation domain 1 and its role in controlling gene
expression in response to cellular zinc status. Mol Microbiol 57, 834-846.
Hermann, G.J., Schroeder, L.K., Hieb, C.A., Kershner, A.M., Rabbitts, B.M., Fonarev, P.,
Grant, B.D., and Priess, J.R. (2005). Genetic analysis of lysosomal trafficking in
Caenorhabditis elegans. Mol Biol Cell 16, 3273-3288.
Hieb, W.F., and Rothstein, M. (1968). Sterol requirement for reproduction of a free-living
nematode. Science 160, 778-780.
Hieb, W.F., Stokstad, E.L., and Rothstein, M. (1970). Heme requirement for reproduction
of a free-living nematode. Science 168, 143-144.
Ho, E., Quan, N., Tsai, Y.H., Lai, W., and Bray, T.M. (2001). Dietary zinc
supplementation inhibits NFkappaB activation and protects against chemically
induced diabetes in CD1 mice. Exp Biol Med (Maywood) 226, 103-111.
Horvitz, H.R., Chalfie, M., Trent, C., Sulston, J.E., and Evans, P.D. (1982). Serotonin
and octopamine in the nematode Caenorhabditis elegans. Science 216, 1012-1014.
203

Huang, L., and Gitschier, J. (1997). A novel gene involved in zinc transport is deficient in
the lethal milk mouse. Nat Genet 17, 292-297.
Huang, L., Yu, Y.Y., Kirschke, C.P., Gertz, E.R., and Lloyd, K.K. (2007). Znt7 (Slc30a7)deficient mice display reduced body zinc status and body fat accumulation. J Biol
Chem 282, 37053-37063.
Huffman, D.L., Abrami, L., Sasik, R., Corbeil, J., van der Goot, F.G., and Aroian, R.V.
(2004). Mitogen-activated protein kinase pathways defend against bacterial poreforming toxins. Proc Natl Acad Sci U S A 101, 10995-11000.
Jackson, K.A., Helston, R.M., McKay, J.A., O'Neill, E.D., Mathers, J.C., and Ford, D.
(2007). Splice variants of the human zinc transporter ZnT5 (SLC30A5) are
differentially localized and regulated by zinc through transcription and mRNA
stability. J Biol Chem 282, 10423-10431.
Kamath, R.S., Fraser, A.G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le
Bot, N., Moreno, S., Sohrmann, M., et al. (2003). Systematic functional analysis of
the Caenorhabditis elegans genome using RNAi. Nature 421, 231-237.
Kambe, T., Geiser, J., Lahner, B., Salt, D.E., and Andrews, G.K. (2008). Slc39a1 to 3
(subfamily II) Zip genes in mice have unique cell-specific functions during
adaptation to zinc deficiency. Am J Physiol Regul Integr Comp Physiol 294,
R1474-1481.
Kambe, T., Narita, H., Yamaguchi-Iwai, Y., Hirose, J., Amano, T., Sugiura, N., Sasaki, R.,
Mori, K., Iwanaga, T., and Nagao, M. (2002). Cloning and characterization of a
novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in
pancreatic beta cells. J Biol Chem 277, 19049-19055.
Kambe, T., Suzuki, T., Nagao, M., and Yamaguchi-Iwai, Y. (2006). Sequence similarity
and functional relationship among eukaryotic ZIP and CDF transporters. Genomics
Proteomics Bioinformatics 4, 1-9.
Kambe, T., Yamaguchi-Iwai, Y., Sasaki, R., and Nagao, M. (2004). Overview of
mammalian zinc transporters. Cell Mol Life Sci 61, 49-68.

204

Kawachi, M., Kobae, Y., Mimura, T., and Maeshima, M. (2008). Deletion of a histidinerich loop of AtMTP1, a vacuolar Zn(2+)/H(+) antiporter of Arabidopsis thaliana,
stimulates the transport activity. J Biol Chem 283, 8374-8383.
Kelleher, S.L., and Lonnerdal, B. (2003). Zn transporter levels and localization change
throughout lactation in rat mammary gland and are regulated by Zn in mammary
cells. J Nutr 133, 3378-3385.
Kemp, B.J., Church, D.L., Hatzold, J., Conradt, B., and Lambie, E.J. (2009). gem-1
Encodes an SLC16 Monocarboxylate Transporter-Related Protein That Functions
in Parallel to the gon-2 TRPM Channel During Gonad Development in
Caenorhabditis elegans. Genetics 181, 581-591.
Kirschke, C.P., and Huang, L. (2003). ZnT7, a novel mammalian zinc transporter,
accumulates zinc in the Golgi apparatus. J Biol Chem 278, 4096-4102.
Kitamura, H., Morikawa, H., Kamon, H., Iguchi, M., Hojyo, S., Fukada, T., Yamashita,
S., Kaisho, T., Akira, S., Murakami, M., et al. (2006). Toll-like receptor-mediated
regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 7,
971-977.
Klaassen, C.D., and Liu, J. (1998). Metallothionein transgenic and knock-out mouse
models in the study of cadmium toxicity. J Toxicol Sci 23 Suppl 2, 97-102.
Koh, J.Y., Suh, S.W., Gwag, B.J., He, Y.Y., Hsu, C.Y., and Choi, D.W. (1996). The role
of zinc in selective neuronal death after transient global cerebral ischemia. Science
272, 1013-1016.
Kostich, M., Fire, A., and Fambrough, D.M. (2000). Identification and molecular-genetic
characterization of a LAMP/CD68-like protein from Caenorhabditis elegans.
Journal of cell science 113 ( Pt 14), 2595-2606.
Krebs, N.E., and Hambidge, K.M. (2001). Zinc metabolism and homeostasis: the
application of tracer techniques to human zinc physiology. Biometals 14, 397-412.
Krebs, N.F. (2000). Overview of zinc absorption and excretion in the human
gastrointestinal tract. J Nutr 130, 1374S-1377S.

205

Kury, S., Dreno, B., Bezieau, S., Giraudet, S., Kharfi, M., Kamoun, R., and Moisan, J.P.
(2002). Identification of SLC39A4, a gene involved in acrodermatitis
enteropathica. Nat Genet 31, 239-240.
Langmade, S.J., Ravindra, R., Daniels, P.J., and Andrews, G.K. (2000). The transcription
factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem 275,
34803-34809.
Lemaire, K., Ravier, M.A., Schraenen, A., Creemers, J.W., Van de Plas, R., Granvik, M.,
Van Lommel, L., Waelkens, E., Chimienti, F., Rutter, G.A., et al. (2009). Insulin
crystallization depends on zinc transporter ZnT8 expression, but is not required for
normal glucose homeostasis in mice. Proc Natl Acad Sci U S A 106, 14872-14877.
Li, L., and Kaplan, J. (2001). The yeast gene MSC2, a member of the cation diffusion
facilitator family, affects the cellular distribution of zinc. J Biol Chem 276, 50365043.
Liang, J.Y., Liu, Y.Y., Zou, J., Franklin, R.B., Costello, L.C., and Feng, P. (1999).
Inhibitory effect of zinc on human prostatic carcinoma cell growth. The Prostate
40, 200-207.
Liao, V.H., and Freedman, J.H. (1998). Cadmium-regulated genes from the nematode
Caenorhabditis elegans. Identification and cloning of new cadmium-responsive
genes by differential display. J Biol Chem 273, 31962-31970.
Lichten, L.A., and Cousins, R.J. (2009). Mammalian zinc transporters: nutritional and
physiologic regulation. Annu Rev Nutr 29, 153-176.
Lichtlen, P., and Schaffner, W. (2001). The "metal transcription factor" MTF-1:
biological facts and medical implications. Swiss Med Wkly 131, 647-652.
Liuzzi, J.P., Blanchard, R.K., and Cousins, R.J. (2001). Differential regulation of zinc
transporter 1, 2, and 4 mRNA expression by dietary zinc in rats. J Nutr 131, 46-52.
Liuzzi, J.P., and Cousins, R.J. (2004). Mammalian zinc transporters. Annu Rev Nutr 24,
151-172.

206

Liuzzi, J.P., Lichten, L.A., Rivera, S., Blanchard, R.K., Aydemir, T.B., Knutson, M.D.,
Ganz, T., and Cousins, R.J. (2005). Interleukin-6 regulates the zinc transporter
Zip14 in liver and contributes to the hypozincemia of the acute-phase response.
Proc Natl Acad Sci U S A 102, 6843-6848.
Lu, M., and Fu, D. (2007). Structure of the zinc transporter YiiP. Science 317, 1746-1748.
Lu, N.C., and Goetsch, K.M. (1993). Carbohydrate requirement of Caenorhabditis
elegans and the final development of a chemically defined meduim. Nematologica
39, 303-311.
Lu, N.C., Hugenberg, G., Briggs, G.M., and Stokstad, E.L. (1978). The growth-promoting
activity of several lipid-related compounds in the free-living nematode
Caenorhabditis briggsae. Proc Soc Exp Biol Med 158, 187-191.
MacDiarmid, C.W., Gaither, L.A., and Eide, D. (2000). Zinc transporters that regulate
vacuolar zinc storage in Saccharomyces cerevisiae. Embo J 19, 2845-2855.
MacDiarmid, C.W., Milanick, M.A., and Eide, D.J. (2002). Biochemical properties of
vacuolar zinc transport systems of Saccharomyces cerevisiae. J Biol Chem 277,
39187-39194.
Maduro, M., and Pilgrim, D. (1995). Identification and cloning of unc-119, a gene
expressed in the Caenorhabditis elegans nervous system. Genetics 141, 977-988.
Manning, D.L., Daly, R.J., Lord, P.G., Kelly, K.F., and Green, C.D. (1988). Effects of
oestrogen on the expression of a 4.4 kb mRNA in the ZR-75-1 human breast
cancer cell line. Mol Cell Endocrinol 59, 205-212.
Maverakis, E., Fung, M.A., Lynch, P.J., Draznin, M., Michael, D.J., Ruben, B., and Fazel,
N. (2007). Acrodermatitis enteropathica and an overview of zinc metabolism.
Journal of the American Academy of Dermatology 56, 116-124.
McMahon, R.J., and Cousins, R.J. (1998). Regulation of the zinc transporter ZnT-1 by
dietary zinc. Proc Natl Acad Sci U S A 95, 4841-4846.
Mello, C.C., Kramer, J.M., Stinchcomb, D., and Ambros, V. (1991). Efficient gene

207

transfer in C.elegans: extrachromosomal maintenance and integration of
transforming sequences. Embo J 10, 3959-3970.
Moynahan, E.J. (1974). Letter: Acrodermatitis enteropathica: a lethal inherited human
zinc-deficiency disorder. Lancet 2, 399-400.
Munoz, M., Villar, I., and Garcia-Erce, J.A. (2009). An update on iron physiology. World
J Gastroenterol 15, 4617-4626.
Murakami, M., and Hirano, T. (2008). Intracellular zinc homeostasis and zinc signaling.
Cancer Sci 99, 1515-1522.
Murgia, C., Vespignani, I., Cerase, J., Nobili, F., and Perozzi, G. (1999). Cloning,
expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal
tissue and cells. Am J Physiol 277, G1231-1239.
Murphy, J.T., Bruinsma, J.J., Schneider, D.L., Collier, S., Guthrie, J., Chinwalla, A.,
Robertson, J.D., Mardis, E.R., and Kornfeld, K. (2011). Histidine Protects Against
Zinc and Nickel Toxicity in Caenorhabditis elegans. PLoS Genet 7, e1002013.
Nies, D.H. (2007). Biochemistry. How cells control zinc homeostasis. Science 317,
1695-1696.
Outten, C.E., and O'Halloran, T.V. (2001). Femtomolar sensitivity of metalloregulatory
proteins controlling zinc homeostasis. Science 292, 2488-2492.
Palmiter, R.D., Cole, T.B., and Findley, S.D. (1996a). ZnT-2, a mammalian protein that
confers resistance to zinc by facilitating vesicular sequestration. Embo J 15, 17841791.
Palmiter, R.D., Cole, T.B., Quaife, C.J., and Findley, S.D. (1996b). ZnT-3, a putative
transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A 93, 1493414939.
Palmiter, R.D., and Findley, S.D. (1995). Cloning and functional characterization of a
mammalian zinc transporter that confers resistance to zinc. Embo J 14, 639-649.
Palmiter, R.D., and Huang, L. (2004). Efflux and compartmentalization of zinc by
208

members of the SLC30 family of solute carriers. Pflugers Arch 447, 744-751.
Peters, J.L., Dufner-Beattie, J., Xu, W., Geiser, J., Lahner, B., Salt, D.E., and Andrews,
G.K. (2007). Targeting of the mouse Slc39a2 (Zip2) gene reveals highly cellspecific patterns of expression, and unique functions in zinc, iron, and calcium
homeostasis. Genesis 45, 339-352.
Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res 29, e45.
Praitis, V., Casey, E., Collar, D., and Austin, J. (2001). Creation of low-copy integrated
transgenic lines in Caenorhabditis elegans. Genetics 157, 1217-1226.
Prasad, A.S., Brewer, G.J., Schoomaker, E.B., and Rabbani, P. (1978). Hypocupremia
induced by zinc therapy in adults. JAMA 240, 2166-2168.
Pulak, R. (2006). Techniques for analysis, sorting, and dispensing of C. elegans on the
COPAS flow-sorting system. Methods Mol Biol 351, 275-286.
Rabbitts, B.M., Ciotti, M.K., Miller, N.E., Kramer, M., Lawrenson, A.L., Levitte, S.,
Kremer, S., Kwan, E., Weis, A.M., and Hermann, G.J. (2008). glo-3, a novel
Caenorhabditis elegans gene, is required for lysosome-related organelle biogenesis.
Genetics 180, 857-871.
Radtke, F., Heuchel, R., Georgiev, O., Hergersberg, M., Gariglio, M., Dembic, Z., and
Schaffner, W. (1993). Cloned transcription factor MTF-1 activates the mouse
metallothionein I promoter. Embo J 12, 1355-1362.
Rajagopal, A., Rao, A.U., Amigo, J., Tian, M., Upadhyay, S.K., Hall, C., Uhm, S.,
Mathew, M.K., Fleming, M.D., Paw, B.H., et al. (2008). Haem homeostasis is
regulated by the conserved and concerted functions of HRG-1 proteins. Nature 453,
1127-1131.
Riddle, D.L., Blumental, T., Meyer, B.J., and Preiss, J.R. (1997). C. elegans II (Cold
Spring Harbor, NY, Cold Spring Harbor Laboratory Press).
Rutter, G.A. (2010). Think zinc: New roles for zinc in the control of insulin secretion.

209

Islets 2, 49-50.
Schneider, J., Ruschhaupt, M., Buness, A., Asslaber, M., Regitnig, P., Zatloukal, K.,
Schippinger, W., Ploner, F., Poustka, A., and Sultmann, H. (2006). Identification
and meta-analysis of a small gene expression signature for the diagnosis of
estrogen receptor status in invasive ductal breast cancer. Int J Cancer 119, 29742979.
Schroeder, L.K., Kremer, S., Kramer, M.J., Currie, E., Kwan, E., Watts, J.L., Lawrenson,
A.L., and Hermann, G.J. (2007). Function of the Caenorhabditis elegans ABC
transporter PGP-2 in the biogenesis of a lysosome-related fat storage organelle.
Mol Biol Cell 18, 995-1008.
Setty, S.R., Tenza, D., Sviderskaya, E.V., Bennett, D.C., Raposo, G., and Marks, M.S.
(2008). Cell-specific ATP7A transport sustains copper-dependent tyrosinase
activity in melanosomes. Nature 454, 1142-1146.
Seve, M., Chimienti, F., Devergnas, S., and Favier, A. (2004). In silico identification and
expression of SLC30 family genes: an expressed sequence tag data mining strategy
for the characterization of zinc transporters' tissue expression. BMC Genomics 5,
32.
Sindreu, C., Palmiter, R.D., and Storm, D.R. (2011). Zinc transporter ZnT-3 regulates
presynaptic Erk1/2 signaling and hippocampus-dependent memory. Proc Natl Acad
Sci U S A 108, 3366-3370.
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D.,
Belisle, A., Hadjadj, S., et al. (2007). A genome-wide association study identifies
novel risk loci for type 2 diabetes. Nature 445, 881-885.
Smirnova, I.V., Bittel, D.C., Ravindra, R., Jiang, H., and Andrews, G.K. (2000). Zinc and
cadmium can promote rapid nuclear translocation of metal response elementbinding transcription factor-1. J Biol Chem 275, 9377-9384.
Stryer, L. (1995). Biochemistry, 4 edn (New York, W. H. Freeman and Company).
Sulston, J.E., and Horvitz, H.R. (1977). Post-embryonic cell lineages of the nematode,

210

Caenorhabditis elegans. Developmental biology 56, 110-156.
Sundaram, M.V. (2004). Vulval development: the battle between Ras and Notch. Curr
Biol 14, R311-313.
Szewczyk, N.J., Kozak, E., and Conley, C.A. (2003). Chemically defined medium and
Caenorhabditis elegans. BMC Biotechnol 3, 19.
Szewczyk, N.J., Udranszky, I.A., Kozak, E., Sunga, J., Kim, S.K., Jacobson, L.A., and
Conley, C.A. (2006). Delayed development and lifespan extension as features of
metabolic lifestyle alteration in C. elegans under dietary restriction. J Exp Biol 209,
4129-4139.
Tapiero, H., and Tew, K.D. (2003). Trace elements in human physiology and pathology:
zinc and metallothioneins. Biomed Pharmacother 57, 399-411.
Taubert, S., Hansen, M., Van Gilst, M.R., Cooper, S.B., and Yamamoto, K.R. (2008). The
Mediator subunit MDT-15 confers metabolic adaptation to ingested material. PLoS
Genet 4, e1000021.
Taylor, K.M., Morgan, H.E., Smart, K., Zahari, N.M., Pumford, S., Ellis, I.O., Robertson,
J.F., and Nicholson, R.I. (2007). The emerging role of the LIV-1 subfamily of zinc
transporters in breast cancer. Mol Med 13, 396-406.
Taylor, K.M., Vichova, P., Jordan, N., Hiscox, S., Hendley, R., and Nicholson, R.I.
(2008). ZIP7-mediated intracellular zinc transport contributes to aberrant growth
factor signaling in antihormone-resistant breast cancer Cells. Endocrinology 149,
4912-4920.
Terres-Martos, C., Navarro-Alarcon, M., Martin-Lagos, F., Lopez, G.d.l.S.H., PerezValero, V., and Lopez-Martinez, M.C. (1998). Serum zinc and copper
concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes. J Trace
Elem Med Biol 12, 44-49.
Treusch, S., Knuth, S., Slaugenhaupt, S.A., Goldin, E., Grant, B.D., and Fares, H. (2004).
Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is
required for lysosome biogenesis. Proc Natl Acad Sci U S A 101, 4483-4488.

211

Vallee, B.L., and Falchuk, K.H. (1993). The biochemical basis of zinc physiology.
Physiol Rev 73, 79-118.
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and
Speleman, F. (2002). Accurate normalization of real-time quantitative RT-PCR
data by geometric averaging of multiple internal control genes. Genome Biol 3,
RESEARCH0034.
Vatamaniuk, O.K., Bucher, E.A., Ward, J.T., and Rea, P.A. (2001). A new pathway for
heavy metal detoxification in animals. Phytochelatin synthase is required for
cadmium tolerance in Caenorhabditis elegans. J Biol Chem 276, 20817-20820.
Wang, F., Dufner-Beattie, J., Kim, B.E., Petris, M.J., Andrews, G., and Eide, D.J. (2004).
Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc
uptake transporters. J Biol Chem 279, 24631-24639.
Wang, K., Zhou, B., Kuo, Y.M., Zemansky, J., and Gitschier, J. (2002). A novel member
of a zinc transporter family is defective in acrodermatitis enteropathica. American
journal of human genetics 71, 66-73.
Wenzlau, J.M., Juhl, K., Yu, L., Moua, O., Sarkar, S.A., Gottlieb, P., Rewers, M.,
Eisenbarth, G.S., Jensen, J., Davidson, H.W., et al. (2007). The cation efflux
transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc
Natl Acad Sci U S A 104, 17040-17045.
Wimmer, U., Wang, Y., Georgiev, O., and Schaffner, W. (2005). Two major branches of
anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione.
Nucleic Acids Res 33, 5715-5727.
Wood, W.B. (1988). The Nematode Caenorhabditis elegans (Cold Spring Harbor, New
York, Cold Spring Harbor Laboratory Press).
Yamashita, S., Miyagi, C., Fukada, T., Kagara, N., Che, Y.S., and Hirano, T. (2004). Zinc
transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula
organizer. Nature 429, 298-302.
Yoder, J.H., Chong, H., Guan, K.L., and Han, M. (2004). Modulation of KSR activity in

212

Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase. Embo J
23, 111-119.
Zerial, M., and McBride, H. (2001). Rab proteins as membrane organizers. Nat Rev Mol
Cell Biol 2, 107-117.
Zhang, Y., Li, X., Grassme, H., Doring, G., and Gulbins, E. (2010). Alterations in
ceramide concentration and pH determine the release of reactive oxygen species by
Cftr-deficient macrophages on infection. J Immunol 184, 5104-5111.
Zhao, H., and Eide, D. (1996a). The yeast ZRT1 gene encodes the zinc transporter
protein of a high-affinity uptake system induced by zinc limitation. Proc Natl Acad
Sci U S A 93, 2454-2458.
Zhao, H., and Eide, D. (1996b). The ZRT2 gene encodes the low affinity zinc transporter
in Saccharomyces cerevisiae. J Biol Chem 271, 23203-23210.
Zhao, H., and Eide, D.J. (1997). Zap1p, a metalloregulatory protein involved in zincresponsive transcriptional regulation in Saccharomyces cerevisiae. Mol Cell Biol
17, 5044-5052.

213

